Archives

The Scoop on Pharmacy Burnout: Description and Management Strategies

Learning Objectives

 

After completing this application-based continuing education activity, pharmacists and pharmacy technicians will be able to

  • Describe burnout and its effects in the pharmacy
  • Discuss risk factors and possible causes of burnout in the pharmacy
  • Differentiate between different burnout subscales
  • Identify strategies to manage burnout

man knocked down by burnout

Release Date:

Release Date: February 20, 2025

Expiration Date: February 20, 2028

Course Fee

Pharmacist:  $7

Pharmacy Technician: $4

ACPE UANs

Pharmacist: 0009-0000-25-009-H04-P

Pharmacy Technician: 0009-0000-25-009-H04-T

Session Codes

Pharmacist: 22YC01-JXX46

Pharmacy Technician: 22YC01-XWK93

Accreditation Hours

2.0 hours of CE

Accreditation Statements

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit for the online activity ACPE UAN 0009-0000-25-009-H04-P/T  will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

 

Disclosure of Discussions of Off-label and Investigational Drug Use

The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Faculty

Yvonne Riley-Poku, PharmD
Medical Writer
Storrs, CT

Faculty Disclosure

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

Yvonne Riley-Poku, PharmD, has no relationship with an ineligible company and therefore has nothing to disclose.

ABSTRACT

Burnout is a response to prolonged work-related stress that has not been managed adequately. Although burnout is present in other professions, researchers have found it to be more prevalent in health services professions. In the pharmacy profession, increasing workload, staffing shortages, and hard-to meet company performance metrics are among the factors that contribute to burnout. The consequences of burnout in the pharmacy are substantial and range from low morale and employee turnover to serious dispensing errors. The onus for addressing burnout lies with employers and companies, although employees have a role to play as well. Several states are enacting new laws to address working conditions in pharmacies. Recently passed laws include mandating breaks for pharmacists, capping shift lengths, and disallowing excessive metrics.

CONTENT

Content

INTRODUCTION

Burnout is a response to prolonged work-related stress that can impair physical health and psychological wellbeing.1,2 Interest in burnout is growing. Employers and employees alike would like to understand burnout and determine a solution that will keep employees engaged and enthusiastic about work. For healthcare professionals and the pharmacy team to carry out their roles in improving the health of the population optimally, they must pay attention to their physical and psychological wellbeing. Consequences of burnout adversely affect both providers and patients in their care.

People who experience burnout feel emotional exhaustion, depersonalization, and reduced personal accomplishment.1 The Maslach Burnout Inventory (MBI) is the most widely used research measure on burnout.1 The Maslach Burnout Inventory Human Services Survey (MBI-HSS) is an assessment tool for burnout syndrome in human services occupations such as healthcare.1 Christina Maslach, a psychology professor at the University of California, Berkeley, is one of the pioneering researchers on burnout and its definition, predictors, and measurement.3 She is the architect of the Maslach Burnout Inventory and based on her work, the World Health Organization (WHO) included burnout as an occupational phenomenon in the International Classification of Diseases (ICD).3 Maslach and her colleagues’ initial research into burnout included surveys, interviews, and field observations of workers in human services professions such as health care, social services, mental health, criminal justice, and education. Their findings indicated that burnout could reduce the quality of care or service provided by the worker.1 Their findings also found a link between burnout and negative health outcomes for the worker such as headaches, muscle tension, hypertension, sleep disturbances, and cold and flu episodes.2 Burnout also seemed to be associated with personal dysfunction such as physical exhaustion, insomnia, increased use of substances, and poor interpersonal relationships.1

The Agency for Healthcare Research and Quality estimates that 30% to 50% of physicians, nurse practitioners, and physician assistants may be affected by burnout.4 Various professional organizations and studies have extensively reported on burnout in physicians. While more research is needed, researchers have conducted some studies to identify occupational burnout’s prevalence and risk factors in pharmacists and pharmacy technicians. These studies detail the existence of burnout among pharmacy staff.

Health care providers’ well-being impacts patient safety and patient care quality. It is essential that pharmacy team members understand burnout syndrome, and stakeholders in the profession must take steps to improve employee well-being.

Pause and Ponder: How would you describe the working conditions at your workplace?

Burnout Definition and Description

In the early 1970s, psychologist Herbert Freudenberger was one of the first to describe professional exhaustion and is credited with introducing the concept of burnout.4,5   Freudenberger did his burnout research observing staff working in a free medical clinic.4,5 After he completed his normal workday, he worked at a free clinic that he had helped organize during the Free Clinic Movement—a movement that involved healthcare providers in work that required almost endless effort and empathy. During these work shifts, he recognized the syndrome. He described burnout as putting a great deal of yourself into your work, with the staff and population you serve demanding this of you, while you also demand it of yourself. He further described it as eventually finding yourself in a state of exhaustion.5

Similar to Freudenberger’s description, the WHO defines burnout as a syndrome conceptualized as resulting from chronic workplace stress that has been poorly managed.6 Burnout can develop in employees such as healthcare professionals who work with other people in some capacity.1 Note that burnout is limited to work environments, an occupational hazard, if you will, and the ICD does not classify it as medical condition.6

Indicators of Burnout

Burnout has three subscales (scales used to obtain a rating or measurement that contributes to a rating or measurement on a larger scale). The terms that describe burnout’s three components may be familiar to pharmacists and technicians, but they have specific meaning when used to describe burnout. If pharmacists and technicians recognize how burnout presents, they will be better prepared to intervene early if they or their colleagues exhibit any of the feelings or attitudes described in the subscales.

The following are burnout’s subscales1:

  • Emotional exhaustion: Presents as feelings of energy depletion or exhaustion attributed to one’s work. As emotional resources are depleted, workers feel they are no longer able to give more of themselves on a psychological level.1 Other descriptions of emotional exhaustion are being worn out, having a loss of energy and enthusiasm for work, or feeling drained and fatigued.7
  • Depersonalization: Increased mental distance from one’s job, or feelings of negativity or cynicism related to one’s job. Other descriptions of this state are negative and cynical attitudes and feelings about one’s clients or negative, inappropriate, and irritable attitude toward clients.1 This perception of others may lead staff to view clients or patients as somehow deserving of their troubles.1
  • Decreased sense of personal accomplishment: Reduced professional efficacy, or feelings of reduced personal accomplishment. Workers may evaluate themselves negatively regarding their work and may also feel dissatisfied with their accomplishments on the job.1 Some words used to describe this condition include reduced productivity or capability, and low morale.

 

Table 1 describes studies and research on burnout in different pharmacy practice settings and their findings.

Table 1. Burnout Studies in Different Pharmacy Practice Settings8-12

Target Population Study Design and Description Result
Community pharmacists ·       Anonymous electronic surveys including the MBI-HSS and a work-factors-based questionnaire

·       To identify the prevalence and risk factors for occupational burnout in community pharmacists

74.9% of respondents reported burnout in at least one MBI-HSS subscale, most owing to emotional exhaustion (68.9%).
Health system pharmacists ·       Multi-center cross-sectional cohort survey study

·       Used MBI-HSS

·       To determine levels of, and risk factors for professional burnout among health system pharmacists

53.2% of study participants reported a high level in at least one MBI-HSS subscale.

 

8.5% of study participants had scores that indicated burnout on all 3 MBI-HSS subscales.

Clinical pharmacists in a hospital inpatient setting ·       Prospective, cross-sectional pilot study

·       Online survey

·       To characterize the level of and identify factors independently associated with burnout among clinical pharmacists practicing in an inpatient hospital setting within the United States

Low response rate. However, 61.2% of respondents reported burnout, largely driven by high emotional exhaustion.
Pharmacy residents ·       Electronic anonymous survey

·       To quantify burnout status of pharmacy residents and to correlate burnout to professional conduct and career outlook

74.4% burnout rate was reported among respondents.
Pharmacy technicians ·       Used MBI-HSS

·       To assess burnout among pharmacy technicians working in a hospital or health system setting

69.1% of respondents were experiencing burnout.
ABBREVIATIONS: MBI-HSS = Maslach Burnout Inventory-Human Services Survey

 

Risk Factors and Causes of Burnout

Across many occupations, common risk factors contribute to burnout. Table 2 describes those risk factors.

Table 2. Risk Factors for Burnout2

Risk Factor Description
Workload ·       Job demands exceeds human limits

·       Workload is unsustainable

·       No opportunity to recover from, or have a restful period after a particularly demanding event such as meeting a deadline or addressing a crisis resulting in acute fatigue

·       Prolonged overload becomes a chronic job condition leading to exhaustion

Control ·       Employees have no personal control in the workplace

·       Role conflict

·       Lack of opportunity to contribute to or participate in organizational decision-making

Reward ·       Insufficient reward be it financial, institutional, or social

·       Lack of recognition from managers, workers, and stakeholders devalues the work and leaves the worker with a sense of inefficacy

Community ·       The overall quality of social interaction at work and the ability to work as a team is inadequate.

·       Lack of a supportive and positive work environment

Fairness ·       Decisions at work are perceived as unfair or inequitable

·       Employees perceive an imbalance between their inputs (time, effort, expertise) and outputs (reward, recognition)

Values ·       A conflict exists between individual and organizational values

o   Values are the ideals or principles that originally draw people to a particular job.

·       Individual values unaligned with organizational goals could lead to burnout

Although employees in other professions experience burnout, workers in the human services professions such as healthcare, social services, mental health, criminal justice, and education are more prone to burnout.4 Workers in human services professions spend considerable amounts of time with other people. Their relationships often involve addressing a patient’s or a client’s health needs (medical, psychological, physical).1 Patients and clients have continuous health needs and challenges and frequently require ongoing, lengthy, or chronic support and care. In an effort to make a positive impact on the lives of others, healthcare workers can become overwhelmed.1 The nature of healthcare work coupled with stressful working conditions can be emotionally draining and lead to burnout.

Pharmacy professionals like other healthcare professionals are prone to burnout due to common risk factors and profession specific factors.

The following risk factors contribute to burnout among the pharmacy team4,10,13

  • Long professional work hours
  • Workload and inability to meet company specified performance metrics
  • Staffing shortages
  • Incompatibility between skills and actual daily tasks

Because the pharmacy profession is highly regulated, the pharmacy team must remain up to date with regulatory requirements.4 Everyone on the team must document extensively with no room for error. Attention to detail is a required skill for the pharmacy team because errors could lead to injury or potentially death.

An increasing workload, long working hours, and day-to-day tasks that may sometimes be incongruent with employees’ actual skills may lead to burnout at some point.4 A fear of retribution from speaking up about working conditions further exacerbates the risk of burnout.14

In a March 2021 NBC news story “Overworked, understaffed: Pharmacists say industry in crisis puts patient safety at risk” that aired, NBC news interviewed 31 retail pharmacists and technicians from 15 states.14 These pharmacists and technicians described extremely busy 12-hour shifts during which they were unable to take lunch or bathroom breaks. The interviewees further described crying in their cars after work and enduring sleepless nights from worrying about mistakes they may have made while working under such busy and rushed conditions.14 For a common daily scenario in a busy community pharmacy, see the SIDEBAR.

SIDEBAR: Does this busy community pharmacy sounds familiar?14

  • Long lines while short-staffed
  • Ringing phones
  • Busy drive-through
  • Weekly order that still needs to be put away on shelves
  • Patients waiting for vaccines

 

The story described working conditions in community pharmacies where pharmacists were being “pushed to do more with less.”14 Pharmacists described working faster to fill more orders, while juggling a wider range of tasks with fewer staff members at a rate that compromised patient safety.

A 2019 national pharmacist workforce study found two-thirds of pharmacists experienced increased workload in the past year. A high percentage of retail chain pharmacists in this survey rated their workloads as high or excessively high.15

Burnout rates among pharmacy employees may differ depending on practice setting.4 Community pharmacists report higher rates of burnout than employees in other practice settings like hospitals and independent pharmacies.9

Pause and Ponder: Do you dread your upcoming shift and live for your day off? Why or why not?

BURNOUT ASSESSMENT

Assessing burnout in the pharmacy profession is necessary for research and most importantly for interventions. With the MBI-HSS specifically, employers can design interventions to address the specific burnout subscale that their employees may report.1 Interventions addressing emotional exhaustion will differ from those addressing a reduced sense of personal accomplishment. Organizations or employers can focus strategies to address employee burnout.1 Finally, the assessment of burnout and the subsequent awareness that a problem exists can be the initial step in preventing or alleviating full blown job burnout.

The Maslach Burnout Inventory

The MBI is an assessment tool for the three components of burnout syndrome: emotional exhaustion, depersonalization, and a reduced sense of personal accomplishment.1 Although other measurements for burnout exist, the MBI is largely considered the gold standard for assessing burnout in a group of workers in a profession. The MBI is not an individual diagnostic instrument.1 This assessment tool was designed originally to measure burnout in human services professions such as healthcare, social work, and criminal justice.1 Maslach has since developed alternate forms of the MBI: the MBI-Educators Survey (MBI-ES) for the teaching profession, and the MBI-General Survey (MBI-GS) for other occupational groups.1 The MBI-HSS distinguishes burnout in health services occupations from burnout in other professions.1 This questionnaire is a self-administered tool and takes approximately 15 minutes to complete.1

The MBI is copyrighted.1 Researchers and individuals can purchase and administer it either as an online survey or as a paper and pencil survey.16 For the online surveys, score reports are generated online.16

The MBI is divided into three components, each of which includes personal statements that the respondent must rank.1 Examples of such personal statements are “I feel burned out from my work” and “I don’t really care what happens to some recipients.” MBI-HSS administrators score the items on the questionnaire on a seven-point scale. The scale ranges from a 0 response for “never,” to a 6 response for “every day.” Below are the three components1:

  • Emotional exhaustion – nine statements on this subscale assess “feelings of being emotionally overextended and exhausted by one’s work.”
  • Depersonalization – five statements on this subscale assesses an unfeeling and impersonal response the employee has towards their patients or clients.
  • Personal accomplishments – eight statements on this subscale assess “feelings of competence and achievements in one’s work with people.”

Each subscale is scored separately as low, average, or high using directions from the scoring key. There is not a total combined score. Respondents receive three separate scores—one score for each subscale. Receiving a score for each subscale benefits the assessment-taker because interventions to reduce burnout can be designed based on the specific component of burnout that needs to be addressed.1

For the emotional exhaustion and depersonalization subscales, a higher score corresponds to a higher degree of burnout. For the personal accomplishment subscale, however, a lower scale corresponds to a higher degree of burnout.1

The MBI has several drawbacks. Everyone has a different view of burnout and because the questionnaire is self-administered, respondents’ answers may be influenced by talking to other people such as friends and coworkers. For this reason, respondents should complete the MBI privately without knowing how other respondents are answering. The survey has also been labeled “MBI Human Services Survey” rather than “Maslach Burnout Inventory.” This reduces the chances of respondents linking the survey specifically to burnout; rather, the questionnaire’s title suggests it measures job-related attitudes and issues.1 Once all respondents have completed the survey, an open discussion of burnout is then appropriate. MBI administrators require no special qualifications. However, as a best practice, managers or supervisors should not administer the survey since this would affect how employees respond, i.e., employees may not be candid about their feelings.1

Although the MBI cannot be used as an individual diagnostic tool, it can be used as a self-assessment tool.1 Employees can compare their scores to those of others in their occupational group so they can recognize potential problems.1

ICD-11 Codes for Burnout

The ICD is the international standard for reporting diseases and health conditions and is the diagnostic classification standard for all clinical and research purposes.17 ICD-11 is the global standard for health data, clinical documentation, and statistical aggregation. It is scientifically up to date with multiple uses including use in primary care. The ICD defines diseases, disorders, injuries, and other related health conditions.17 The WHO maintains the ICD.17

The WHO’s 11th revision of the International Classification of Diseases (ICD-11) includes burnout, defining it as “a syndrome conceptualized as resulting from workplace stress that has not been successfully managed.”6 The previous revision, ICD-10, also included burnout. The definition in the 11th revision is now more detailed. According to this classification, burnout is work-related and does not apply to experiences in other areas of life.6

Alternative Measures to Assess Burnout

While experts consider the MBI to be the gold standard for burnout assessment, other measures exist that are not copyrighted, require no payment to use, and are publicly available.18

  • The Oldenburg Burnout Inventory – developed in Germany, this 16-item survey measures burnout in any occupational group. It covers two areas: exhaustion (physical, cognitive, and affective aspects) and disengagement from work (negative attitudes toward work objects, work content or work in general). It treats each burnout dimension separately.18
  • Single Item Burnout Measure – developed in the U.S., it measures burnout in any occupational group. The single question on the measure asks users to rate their burnout level based on their own definition of burnout. Users pick from five response options and receive scores that suggest no burnout symptoms, or one or more burnout symptoms.18
  • Copenhagen Burnout Inventory – developed in Denmark, this 19-item survey measures burnout in any occupational group and covers personal-, work-, and client-related burnout. It treats each burnout dimension separately.18

Recognizing Burnout’s Effects

Burnout influences quality of life and the team’s ability to perform optimally in their personal and professional capacities. In addition to negative health outcomes for employees such as muscle tension, headaches, sleep disturbances, hypertension, and cold and flu episodes,2 burnout’s consequences in the workplace include1,13,14,19

  • A decline in the quality of patient care
  • Dispensing errors
  • Low morale
  • Employee turnover
  • Missed days

 

Pause and Ponder: Do you feel rushed daily at work? How might that contribute to dispensing errors?

Dispensing Errors

We have described how an unsustainable workload is a risk factor for burnout (see Table 2). The costly effects of burnout include dispensing errors. Staff shortages, increasing workload, and long professional work hours contribute to dispensing errors in pharmacies.14,19 Community pharmacists and technicians, for example, work to fill prescriptions, give vaccinations, counsel patients, answer phones, tend to the drive-through and the register, and call insurance companies. They do all this while trying to meet their company’s specified performance metrics. The likelihood of a dispensing error is increased when working conditions in the pharmacy are rushed and chaotic.14,19

In 2006, in a comprehensive study of medication errors, the Institute of Medicine estimated that medication errors harmed at least 1.5 million Americans annually.20 Indirect costs of such errors include loss of productivity, emotional stress and suffering, and additional healthcare costs.20 A recent New York Times article tells the story of working conditions in pharmacies and metrics set by companies that pharmacists find hard to meet.19 The article reports several examples of dispensing errors. In one instance, an 85-year-old woman died after receiving the chemotherapy drug methotrexate instead of an antidepressant refill. Another patient went to the emergency room after receiving ear drops instead of eye drops, which caused eye swelling and burning. In another medication mix up, a patient received a blood pressure medication instead of her asthma medication, resulting in a pounding headache, nausea, and dizziness.19

Some states including Illinois and California are trying to change pharmacy practice. In Illinois, a new law requires pharmacists to have scheduled breaks. The state could also impose penalties on companies that do not provide a safe working environment.14 California’s new law requires that pharmacists not work alone.14 Changes from state boards of pharmacy could play an important role in improving the working conditions in pharmacies.

Employee Turnover

Employee turnover is the voluntary or involuntary loss of employees and the act of replacing them. Employees may leave their jobs voluntarily for many reasons including retirement or moving on to other opportunities. Others may leave due to lack of growth opportunities in their current roles, a hostile work environment, or a feeling of not fitting the company culture. Job-seekers and applicants view an unusually high turnover negatively, making turnover costly for employers. Companies must then put great efforts into recruiting, training, and onboarding. It also takes time for employers to train new employees adequately. Others may also view the company as having problems with their working conditions. Most importantly, high turnover diminishes productivity and the chance to build a cohesive team is lost.21

In 2004 in the U.S., researchers conducted a study to examine the relationship between organizational and individual factors, and pharmacists’ future work plans.13 The study sought to determine factors that contributed to pharmacists either leaving or staying with their current employer.13 Researchers in this cross-sectional study mailed surveys to licensed U.S. pharmacists. Respondents were asked to state whether they would leave or stay with their current employers during the next year. The researchers also asked respondents to rate their top five reasons for leaving or staying from a predetermined list. “Leavers” were those planning to leave their employer, and “stayers” were those planning to stay.

For leavers, 35% cited high stress levels as their exit reason, 31.1% cited excessive workload, and 25% cited poor salary or insufficient staffing.13

Stayers’ top reasons were good salary (50%), relationships with coworkers (46.6%), and good benefits (42%).13

Researchers also asked respondents to identify one main factor that influenced their decision to leave or to stay. A majority of these factors were under the employer’s control. Flexible schedules, ability to use skills, and salary/benefits influenced the stayers, while insufficient or unqualified staffing, poor scheduling and salary, and workload influenced the leavers.13

COVID-19 and Burnout in Healthcare Workers

In March 2020, the WHO declared the novel coronavirus disease (COVID-19) a global pandemic. COVID-19 is a highly contagious respiratory illness. As of January 4, 2022, COVID-19 had affected more than 54 million Americans and claimed the lives of more than 820,000.22 Factors such as preparedness for a pandemic, political leadership, availability of personal protective equipment (PPE), and the fear of infection and infecting others have played a role in the nation’s response to the pandemic. At the forefront of these crises were healthcare workers. The pandemic increased the levels of burnout among healthcare workers who have additionally had to witness patient suffering.

Before the pandemic, several studies across various pharmacy practice settings reported burnout among pharmacists. The 2019 national pharmacists’ workforce study reported 71% of practicing pharmacists characterizing their workload as either high or excessively high.15 During the COVID-19 pandemic however, studies showed that burnout has increased among healthcare workers, pharmacists included.23,24 Healthcare visits to hospitals and doctors’ offices are sometimes limited during the pandemic, however, community pharmacists are available for face-to face consults. While this is beneficial for patients, pharmacists and technicians face an increased risk of exposure to the virus. Additionally, pharmacists have had to take on new roles and responsibilities during the pandemic.25 The U.S. Department of Health and Human Services (DHS) authorized pharmacists to procure, dispense, and administer COVID-19 vaccines when they became available.25 DHS also authorized pharmacists to order and administer COVID-19 tests to aid in testing expansion in response to the COVID-19 pandemic.26

In the U.S., researchers studied the impact of COVID-19 on pharmacist workload, employment status, feelings of burnout, and overall emotional health.23 The Wisconsin Pharmacist Workforce Study was a cross-sectional study conducted before the COVID-19 vaccine was available but after the Department of Health and Human Services made the decision to permit pharmacists to administer it.23 Researchers focused on questions related to burnout domains and emotional health. For the reward domain, questions focused on changes in personal employment, while questions for the workload domain focused on exhaustion. Researchers used questions to measure depersonalization for the social interaction domain and developed questions about pharmacists’ social and emotional health. The study focused on the 2 largest pharmacist populations – community and hospital pharmacists – and had a 33% response rate. Study results are shown in Table 3.

Table 3. The Wisconsin Pharmacist Workforce Study Results23

Domain Questions Percentage of Community Pharmacists Reporting Percentage of Hospital Pharmacists Reporting
Hours Reduced 13 36
Hours Increased 19 8
Reduction in Wages 1 6
Temporary Furloughs 2 6
Concern About Being Furloughed or Losing Job 26 14
Increase in Workload or Work-Related responsibilities 41 42
Reduced interest in talking with patients 26 22
Social/emotional health Approximately 40% reported increased anxiety. Approximately 25% experienced increased sadness or depression.

 

The Wisconsin Pharmacist Workforce Study had imitations. Researchers only studied Wisconsin pharmacists, which makes generalization difficult. A non-response bias was also present; pharmacists with the highest workload would have had the least amount of time to respond to the survey. Despite these limitations, the study suggested that although pharmacists rose to the challenge during the pandemic, they experienced increased burnout as a result of COVID-19.23

Another study conducted across pharmacy practice settings in Australia to measure burnout in pharmacists during the coronavirus pandemic showed that burnout had increased.24 The study, an online survey, consisted of three parts. Researchers collected demographic information such as age, sex, primary practice area, and years of practice. They also used the MBI-HSS to measure burnout, and then asked questions pertaining to psychosocial issues. The questions focused on the pharmacists’ degree of concern for personal and family health, whether duties such as working overtime and workloads changed, and if precautionary measures in the workplace (e.g., PPE and infection control) were appropriate.24

Although only 17.8% of respondents reported caring for COVID-positive patients, an overwhelming 96.3% of pharmacists reported a change in their roles during the pandemic. These changes included increased workload (35.9%) and working overtime (52.2%). The pharmacists reported challenges they faced during the pandemic ranging from medication supply (40.9%) to patient incivility (24%). Regarding precautionary measures however, 71.1% of pharmacists reported that their workplace had sufficient precautionary measures.24

With regards to psychosocial factors, 36% of pharmacists were “very to extremely concerned” about their family’s health and 87.2% reported that their lives had been affected most by isolation from friends and family.24

With the arrival of the COVID-19 pandemic, pharmacy teams have been stretched even further with additional duties such as COVID- 19 testing, deep cleaning, and giving COVID vaccinations. COVID-19 has compounded burnout among the pharmacy team.

The federal government in the U.S. has not yet comprehensively tracked data on healthcare worker deaths, but according to “Lost on the Frontline,” a 12-month investigation by The Guardian, a British newspaper, and Kaiser Health News, more than 3600 healthcare workers in the U.S. died from the coronavirus disease in the pandemic’s first year.27

BURNOUT MANAGEMENT

The responsibility of addressing burnout among the pharmacy team does not only lie with employees but also with employers. In a study to assess burnout among pharmacy technicians working in a hospital or health-system settings in North Carolina, employees’ awareness of burnout resources at their institution was associated with lower odds of burnout, whether employees used those resources or not.11

Employers

The pharmacy profession as a whole must address burnout, and employers’ goals should be to identify and address factors that contribute to burnout.

Prevention strategies for burnout include2

  • Ensuring a sustainable workload at the workplace, while allowing for periods of rest and recovery
  • Encouraging active participation in organizational decision making
  • Providing appropriate rewards for employee achievement
  • Fostering a positive and supportive environment at the workplace
  • Promoting fairness, impartiality, or equity in decisions at work
  • Aligning employees’ personal expectations with the organization’s

Federal and State Legislation

Payment Reform

Pharmacists are generally only paid for filling prescriptions and do not bill for clinical services such as counseling and giving vaccinations. A proposed federal bill if passed, would grant pharmacists “provider status.” The Pharmacy and Medically Underserved Areas Enhancement Act (H.R. 2759/S.1362) was introduced in both the U.S. House of Representatives and the U.S. Senate in April 2021. This bill proposes pharmacist recognition as health care providers and allows compensation for their services to Medicare patients in medically underserved areas.28,29 With this status, pharmacists could bill insurers for clinical services for Medicare patients under Medicare Part B.28

At the state level, several states already assign some form of provider status to pharmacists. The National Alliance of State Pharmacy Associations (NASPA) identifies state provider status-related bills as those that apply to pharmacist scope of practice, payment for pharmacist provided patient care services, and/or the designation of pharmacists as providers. NASPA’s 2021 mid-year update on state provider status reports that in 18 states, 32 such bills have been signed into law. These laws include pharmacist immunization authority, broad prescriptive authority, contraceptive prescribing authority, and payment for services among others.30 In response to the NBC news story “Overworked, understaffed: Pharmacists say industry in crisis puts patient safety at risk,” the American Pharmacists Association (APhA), called for payment reform in pharmacy in a press release. 31 The APhA went on to say that the broken model of paying for the filling of prescriptions has led to a proliferation of productivity and efficiency metrics that have created a situation that compromises patient safety. The press release further stated that the APhA continues to fight for payment reform at both the federal and state levels.31

Burnout can occur when an incompatibility exists between employees’ skills and actual daily tasks. Giving pharmacists the opportunity to consult, provide, and bill for clinical services while spending less time in dispensing activities could be a remedy.13,31

Legislation

States like California, Illinois, and Virginia have passed new laws that will cap shift lengths for pharmacists. These laws also seek to ensure safe staffing levels and prohibit excessive metrics.14 According to the National Association of Boards of Pharmacy, about a third of all states now have some regulation that address working conditions in the pharmacy.14

Assessing Well-Being

Employees in other human services professions experience burnout as well, and it could be beneficial to look to other professions to see what initiatives they have in place to address burnout. The American Medical Association (AMA) for example, has a STEPS Forward program that seeks to prevent provider burnout.32 The program has interactive online educational modules with strategies to confront common challenges in a busy medical practice. The program is physician-developed and physicians can earn continuing medical education credit while learning about practice efficiency and patient care, patient health, physician health, and technology and innovation.32 Programs that improve resilience and well-being among employees might be beneficial to the pharmacy profession.

In an effort to address well-being, the APhA has launched the Well-Being Index, a validated screening tool invented by the Mayo Clinic, to help pharmacists assess their well-being.33 Respondents to the anonymous online survey that evaluates fatigue, depression, burnout, anxiety/stress, and mental/physical quality of life, receive immediate individualized feedback. This allows pharmacists to compare their well-being with their professional peers’ and directs them to tools and resources that can help promote well-being. Participants can also track their scores over time so they can be proactive in making self-care adjustments.33

Authors of a commentary on burnout syndrome among healthcare professionals suggest actions that pharmacy organizations can take to recognize and reduce burnout among their employees. These include4

  • Establishing a panel to evaluate burnout in the profession of pharmacy
  • Conducting further research into the prevalence prevention and effectiveness of treatment strategies of burnout across all practice settings of pharmacy
  • Incorporating strategies that promote mental health wellness and resiliency into pharmacists’ training.

Employees

“You can’t pour from an empty cup” - Unknown

Employees can adopt strategies to guard against burnout. The following strategies guard against burnout and promote wellbeing in the employee.

  • Continue to speak up about workplace conditions that affect patient safety and employee well-being.
  • Adopt self-care habits and foster hobbies outside of work. Ensure adequate sleep, nutrition, and exercise.
  • Be sure to take your vacation time or paid time off to recharge.
  • Foster a supportive and positive work environment by communicating and collaborating with teammates.
  • Keep up with continuing education and join a professional pharmacy organization. This enhances self-esteem and promotes a sense of purpose.

CONCLUSION

The importance of high-quality healthcare cannot be stressed enough. Healthcare professionals including pharmacists and pharmacy technicians play an important role in improving the overall population’s health. Clearly, burnout’s consequences among pharmacy workers could be detrimental for employees, patients, organizations, and society as a whole. It is important to recognize the indicators and risk factors for burnout to be able to address them and improve health care provider well-being. Employers and institutions must implement strategies to combat burnout in their employees. Some state boards of pharmacy are beginning to make changes and institute new laws that will cater to appropriate work environments and employee well-being.

 

Pharmacist & Pharmacy Technician Post Test (for viewing only)

1. Which of the following measures assesses burnout among pharmacy professionals?

A. The Maslach Burnout Inventory
B. DSM-V
C. ICD-11 diagnostic guidelines for anxiety

2. Turnover resulting from burnout in the pharmacy profession can be described as

A. Employees tend to retire immediately after reaching retirement age
B. Employees leave because they don’t fit in with the work culture
C. Employee with good salary/benefits leave due to relocation of spouse’s job

3. Which of the following is a risk factor for burnout among pharmacy professionals?

A. Employees receive hardly any raises or recognition after favorable end-of-year performance reviews
B. Employee is included from decision making in the workplace
C. Employees find the level of social interaction and collaboration at work adequate

4. Which of the following scenarios is a risk factor for burnout among pharmacy professionals?

A. During the COVID-19 pandemic, some pharmacies hired additional staff to help administer covid shots
B. During the COVID-19 pandemic, some pharmacy staff worked overtime, while administering COVID-tests, and consulting face-to-face with patients
C. An extremely busy pharmacy has qualified staffing and flexible scheduling for their employees

5. XY has been a pharmacy technician for 5 years and works at a busy community pharmacy. XY often feels overwhelmed, stressed, and burdened by keeping up with prescription numbers, prior authorizations and patients’ health needs and challenges. What is XY experiencing?

A. Depersonalization
B. Emotional exhaustion
C. A decreased sense of personal accomplishment

6. XY usually lies awake at night dreading the next shift. Pharmacy practice now feels like a chore and XY finds patients at drop-off and pick-up very irritating. What is XY experiencing?

A. Depersonalization
B. Emotional exhaustion
C. A decreased sense of personal accomplishment
7. XY now finds pharmacy practice unmotivating and often questions having accomplished anything worthwhile, or having had a positive impact on patients. What is XY experiencing?

A. Depersonalization
B. Emotional exhaustion
C. A decreased sense of personal accomplishment

8. Which of the following would be considered a good strategy to combat burnout among the pharmacy team?

A. States must mandate more continuing education requirements for pharmacy technicians
B. Employees must seek medications from their healthcare providers

C. States should pass laws that place caps on pharmacy shift lengths and reduce excessive performance metrics

9. Which of the following is best practice for the employee to prevent full blown burnout?

A. Limit hobbies outside of work as they are distracting and hinders job focus
B. Limit communication and collaboration with team mates to help avoid dispensing errors
C. Use vacation times or restful periods to recharge and avoid fatigue

10. Coworker relationships at XY’s workplace are somewhat cordial. XY however feels blind-sided by recent company decisions about technician break times. What is the BEST way for XY’s employer to ensure that XY avoids burnout?

A. Pharmacy technicians understand that management usually makes workplace decisions without employee input.
B. Pharmacy technicians have more continuing education hour requirements within the organization
C. Pharmacy technicians must be actively involved in making certain workplace decisions

References

Full List of References

References

  1. Maslach C, Jackson S, Leiter M. Maslach burnout inventory manual. 3rd Consulting Psychologists Press; 1996.
  2. Maslach C, Leiter MP. Early predictors of job burnout and engagement. J Appl Psychol. 2008;93:498-512.
  3. Berkeley University of California. Psychology. Christina Maslach. Accessed January 3, 2022. https://psychology.berkeley.edu/people/christina-maslach
  4. Bridgeman PJ, Bridgeman MB, Barone, J. Burnout syndrome among healthcare professionals. Am J Health-Syst Pharm. 2018;75:147-152.
  5. Fontes, F. Herbert J. Freudenberger and the making of burnout as a psychopathological syndrome. Accessed January 3, 2022. https://www.researchgate.net/publication/346586006_
  6. World Health Organization. Burn-out an “occupational phenomenon”: International classification of diseases. May 28, 2019. Accessed January 3, 2022.

https://www.who.int/news/item/28-05-2019-burn-out-an-occupational-phenomenon-international-classification-of-diseases

  1. Shrijver I. Pathology in the medical profession? Taking the pulse of physician wellness and burnout. Arch Pathol Lab Med. 2016;140:976-982.
  2. Durham ME, Bush PW, Ball AM. Evidence of burnout in health-system pharmacists. Am J Health-Syst Pharm. 2018;75:S93-S100.
  3. Patel SK, Kelm MJ, Lee HJ, et al. Prevalence and risk factors of burnout in community pharmacists. J Am Pharm Assoc. 2021;61:145-150.
  4. Jones GM, Roe NA, Louden L, Tubbs C. Factors associated with burnout among US hospital clinical practitioners: Results of a nationwide pilot study. Hosp Pharm. 2017;52:742-751.
  5. Kang K, Absher R, Granko RP. Evaluation of burnout among hospital and health-system pharmacy technicians in North Carolina. Am J Health Syst Pharm. 2020;77(24):2041-2042.
  6. Gonzalez J, Brunetti L. Assessment of burnout among postgraduate pharmacy residents: A pilot study. Curr Pharm Teach Learn. 2021;13(1):42-48.
  7. Gaither CA, Nadkarni A, Mott DA, et al. Should I stay or should I go? The influence of individual and organizational factors on pharmacists’ future work plans. J Am Pharm Assoc. 2007;47:165-173.
  8. Kaplan A, Nguyen V, Godie M. Overworked, understaffed: Pharmacists say industry in crisis puts patient safety at risk. NBC News. March 16, 2021. Accessed January 3, 2022.

https://www.nbcnews.com/health/health-care/overworked-understaffed-pharmacists-say-industry-crisis-puts-patient-safety-risk-n1261151

  1. American Association of Colleges of Pharmacy. National pharmacist workforce studies. Accessed January 3, 2022. https://www.aacp.org/article/national-pharmacist-workforce-studies

 

  1. Mind Garden. MBI: Human Services Survey. Accessed January 3, 2022.

https://www.mindgarden.com/314-mbi-human-services-survey

  1. World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD). Accessed at https://www.who.int/standards/classifications/classification-of-diseases, January 3, 2022.
  2. National Academy of Medicine. Valid and reliable survey instruments to measure burnout, well-being, and other work-related dimensions. Accessed January 3, 2022. https://nam.edu/valid-reliable-survey-instruments-measure-burnout-well-work-related-dimensions/
  3. Gabler E. How chaos at chain pharmacies is putting patients at risk. New York Times. January 31, 2020. Accessed January 3, 2022.

https://www.nytimes.com/2020/01/31/health/pharmacists-medication-errors.html

  1. Eastman, P. IOM Report. Medication errors injure millions. Emergency Medicine News. 2006;28(9):44-46.
  2. Dik, B. Staff attrition vs staff turnover: What’s the difference? March 28, 2018. Accessed at https://jobzology.com/staff-attrition-vs-staff-turnover-whats-the-difference/, June 22, 2021.
  3. Centers for Disease Control and Prevention. Covid data tracker. Accessed January 3, 2022. https:// COVID.cdc.gov/ COVID-data-tracker/#datatracker-home
  4. Bakken BK, Winn AN. Clinician burnout during the COVID-19 pandemic before vaccine administration. J Am Pharm Assoc. 2021;S1544-3191(21)00164-3. doi:10.1016/j.japh.2021.04.009
  5. Johnston K, O'Reilly CL, Scholz B, et al. Burnout and the challenges facing pharmacists during COVID-19: results of a national survey. Int J Clin Pharm. 2021;1-10.
  6. S. Department of Health and Human Services. Trump administration takes action to expand access to COVID-19 vaccines. Accessed June 20,2021. https://www.hhs.gov/about/news/2020/09/09trump-administration-takes-action-to-expand-access-to- COVID-19-vaccines.html
  7. S. Department of Health and Human Services. Guidance for licensed pharmacists, COVID-19 testing, and immunity under the PREP Act. April 8, 2020. Accessed January 3, 2022. https://www.hhs.gov/guidance/sites/default/files/hhs-guidance-documents/authorizing-licensed-pharmacists-to-order-and-administer-covid-19-tests.pdf
  8. Spencer J. KHN. Lost on the frontline. 12 months of trauma: More than 3600 US health workers died in Covid’s first year. April 8, 2021. Accessed January 3, 2022. https://khn.org/news/article/us-health-workers-deaths- COVID-lost-on-the-frontline/
  9. Press Release. Pharmacy associations applaud introduction of bill expanding Medicare patients’ access to pharmacist services. April 21, 2021. Accessed at Accessed January 3, 2022. https://www.ashp.org/News/2021/04/22/ASHP-APHA-Applaud-Introduction-of-Bill-Expanding-Medicare-Patients-Access-to-Pharmacist-Services
  10. APhA Action Center. Provider status for pharmacists.  Accessed January 3, 2022. ttps://actioncenter.pharmacist.com/campaign/provider-status-for-pharmacists/, September 10, 2021.
  11. News. 2021 State provider status mid-year legislative update. June 7, 2021. Accessed January 3, 2022.  https://naspa.us/2021/06/2021-state-provider-status-mid-year-legislative-update/
  12. Chinthamalla K. APhA: NBC news story illustrates the need for fundamental pharmacy payment reform. APhA Press Releases. March 17, 2021. Accessed at Accessed January 3, 2022. https://www.pharmacist.com/About/Newsroom/apha-nbc-news-story-illustrates-the-need-for-fundamental-pharmacy-payment-reform
  13. Mills, RJ. AMA launches Steps Forward to address physician burnout. AMA Press Releases. June 8, 2015. Accessed January 3, 2022. https://www.ama-assn.org/press-center/press-releases/ama-launches-steps-forward-address-physician-burnout
  14. Well-Being Index. Pharmacist Well-Being Index. Accessed January 3, 2022. https://www.mywellbeingindex.org/versions/pharmacist-well-being-index

Are You Curious about Pharmacoeconomics?

Learning Objectives

  After completing this application-based continuing education activity, pharmacists will be able to
  • Define common pharmacoeconomic terms used for economic evaluations.
  • Recall the advantages of pharmacoeconomic analysis for formulary management.
  • Compare and contrast different types of pharmacoeconomic analyses.
  • List the pharmacoeconomic tools a pharmacy benefit manager uses to lower drug costs.
After completing this application-based continuing education activity, pharmacy technicians will be able to:
  • Define common pharmacoeconomic terms used for economic evaluations.
  • Recall the advantages of pharmacoeconomic analysis for formulary management.
  • Compare and contrast different types of pharmacoeconomic analyses.
  • List the pharmacoeconomic tools a pharmacy benefit manager uses to lower drug costs.

Person wearing a white coat surrounded by one dollar bills holding two vials marked with dollar signs

 

Release Date:

Release Date:  February 15, 2025

Expiration Date: February 15, 2028

Course Fee

Pharmacist $7

Pharmacy Technician $4

There is no funding for this CPE activity.

ACPE UANs

Pharmacist: 0009-0000-25-003-H04-P

Pharmacy Technician: 0009-0000-25-003-H04-T

Session Codes

Pharmacist: 25YC03-QPL37

Pharmacy Technician: 25YC03-LPQ73

Accreditation Hours

2.0 hours of CE

Accreditation Statements

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit for the online activity ACPE UAN 0009-0000-25-003-H04-P/T  will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

 

Disclosure of Discussions of Off-label and Investigational Drug Use

The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Faculty

Peter Gordinier Jr.
2025 PharmD Candidate
UConn School of Pharmacy
Storrs, CT

Jack Vinciguerra, PharmD.
Freelance Medical Writer
East Hartford, CT

Jeannette Y. Wick, RPh, FBA, FASCP
Director, Office of Pharmacy Professional Development
UConn School of Pharmacy
Storrs, CT


 

Faculty Disclosure

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

Dr. Vinciguerra, Mr. Gordinier Jr., and Ms. Wick have no financial relationships with ineligible companies.

ABSTRACT

Many pharmacy practitioners have heard of pharmacoeconomics, but don't have a clear understanding of what that term means. This field of study has a unique vocabulary associated with it and compares different aspects of drugs to determine which drug will produce the best clinical and economic outcomes. Many Pharmacy and Therapeutics Committees are now requiring pharmacoeconomic analysis when they consider formulary changes, but these analysis come in several different forms. Depending on the type and quantity of information available, people preparing reports for Pharmacy and Therapeutics Committee meetings will need to decide which model or studies to use. The foundation for several of the models is quality adjusted life years or QALYs, which have advantages and limitations.  Pharmacy benefit managers use cost control tools and pharmacoeconomic analysis to control costs. Some tools that they may use are negotiated price, generic substitution, rebates, and patient copayments. Not all pharmacoeconomic studies are perfect, and this continuing education activity points out some of the ways in which they may be flawed.

CONTENT

Content

INTRODUCTION

Let’s start with an old joke. An economics student once asked her professor how much his shoes cost. The professor responded with “I don’t know, I haven’t finished wearing them yet.” Drugs are just like shoes because their sticker price does not reflect their true cost or value.

 

PHARMACOECONOMICS BACKGROUND

The term pharmacoeconomics dates back to 1986.1 Dr. Raymond Townsend used the term in a presentation for pharmacists in Canada.2 Dr. Townsend earned his PharmD at the University of California, San Francisco and developed the pharmacoeconomic research department at the Upjohn Company.3 The Upjohn team developed pharmacoeconomics to address payment concerns as the healthcare system transitioned from a cash-based system to a third-party payer system. Its goal was to ensure drug spending was efficient and effective.4 Pharmacoeconomics has evolved over the ensuing 30-plus years to become a subbranch of economics.

 

Pharmacoeconomics compares different aspects of drugs to determine which drug will produce the best clinical and economic outcomes.1 Pharmacists who work for pharmacy benefits managers (PBMs) or prepare for Pharmacy and Therapeutics (P&T) committee meetings are most likely to use pharmacoeconomic tools. But all healthcare personnel should understand pharmacoeconomics so they can use these tools as part of their efforts to optimize patient care or explain how health systems select medications to include on a formulary.

 

While these tools are useful, many pharmacists will avoid using pharmacoeconomics. In preparing to write this continuing education activity (CE), we asked faculty from two Schools of Pharmacy to identify pharmacoeconomic studies that have had significant clinical impact. One university pharmacy professor said, “Most pharmacoeconomics studies are ignored in clinical practice because practitioners don’t understand them or use other reasons to select a drug.” This CE activity should address both of those barriers—lack of understanding and the other considerations when selecting drugs.

 

MEET GEORGE

In this CE, George will join you. George just graduated from pharmacy school. He was hired at Man with the Yellow Hat Hospital and was put in charge of a presentation for the P&T Committee meeting. George is tasked with presenting a proposal to add a new drug, Monkeydex, to the formulary. If the Committee adds Monkeydex, he also needs to make a recommendation about the similar drug that is already on the formulary, Curiosan: should it remain on the formulary or be removed? The U.S. Food and Drug Administration (FDA) has approved both drugs for adventure-induced curiosity overload (AICO). Ted, another pharmacist, suggested George use pharmacoeconomic tools to analyze each drug’s effectiveness and cost.

 

PAUSE AND PONDER: Before reading further, write down as many pharmacoeconomic terms as you can!

 

Common Pharmacoeconomic Terms

George figured that common pharmacoeconomic terms are the best spot to begin his learning. George found these terms most helpful 5,6:

 

  • Comparators: the interventions being compared (and it’s possible to have two or more comparators)
  • Costs
    • Direct costs: paid by the health system (salary costs, drug acquisition costs)
    • Indirect costs: experienced by the patient (including decreased productivity, loss of earnings, hospital travel costs)
    • Intangible costs: costs of patient/family’s feelings (worry, distress)
  • Economic evaluation: comparing two different interventions and assessing their costs and outcomes
  • Opportunity cost: the loss of benefit from the option not chosen; for example, if you decide to spend two hours on a Friday night paying bills, the opportunity cost is that you cannot spend two hours pursuing leisure activities
  • Outcomes: the expected results from an intervention
  • Perspective: the different viewpoint from which an intervention can be assessed (patient, provider, payor, or just a population in general)
  • Target population: the group of patients who will benefit from the intervention
  • Willingness to pay: the maximum amount an individual, a system, an organization, or a payor will pay for an intervention

 

George compared the two interventions (Curiosan vs. Monkeydex) in Table 1. George used the new terms he learned.

 

PAUSE AND PONDER: Why is it necessary for a health system to consider indirect and intangible costs when entertaining the possibility of adding a medication to the formulary?

 

Table 1. George’s Use of Pharmacoeconomic Terms to Compare Two Interventions

Term Intervention Comparison
Economic Evaluation George will compare Curiosan vs. Monkeydex with the terms provided below
Target Population Curiosan: Treatment of AICO

Monkeydex: Treatment of AICO

Comparators Curiosan and Monkeydex
Opportunity Cost The hospital won’t be able to benefit from the drug not chosen
Outcomes Curiosan Pivotal Trial

-       Participants: 400 Patients aged 18-40 with AICO

-       Endpoints: reduction of AICO events per year

-       Results: patients experienced a 55% reduction in AICO events over a year

-       Adverse Effects: 15% of patients reported minor adverse effects from the drug such as nausea, infusion site pain, and light headedness

 

Monkeydex Pivotal Trial

-       Participants: 650 Patients aged 25-45 with AICO

-       Endpoints: reduction of AICO events per year

-       Results: patients experienced a 45% reduction in AICO events over a year

-       Adverse Effects: 20% of patients reported minor adverse effects such as headaches, constipation, and mild weight gain

Willingness to Pay The hospital is willing to pay up to $4500 for either medication
Perspective Each intervention will be assessed from the hospital’s viewpoint
Direct Costs Curiosan (TOTAL - $3900)

-       Administration - infusion once a month for six months ($400/month) plus each infusion costs $100 in medical service fees

-       Monitoring - monthly blood tests ($100)

-       Adverse Effect Treatment - requires OTC products ($50/month)

 

Monkeydex (TOTAL - $4200)

-       Administration - oral tablet taken once daily for twelve months ($300/month)

-       Monitoring - monthly blood tests ($25)

-       Adverse Effect Treatment - requires OTC products ($25/month)

Indirect Costs Curiosan

-       Patients may lose productivity time due to travel to the infusion center and medication administration times (~2-3 hour/day)

-       Transportation costs for gas (~$10 each visit)

 

Monkeydex

-       Patients may lose productivity time due to adverse effects of drug interrupting the day (~1 hour/day)

-       Hospital offers free mail deliver for Monkeydex

Intangible Costs Curiosan

-       Patients may feel stressed about injections and possible adverse effects

-       Monthly infusions can take a toll on a patient’s life and having to take off work for monthly injections can be stressful

-       After six months the patient will be cured

 

Monkeydex

-       Patients may feel calmer when taking a tablet

-       Patient receives the medication monthly and does not need to make any appointments

-       Patient needs to be on the medication for one year and they will be cured

ABBREVIATIONS: AICO = Adventure-Induced Curiosity Overload

 

 

ADVANTAGE OF PHARMACOECONOMIC TOOLS FOR FORMULARY DECISIONS

George learned a ton of new pharmacoeconomic terms and understands how they will be useful for his presentation on Curiosan and Monkeydex. George’s curiosity about formularies and the advantages of pharmacoeconomic information prompted him to look for additional material.

 

What is a formulary?

A drug formulary is a continuously updated list of safe and effective medications approved by a healthcare institution or insurer. The P&T committee is responsible for adding, keeping, or removing medications from the formulary. Although the P&T committee deals heavily with issues related to medications, it has representation from many departments: administrative people, nurses, pharmacists, physicians, and others. The broad membership reflects the fact that medication use is a transdisciplinary function. The P&T committee meets regularly to discuss new FDA drug approvals, revised and updated guidelines, firsthand patient drug experiences, institution policy, and new clinical trials.7 (See the SIDEBAR.)

 

SIDEBAR: P&T Committee Duties8

  • Manage the formulary including any changes and the addition of new drugs
    • Evaluate any candidate for the formulary using current evidence and clinical studies to either support or refute a drug’s addition
    • Conduct periodic drug use evaluation for all classes of medication
  • Consider patient safety in all decision processes
  • Ensure the electronic health record (EHR) integrates strategies to support drug selection
    • Specifically, the EHR should help with dosing and monitoring of patients to prevent errors
  • Develop strategies during drug shortages. The P&T committee finds bioequivalent drugs and decides how to ration the available drugs
  • Implement medication use policies. Medication use policies guide the use of a medication through prescriber education, pharmacist communication, or team rounds/meetings
  • Understand the reimbursement process for health systems concerning which insurances will pay for medications

 

Most formularies are based on a tiered system. A medication’s tier in the formulary reflects the plan’s coverage. Generic medications usually have a preferred tier and lower out of pocket costs, while brand name medications would be placed on a higher tier unless the PBM, healthcare system, or payer has negotiated a better price for a specific product (discussed below). Two types of formularies exist7:

  • Open Formulary – the plan provides coverage for all medications, even if they are not on the formulary. Certain medication classes, such as over-the-counter medications, are not covered.
  • Closed Formulary – the plan covers only medications that are on the formulary. Non-formulary medications may be covered when a healthcare practitioner deems it necessary, but the prescriber may need to submit a nonformulary drug request or paperwork for prior authorization. Typically, hospitals operate with a closed formulary.

 

Decision Analysis in Formulary Management

Pharmacoeconomics employs decision analysis to pool data related to medication to determine if one medication is more cost effective than a comparator. It’s easy to determine if a drug costs less than another based sheerly on acquisition price. But it can be a challenge to determine if a more or less expensive drug is a better, more effective choice.9 It is important to note that a drug’s effectiveness refers to how it performs in the real world. A drug’s effectiveness differs from its efficacy, which reflects how well a drug performs in clinical trials. Once the trials are over, drugs rarely perform as well in the real world where people who take the drug don’t receive that same support and may have characteristics that study participants did not have.10 Pharmacoeconomic researchers take into account a multitude of factors including cost, outcomes, and adverse events when analyzing two comparators.9

 

Many people, like the professor quoted at the start of this CE, wonder if pharmacoeconomics is useful. To highlight the effectiveness of decision analysis in the pharmacy profession, the University of Cincinnati James L. Winkle School of Pharmacy added a collaborative decision analysis project to its curriculum.11 Its purpose was for students to evaluate a drug based on multiple factors, not just cost. Students used a decision analysis model in Microsoft Excel to compare two antibiotics, using the model to recommend the better option. Professors released a student survey at the end of the project. The survey found that more than 90% of students felt the project was useful and said it widened their thinking skills about what a drug’s cost involves. Sticker price is not the only consideration.11

 

While decision analysis incorporates a medication’s cost and clinical outcomes, some organizations take a different approach, eschewing pharmacoeconomics entirely. The United States Preventive Services Task Force (USPSTF) makes education-based medication recommendations.12 It does not consider a medication’s cost at all when it makes a recommendation for its use. The USPSTF made this decision to focus solely on a medication’s clinical effectiveness because it does not want to limit a patient’s healthcare options based on cost.12

 

Overall, pharmacoeconomic analysis offers tools for formulary management including enhanced decision making, cost savings, and overcoming barriers. Using pharmacoeconomic analyses in formulary decision-making evaluates changes comprehensively and helps select the best intervention.9 Additionally, decision makers can select a more informed approach to keep a drug on a formulary by analyzing a drug’s effects in addition to its cost. Last, by using pharmacoeconomic tools more often, it can become more mainstream in formulary decision making.9

 

PAUSE AND PONDER: What drugs or drug classes used in your pharmacy would benefit from pharmacoeconomic analysis?

 

Common Types of Pharmacoeconomic Analyses

George learned a considerable amount of new information about decision analysis. He sees his error in only considering these medications’ acquisition prices in the past. George was curious about the methods pharmacoeconomic professionals use in their studies to report a medication’s overall effectiveness. He decided to look at the types of analyses.

 

The four types of analysis in pharmacoeconomic studies are cost benefit analysis (CBA), cost effectiveness analysis (CEA), cost minimization analysis (CMA), and cost utility analysis (CUA). Table 2 provides more information about each type of analysis.6

 

Table 2. Overview of Different Analyses6

  CBA CEA CMA CUA
Purpose -Calculates the cost benefit of an intervention

 

-Both the intervention and its benefits are converted to monetary values

Measures the health benefit in natural units (ex. ulcers healed) and monetary units -Focuses only on costs to a health service

 

-Used when two interventions have an identical benefit

-Interventions compared based on their impact on a patient’s life

 

-Measured in QALYs

 

Advantages Helps to compare the costs of different interventions in completely different therapeutic areas Compares two or more different drugs with similar outcomes, but different success rates Great tool to use when comparing a generic drug with its brand name counterpart Outcomes do not need to be measured on a monetary scale
Disadvantages May ignore benefits that cannot be measured by money value (ex. anxiety relief) Cannot compare drugs that treat different conditions Both interventions need to have identical benefits, besides cost Measurements in QALYs may differ in different disease states
ABBREVIATIONS: CBA = cost benefit analysis; CEA = cost effectiveness analysis; CMA = cost minimization analysis; CUA = cost utility analysis; QALYs = Quality Adjusted Life Years

 

George acquired a great basic knowledge of the analyses. He was curious to learn more about some new concepts he found in his research. Specifically, he wanted to know more about calculating outcomes costs for interventions, incremental cost-effectiveness ratio calculations, and how to determine quality-adjusted life years (QALYs). As a basis to understand the different analyses, it’s critical to look at QALY first.

 

Health economists calculate quantity of and quality of years, which are combined into QALYs.13 To calculate a QALY, begin with the utility score, which is scaled from 0 to 1. A chronic condition may have a utility score of 0.6. The Health Utilities Index Mark 3 (HUI3) is used to measure utility scores. The HUI3 asks a serious of questions about eight attributes (e.g., ambulation, cognition, dexterity, emotion, hearing, pain, speech, vision) and combines them into a score that ranges from 0 to 1. The numeral 1 means perfect health and 0 represents death.14 To calculate QALY, the utility score is multiplied by the time spent in each state, which translates into the number of years of life the typical patient gains on a treatment. For example, consider patients with a chronic condition (utility score of 0.6) receiving a treatment that will add seven years to their life. To calculate the QALY, multiply 0.6 x 7, which equals 4.2 QALYs gained.15

 

While QALYs can effectively determine how many life years are gained in many situations, they have some downsides.16 QALYs are blind to health conditions and personal characteristics such as age, disease severity, residence location, and sex. Additionally, the QALY does not encompass all aspects of an intervention’s benefit. For example, if a single mother takes a medication that rapidly improves her health, it can also improve the health of her kids and allow her to return to work quicker.16

 

Cost Benefit Analysis. The main purpose is to compare interventions with different outcomes. Typically, a CBA involves adding all the costs of an intervention and subtracting that figure from the expected benefits of the intervention. A CBA helps an organization to see an intervention’s return on investment. When doing a CBA, it’s important to identify an intervention’s direct, indirect, and intangible costs to compare against the intervention’s benefits.17 George found this explanation straightforward but had to ask Ted how he would estimate the expected benefits. To calculate the expected benefits, Ted told George to list the indirect and intangible benefits of the interventions and make educated guesses about monetary values for each, looking first to see if any studies have assigned or estimated costs. George can then subtract the intervention’s costs from these expected benefits to equal the net benefits.18

 

Cost Effectiveness Analysis compares the cost and outcomes for two or more interventions for the same condition. A CEA is centered around the incremental cost-effectiveness ratio (ICER). This explanation had George scratching his head, and he had to review it several times to really understand it. The ICER is the ratio of cost differences to outcomes differences between interventions.19 The ICER is useful because it shows the added cost per unit of health outcome gained from a new intervention.19 The ICER is calculated using the equation ICER = costs1 minus costs2 divided by effect1 minus effect2. For example, intervention 1 costs $200 with an 8 QALY benefit and intervention 2 costs $100 with a 4 QALY benefit. Plug these numbers into the equation and the ICER = 25. This means $25 per QALY for intervention 1 over intervention 2.20

 

Cost Minimization Analysis considers only half of an economic evaluation because it does not consider the outcomes of interventions. It simply looks at cost. For a CMA to be considered a full evaluation, health economists would need to consider the outcomes of interventions, such as how many life years are saved. If the interventions’ outcomes are equal, then the CMA can be useful.21

 

Cost utility analysis helps compare costs and benefits from different interventions. CUA takes into account benefits in terms of how many years are saved and quality of life.13 CUA is helpful to quantify how much an intervention can extend and improve someone’s life. QALYs are used in a CUA to display quality and quantity of years saved for a patient’s life. The best time to use a CUA is when someone wants to determine the cost-effectiveness of a product that is a high cost for the payer. A CUA study plans to show where resources should be allocated for maximum health benefit.13

 

George decided to put together his own CEA after learning more about the pharmacoeconomic analyses. He chose this approach since he was able to acquire the most information about how to properly perform a CEA. Table 3 shows George’s CEA for Curiosan compared with Monkeydex.

 

Table 3. CEA for Curiosan and Monkeydex

Curiosan Monkeydex
Total Cost (Both direct and indirect/intangible) $3900 (direct costs) + $200 (indirect/intangible costs) $4200 (direct costs) + $100 (indirect/intangible costs)
Effect (Reduction in Curiosity Overload Events per Year) 3 events prevented 5 events prevented
ICER

($4100 - $4300) / (3 - 5)
Outcome of ICER $100 from each episode prevented by using Curiosan over Monkeydex
ABBREVIATIONS: ICER = Incremental Cost-Effectiveness Ratio

 

George analyzed both costs and outcomes from the two interventions. He concluded $100 from each adventure-induced curiosity overload episode was saved by using Curiosan over Monkeydex. The CEA shows Curiosan’s effectiveness over Monkeydex when considering costs and outcomes. Let’s re-examine the pharmacy professor’s quote in which he said, “Most pharmacoeconomic studies are ignored in clinical practice because practitioners don’t understand them or use other reasons to select a drug to use.” What factors is he referring to? One other factor might be patient volume. This hospital generally sees about five AICO patients per day and they are treated in the emergency department. The P&T Committee knows that Man with the Yellow Hat Hospital has an emergency department with 20 available beds that can usually accommodate all these patients. If the emergency room experiences overflow, hospital management has designated the adjacent hallway to hold up to five excess patients. If the hospital only had a total of five beds available, however, or it was having difficulty staffing the ED, the P&T committee’s deliberations might be different.

 

PHARMACOECONOMIC TOOLS IN PHARMACY BENEFIT MANAGEMENT

George checked the major dailies—the most reliable newspapers across the country that fact-check before they publish—to see if any recent articles talked about the impact of pharmacoeconomics while doing his research. George checked these publications because he wanted to identify any recent major developments in the healthcare industry. He found multiple feature articles and opinion pieces on the function of PBMs. George read that PBMs contribute to formulary decision making for payors or employers and use different pharmacoeconomic tools to support their choices. George wanted to find out more about the PBM’s role and how they contribute to the formulary, so he delved into the topic again.

 

PBM History

PBMs surfaced in the 1950s due to a demand for special management of drug benefits.22 Pharmacists started the first PBMs, founding Prescription Services, Inc in Canada in 1958 and PAID Prescriptions in the United States (U.S.) in 1965. Through the years, health systems and payors began to collaborate with PBMs more often and they grew in size and scope. Now, PBMs handle a wide variety of tasks including formulary maintenance, pharmacy networks, mail order pharmacy operations, and contracts with wholesalers and manufacturers. A PBM’s most important service is maintaining a drug formulary. Most PBMs will handle multiple formularies for different clients. PBMs cover certain drugs on a formulary and some drugs require patients to pay a portion of the costs.22

 

George learned from his reading of current events that the Federal Trade Commission (FTC) is looking into PBMs and considering preventing them from combining. 22 The FTC often refers to PBMs as the prescription drug middleman industry and has launched inquiries into their operations and practices.23 It theorizes that if PBMs continue to combine and integrate, they could possibly have unprecedented control over drug prices, blocking competition. Their concern of market concentration is based on the oligopoly theory which states that if five firms in an industry account for more than 60% of the market, competition is stifled. The FTC alleges that the three largest PBMs processed almost 80% of prescriptions dispensed by U.S. pharmacies in 2023, and the top six processed more than 90%. Describing PBM operations as opaque, the FTC reported in July 2024 that despite their efforts to obtain records from six PBMs, several have refused to comply. A significant concern is that the current PBM structure may disadvantage small pharmacies that are not in the PBM network and the patients they serve.23,24 The FTC’s efforts are focused on promoting fair competition and protecting consumers from high medication prices.25

 

PAUSE AND PONDER: What are some cost control tools used lower drug costs in your pharmacy?

 

PBM Cost Control Tools

PBMs use an assortment of cost control tools to control costs26,27,28:

  • Negotiated prices. PBMs work on securing a specific price for drugs. PBMs that purchase drugs at a high volume can negotiate discounted prices. The price paid by the PBM is often much lower than other plans’ prices, such as Medicaid. PBMs will apply this discount to the pharmacies in its network, guaranteeing access for pharmacies that contract exclusively with the PBM.
  • Generic substitution. Here, the goal is to increase the use of generic medication whenever possible. Generally, generic drugs cost 80% to 85% less than their brand name equivalents. Pharmacists may receive an incentive for dispensing a higher number of generics.
  • Rebates. A rebate is money returned by the seller to the drug purchaser under certain conditions. The seller gives rebates to incentivize higher volume purchases and to stay competitive without directly lowering costs. The PBM often negotiates a rebate and reaches an agreement with the drug manufacturers. A rebate program may stimulate the PBM to increase its use of rebated drugs; on the flip side, rebates may cause the PBM to place high-priced drugs in better tiers than drugs that are more cost-effective, which creates higher out-of-pocket costs for some patients.
  • Copayments. A copayment is a fixed amount that patients, insureds, or beneficiaries pay for their prescriptions. PBMs use copayments as a cost-sharing mechanism to reduce the insurer’s or employer’s overall medication costs. PBMs adjust copayments depending on the plan they are managing. Generic medications generally have lower copayments, but brand and some generic medications may require a higher copayment.

 

Do PBMs Create Value in Healthcare?

PBMs have had many significant impacts on the drug distribution system. At their inception, they created systems to replace the manual claims filing process that was dependent on paper with electronic systems that communicated among stakeholders quickly. Today’s systems operate in real-time, which is advantageous to all stakeholders.29

 

Controversy surrounds PBMs (See the SIDEBAR). PBMs add value to their stakeholders (e.g., insurers, health systems, payors), but it is uncertain whether PBMs contribute significant value to the U.S. healthcare system. PBMs have proprietary contracts that prevent open discussion of the terms they negotiate and tools they use. Some experts allege that PBMs engage in “spread pricing,” meaning they charge health plans and employers more for generic drugs than what they reimburse pharmacies for these drugs, keeping the difference. Again, a lack of transparency allows this to happen: PBMs’ operations are proprietary and confidential. They often lack transparency and it’s possible to conclude they may take value from healthcare. Some evidence exists indicating that agreements with manufacturers agreements require PBMs to exclude generic drugs and biosimilars from their formularies in exchange for higher rebates.24,27,30

 

SIDEBAR: Have PBMs Abused the Drug Rebate System?

The 3 major PBMs—Caremark Rx, Express Scripts (ESI), and OptumRX—are currently in the FTC’s crosshairs for allegedly artificially inflating insulin drug prices. The FTC has filed an administrative complaint citing that 3 PBMs have developed and abused a drug rebate system that prioritizes high rebates from drug manufacturers, forcing consumers to spend more on life-saving medication.25

 

The crux of the issue centers on PBMs ability to establish discounts on the manufacturer’s initial sticker price of brand name drugs. Drug companies will agree to these discounts in exchange for preference and availability on the PBM’s formularies. As the discounts grew larger over time, pharmaceutical companies were forced to raise their initial sticker prices to maintain profits. Therefore, while PBMs have cut prices in half for their clients, patients have suffered because the price at point of service often reflects the initial sticker price.31 Even if less expensive insulins become available, PBMs are able to design their formularies strategically to exclude those options in favor of equivalent high list price, highly rebated products.32

 

The PBMs’ “chase-the-rebate” strategy has shifted the burden of high insulin prices directly to patients.25 Take, for example, one insulin product that was listed at $122.59 in 2012. Also in 2012, PBMs introduced exclusionary drug formularies, a tactic weaponized to demand higher rebates in exchange for a desirable spot on the formulary. By 2018, the list price of that specific insulin more than doubled to $289.36. Patients with deductibles or coinsurance do not benefit from rebates at the pharmacy counter. These out-of-pocket expenses for insulin drugs are sometimes even higher than total cost of the drug to the commercial payor.25

 

All three PBMs have pushed back on the allegations from the FTC, claiming the lawsuit “demonstrates a profound misunderstanding of how drug pricing works.”32 The FTC has also acknowledged that PBMs likely did not act alone, and actions against drug manufacturers may be on the horizon. Over the last year, Eli Lily, Novo Nordisk, and Sanofi all promised significant cuts to the list price of their insulins due to public and political pressure. The recently passed Inflation Reduction Act also has chipped away at insulin prices by establishing a $35 per month cap for Medicare Part D patients.32

 

Implications for Pharmacy Teams

Pharmacoeconomics is helpful for pharmacy teams because in a healthcare setting pharmacists need to be able to determine if a drug’s value can be justified by its cost. George learned that a good way to think about cost and value is this: “Value is the results you get divided by the cost. Value is what works, not how cheap it is.”33 Pharmacy employees, especially those who work in procurement or with the P&T Committee, should understand how to differentiate between the four types of pharmacoeconomic analyses. The different analyses help engage in informed decision making between two or more interventions. Pharmacoeconomics can guide clinical and policy decision making. Today, pharmacists in community and hospital settings provide a wide variety of services including vaccinations and medication use counseling. A health economist might perform a pharmacoeconomic analysis to determine if a pharmacist’s services are adding value to the healthcare system. Additionally, a payment model needs to be established to ensure pharmacists are compensated for their non-dispensing work.34

 

Red Flags in Pharmacoeconomic Studies

Pharmacy staff must recognize that pharmacoeconomic studies, like all studies, can be flawed. Certain red flags decrease a study’s validity. Below are some common questions to ask after reading a pharmacoeconomic study. These questions help identify the study’s limitations35:

  • Does the title accurately represent the study’s goals?
  • Did the researchers clearly state the study’s objective?
  • Did the researchers use a large enough data sample? Remember that larger sample sizes lead to more reliable results.
  • If the researchers compared interventions, did they use appropriate comparators?
    • If the researchers were reporting on a new treatment, did they compare it to the current standard of care or the most popular marketed options? Or did the authors compare the treatment to a less popular, less effective, or older (and retired) alternative?
  • Did the researchers provide a description of the competing alternatives’ use in clinical practice?
  • Did the researchers identify which perspective they employed to measure the costs?
  • Did the researchers indicate the study structure (retrospective, prospective, etc.)?
  • Were all the costs of the interventions included?
  • Did the researchers include all important clinical outcomes from various studies?
  • Were the study’s conclusions appropriate for the study? Or did the conclusions go beyond the scope of the target population?
  • Is it possible to extrapolate the findings to your population, or are the populations too different?
  • Did the researchers present the conclusions in an unbiased manner?

 

CONCLUSION

George was able to learn so much about pharmacoeconomics. He feels confident about the different pharmacoeconomics terms used for economic evaluations. George also recalls the advantages of pharmacoeconomic analysis and can compare the different types of analyses. Last, he better understands the PBM’s role and the tools a PBM uses to lower drug costs.

 

 

Pharmacist Post Test (for viewing only)

Are You Curious about Pharmacoeconomics?

Pharmacist Post-test

After completing this continuing education activity, pharmacists and pharmacy technicians will be able to
• Define common pharmacoeconomic terms used for economic evaluations.
• Recall the advantages of pharmacoeconomic analysis for formulary management.
• Compare and contrast different types of pharmacoeconomic analyses.
• List the pharmacoeconomic tools a pharmacy benefit manager uses to lower drug costs.

1. The P&T Committee at Queens Hospital is considering the addition of Fixitall, a new bi-weekly intravenous infusion drug for the treatment of rheumatoid arthritis, to the hospital formulary. Which of the following describe the direct costs of the proposed intervention?

A. Monthly administration, monitoring, and adverse effect OTC treatment costs.
B. Transportation costs to and from the hospital for each treatment.
C. Loss of wages from missing work during bi-weekly infusion center visits.

2. Which of the following best describes an opportunity cost?
A. The amount of money saved by acquiring drug A instead of drug B.
B. The loss of benefit of drug A if drug B is the preferred choice.
C. The negotiation of a rebate for either drug A or drug B.

3. Which of the following defines the pharmacoeconomic term “willingness to pay”?

A. The amount a drug manufacturer will rebate a PBM to indirectly lower drug costs.
B. The calculated ratio of cost differences to outcomes differences between interventions.
C. The maximum amount an individual, system, organization, or payer will pay for an intervention.

4. Which of the following is an advantage of using pharmacoeconomic analysis to inform formulary decisions?

A. Pharmacoeconomic analysis focuses solely on the medication’s cost in an effort to save payers the most money.
B. Pharmacoeconomic analysis considers drug efficacy rather than drug effectiveness to accurately predict real world implications.
C. Pharmacoeconomic analysis considers cost, outcomes, and adverse events when analyzing two or more comparators.

5. Which of the following describes an advantage associated with a cost benefit analysis?

A. Does not require the intervention and its benefits to be converted to monetary values.
B. Compares the cost of different interventions in completely different therapeutic areas.
C. Analyzes the difference in cost of a generic drug compared to its brand name equivalent.

6. Which of the following pharmacoeconomic analyses is measured in QALYs?

A. Cost benefit analysis
B. Cost minimization analysis
C. Cost utility analysis

7. Which of the following strategies do pharmacy benefit managers implement to lower drug costs?

A. Negotiating rebates with drug manufacturers that incentivize higher volume purchases.
B. Limiting the substitution of generic medications due to the lack of incentive provided.
C. Discouraging the use of copayments due to their tendency to increase overall medication costs.

8. Which of the following is an example of an intangible cost?

A. Transportation costs for gas to and from the infusion center.
B. Copayment costs that occur with every infusion treatment.
C. Cost of patient/family’s anxiety over recurrent injections and adverse effects.

9. You are conducting a cost effectiveness analysis of two new ulcerative colitis drugs. Drug A costs $400 with a 6 QALY benefit and Drug B costs $200 with a 4 QALY benefit. Which of the following is the correctly calculated incremental cost-effectiveness ratio (ICER)?

A. $20 per QALY for Drug A over Drug B.
B. $100 per QALY for Drug A over Drug B.
C. $60 per QALY for Drug A over Drug B.

10. Which of the following describes a disadvantage of a cost minimization analysis?

A. Compared interventions must have identical benefits other than cost.
B. Calculated measurements in QALYs may differ in different disease states.
C. Cannot compare a generic drug with its brand name counterpart.

Pharmacy Technician Post Test (for viewing only)

Are You Curious about Pharmacoeconomics?

Pharmacy Technician Post-test

After completing this continuing education activity, pharmacists and pharmacy technicians will be able to
• Define common pharmacoeconomic terms used for economic evaluations.
• Recall the advantages of pharmacoeconomic analysis for formulary management.
• Compare and contrast different types of pharmacoeconomic analyses.
• List the pharmacoeconomic tools a pharmacy benefit manager uses to lower drug costs.

1. The P&T Committee at Queens Hospital is considering the addition of Fixitall, a new bi-weekly intravenous infusion drug for the treatment of rheumatoid arthritis, to the hospital formulary. Which of the following describe the direct costs of the proposed intervention?

A. Monthly administration, monitoring, and adverse effect OTC treatment costs.
B. Transportation costs to and from the hospital for each treatment.
C. Loss of wages from missing work during bi-weekly infusion center visits.

2. Which of the following best describes an opportunity cost?
A. The amount of money saved by acquiring drug A instead of drug B.
B. The loss of benefit of drug A if drug B is the preferred choice.
C. The negotiation of a rebate for either drug A or drug B.

3. Which of the following defines the pharmacoeconomic term “willingness to pay”?

A. The amount a drug manufacturer will rebate a PBM to indirectly lower drug costs.
B. The calculated ratio of cost differences to outcomes differences between interventions.
C. The maximum amount an individual, system, organization, or payer will pay for an intervention.

4. Which of the following is an advantage of using pharmacoeconomic analysis to inform formulary decisions?

A. Pharmacoeconomic analysis focuses solely on the medication’s cost in an effort to save payers the most money.
B. Pharmacoeconomic analysis considers drug efficacy rather than drug effectiveness to accurately predict real world implications.
C. Pharmacoeconomic analysis considers cost, outcomes, and adverse events when analyzing two or more comparators.

5. Which of the following describes an advantage associated with a cost benefit analysis?

A. Does not require the intervention and its benefits to be converted to monetary values.
B. Compares the cost of different interventions in completely different therapeutic areas.
C. Analyzes the difference in cost of a generic drug compared to its brand name equivalent.

6. Which of the following pharmacoeconomic analyses is measured in QALYs?

A. Cost benefit analysis
B. Cost minimization analysis
C. Cost utility analysis

7. Which of the following strategies do pharmacy benefit managers implement to lower drug costs?

A. Negotiating rebates with drug manufacturers that incentivize higher volume purchases.
B. Limiting the substitution of generic medications due to the lack of incentive provided.
C. Discouraging the use of copayments due to their tendency to increase overall medication costs.

8. Which of the following is an example of an intangible cost?

A. Transportation costs for gas to and from the infusion center.
B. Copayment costs that occur with every infusion treatment.
C. Cost of patient/family’s anxiety over recurrent injections and adverse effects.

9. You are conducting a cost effectiveness analysis of two new ulcerative colitis drugs. Drug A costs $400 with a 6 QALY benefit and Drug B costs $200 with a 4 QALY benefit. Which of the following is the correctly calculated incremental cost-effectiveness ratio (ICER)?

A. $20 per QALY for Drug A over Drug B.
B. $100 per QALY for Drug A over Drug B.
C. $60 per QALY for Drug A over Drug B.

10. Which of the following describes a disadvantage of a cost minimization analysis?

A. Compared interventions must have identical benefits other than cost.
B. Calculated measurements in QALYs may differ in different disease states.
C. Cannot compare a generic drug with its brand name counterpart.

References

Full List of References

 

REFERENCES

  1. KurhekarJV. Chapter 4 - Ancient and modern practices in phytomedicine. Editor(s): Egbuna C, Mishra AP, Goyal MR. Preparation of Phytopharmaceuticals for the Management of Disorders, Academic Press, 2021, Pages 55-75, ISBN 9780128202845, https://doi.org/10.1016/B978-0-12-820284-5.00019-8.
  1. Mauskopf JA. Why study pharmacoeconomics?. Expert Rev Pharmacoecon Outcomes Res. 2001;1(1):1-3. doi:10.1586/14737167.1.1.1
  2. Raymond Townsend General Information. Profile previews: Company, investor and advisor profiles | Pitchbook. Accessed August 22, 2024. https://pitchbook.com/profiles.
  3. Wildeman RA. Pharmacoeconomic Challenges in Canada. Vol 29. Drug Info J. Accessed November 10, 2024. https://journals.sagepub.com/doi/abs/10.1177/009286159502900425
  4. Tonin FS, Aznar-Lou I, Pontinha VM, Pontarolo R, Fernandez-Llimos F. Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions. Pharm Pract (Granada). 2021;19(1):2302. doi:10.18549/PharmPract.2021.1.2302
  5. Walley T, Haycox A. Pharmacoeconomics: basic concepts and terminology. Br J Clin Pharmacol. 1997;43(4):343-348. doi:10.1046/j.1365-2125.1997.00574.x
  6. [No author.] Formulary Management. AMCP.org. Accessed August 16, 2024. https://www.amcp.org/concepts-managed-care-pharmacy/formulary-management
  7. Ciccarello C, Billstein Leber M, Leonard MC, Nesbit T. ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System. 2021. Accessed August 27, 2024. https://www.ashp.org/-/media/assets/policy-guidelines/docs/guidelines/gdl-pharmacy-therapeutics-committee-formulary-system.ashx?la=en&hash=EF1E4214CC91C65097AEEECE91BF6EC985AE3E56
  8. Suh DC, Okpara IR, Agnese WB, Toscani M. Application of pharmacoeconomics to formulary decision making in managed care organizations. Am J Manag Care. 2002;8(2):161-169.
  9. Kim SY. Efficacy versus Effectiveness. Korean J Fam Med. 2013;34(4):227. doi:10.4082/kjfm.2013.34.4.227
  10. Cavanaugh TM, Buring S, Cluxton R. A pharmacoeconomics and formulary management collaborative project to teach decision analysis principles. Am J Pharm Educ. 2012;76(6):115. doi:10.5688/ajpe766115
  11. USPSTF and Cost Considerations. United States Preventive Services Taskforce. Accessed August 16, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/task-force-resources/uspstf-and-cost-considerations.
  12. Cost utility analysis: Health economic studies. GOV.UK. Accessed August 23, 2024. https://www.gov.uk/guidance/cost-utility-analysis-health-economic-studies.
  13. Horsman JR. Multi-Attribute Health Status Classification System: Health Utilities Index Mark 3 (HUI3). Health Utilities Inc. “Hui3.” Accessed August 29, 2024. http://www.healthutilities.com/hui3.htm
  14. Prieto L, Sacristán JA. Problems and solutions in calculating quality-adjusted life years (QALYs). Health Qual Life Outcomes. 2003;1:80. doi:10.1186/1477-7525-1-80
  15. Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities, Brit Medl Bul. 2010; 96 (21): 5–21.
  16. Cost-benefit analysis: What it is & how to do it. Business Insights Blog. September 5, 2019. Accessed August 16, 2024. https://online.hbs.edu/blog/post/cost-benefit-analysis
  17. Donnelly S. Cost-benefit analysis: 5 steps to turn data into Smarter Choices. Finance Alliance. May 14, 2024. Accessed August 29, 2024. https://www.financealliance.io/cost-benefit-analysis/
  18. Bang H, Zhao H. Cost-effectiveness analysis: a proposal of new reporting standards in statistical analysis. J Biopharm Stat. 2014;24(2):443-460. doi:10.1080/10543406.2013.860157
  19. Paulden M. Calculating and Interpreting ICERs and Net Benefit [published correction appears in Pharmacoeconomics. 2020 Oct;38(10):1147. doi: 10.1007/s40273-020-00950-2]. Pharmacoeconomics. 2020;38(8):785-807. doi:10.1007/s40273-020-00914-6
  20. Wailoo A, Dixon S. The use of cost minimisation analysis for the appraisal of health technologies. NICE Decision Support Unit; 2019.
  21. Mattingly TJHyman DABai G. Pharmacy Benefit ManagersHistory, Business Practices, Economics, and PolicyJAMA Health Forum.2023;4(11):e233804. doi:10.1001/jamahealthforum.2023.3804
  22. Chen JP. FTC Accuses Drug Managers of Squeezing Patients and Pharmacies. July 29, 2024. Accessed September 2, 2024. https://www.forbes.com/sites/joshuacohen/2024/07/11/ftc-report-accuses-pbms-of-negatively-impacting-patients-and-pharmacies/
  23. Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies. Interim Staff Report. Federal Trade Commission. Accessed September 2, 2024. https://www.ftc.gov/system/files/ftc_gov/pdf/pharmacy-benefit-managers-staff-report.pdf
  24. FTC launches inquiry into prescription drug middlemen industry. Federal Trade Commission. August 20, 2024. Accessed August 29, 2024. https://www.ftc.gov/news-events/news/press-releases/2022/06/ftc-launches-inquiry-prescription-drug-middlemen-industry
  25. Kreling DH. Cost control for prescription drug programs: Pharmacy benefit manager (PBM) efforts, effects, and implications. ASPE. Accessed August 16, 2024. https://aspe.hhs.gov/cost-control-prescription-drug-programs-pharmacy-benefit-manager-pbm-efforts-effects-implications.
  26. Pharmacy Benefit Managers and Their Role in Drug Spending. Commonwealth Funds. April 22, 2019. Accessed September 2, 2024. https://www.commonwealthfund.org/publications/explainer/2019/apr/pharmacy-benefit-managers-and-their-role-drug-spending
  27. UHBlog. Generic vs. brand-name drugs: Is there a difference? University Hospitals. July 21, 2022. Accessed August 27, 2024. https://www.uhhospitals.org/blog/articles/2022/07/generic-vs-brand-name-drugs-is-there-a-difference
  28. Ginder-Vogel K. Alumni Brett Eberle, Nancy Gilbride, and Pat Cory weigh in on the news-making industry’s trends. University of Wisconsin-Madison School of Pharmacy. March 13, 2024. Accessed September 2, 2024. https://pharmacy.wisc.edu/2024/03/13/the-evolution-and-future-of-pharmacy-benefits-managers/
  29. Lyles A. Pharmacy Benefit Management Companies: Do They Create Value in the US Healthcare System?. Pharmacoeconomics. 2017;35(5):493-500. doi:10.1007/s40273-017-0489-1
  30. 31. Abelson R, Robbins R. F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices. Nytimes.com. Published September 20, 2024. https://www.nytimes.com/2024/09/20/health/ftc-drug-price-inflation-insulin.html
  31. 32. Gilbert D. FTC sues pharmacy insurance managers, alleging unfair drug prices. Washington Post. Published September 20, 2024. Accessed September 29, 2024. https://www.washingtonpost.com/business/2024/09/20/prescription-drugs-insurance-ftc-pbm/
  32. Webb K. The Difference Between Cost and Value. Accessed August 20, 2024. https://keithwebb.com/difference-between-cost-value/
  33. Tonin FS, Aznar-Lou I, Pontinha VM, Pontarolo R, Fernandez-Llimos F. Principles of pharmacoeconomic analysis: The case of pharmacist-led interventions. Pharmacy Practice (Granada). Accessed August 28, 2024. https://scielo.isciii.es/scielo.php?pid=S1885-642X2021000100021&script=sci_arttext.
  34. Rascati KL. Essentials of Pharmacoeconomics: Health Economics and Outcomes Research. 3rd edition. Lippincott Williams & Wilkins; 2021.

Demystifying the Medicare Prescription Payment Plan

Learning Objectives

 

After completing this application-based continuing education activity, pharmacists and technicians will be able to

  1. Describe the benefits and features of the Medicare Prescription Payment Plan
  2. Outline the responsibilities of Part D Sponsors and dispensing pharmacies under the Medicare Prescription Payment Plan
  3. Discuss the characteristics of beneficiaries most likely to benefit from participating in the Medicare Prescription Payment Plan
  4. Explain the resources available for Medicare Beneficiaries to learn more about the Medicare Prescription Payment Plan

     

    Release Date: July 25, 2024

    Expiration Date: July 25, 2026

    Course Fee

    FREE

    This CE was funded by Prime Therapeutics

    ACPE UANs

    Pharmacist: 0009-0000-24-033-H04-P

    Pharmacy Technician:  0009-0000-24-033-H04-T

    Session Codes

    Pharmacist:  24YC33-XBK24

    Pharmacy Technician:  24YC33-KXB69

    Accreditation Hours

    1.0 hours of CE

    Accreditation Statements

    The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit for the online activity ACPE UAN 0009-0000-24-033-H04-P/T will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

     

    Disclosure of Discussions of Off-label and Investigational Drug Use

    The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

    Faculty

    Lori R. Donnelly, RPh, PharmD
    Consultant BluePeak Advisors,
    Rolling Meadows, IL

    Faculty Disclosure

    In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

    Lori Donnelly is an employee of BluePeak Advisors, a division of Arthur J. Gallagher & Co.

    Any conflict of interest has been mitigated.

     

    ABSTRACT

    More than 1.4 million Americans paid drug costs of $2000 or more in 2020. Starting January 1, 2025, the M3P allows Medicare Part D members the option to pay for their Part D medications through a monthly invoice while paying nothing at the pharmacy counter. This change has operational and financial impacts for many areas of pharmacy. M3P claims processing requires coordination between Plans, PBMs, and dispensing pharmacies. Pharmacists and pharmacy technicians can help their patients benefit from the M3P by educating themselves and their patients about the program.

    CONTENT

    Content

    INTRODUCTION & BACKGROUND

    The Inflation Reduction Act (IRA) of 2022 is a large piece of legislation that included a wide range of provisions, including clean energy, tax revenues, and healthcare costs. The Medicare Part D changes contained in the IRA aim to make prescription drugs more affordable for Medicare beneficiaries.1

    One of the Medicare Part D changes included in the IRA is the Medicare Prescription Payment Plan (M3P). Starting January 1, 2025, the M3P allows Medicare Part D members the option to pay for their Part D medications through a monthly invoice while paying nothing at the pharmacy counter.2 This change has operational and financial impacts for many areas of pharmacy, including dispensing pharmacies, Medicare Part D Plans (Plans), and Pharmacy Benefit Managers (PBMs).

    Overview of the Medicare Prescription Payment Plan

    The Kaiser Family Foundation estimated that more than 1.4 million Americans paid drug costs of $2000 or more in 2020.3 While the IRA contains other provisions designed to lower prescription drug costs, the M3P does not change the amount that patients pay for their medications. Instead, the M3P (originally called “copay smoothing”) helps Medicare beneficiaries afford their prescriptions by “smoothing” the costs over monthly invoices instead of paying the full amount to their pharmacy. The IRA requires Plans to make the M3P available to any member who has out-of-pocket costs for Part D medications, regardless of their income or out-of-pocket amount. The M3P also requires Plans to4

    • Educate members about the availability of the M3P
    • Notify dispensing pharmacies when members are likely to benefit from participating in the M3P
    • Reflect $0 member payment for approved M3P claims
    • Allow multiple methods for members to opt-in to the M3P
    • Issue monthly M3P invoices to participating members
    • Include all prescriptions covered under Medicare Part D in the M3P
    • Pay the dispensing pharmacy for the member’s portion of the drug cost

    Figure 1 illustrates the basic process for patients who choose to participate in M3P.

    The Centers for Medicare & Medicaid Services (CMS) requires Plans to educate members about the availability of M3P through a variety of channels. Plans must include general M3P information on their websites, when issuing new member identification, and with annual plan document mailings. Plans and dispensing pharmacies must also provide M3P information to targeted members who are likely to benefit from participating in the program. CMS has determined that members with out-of-pocket costs of at least $2000 in the first three quarters of the year or $600 for a single prescription are the most likely to benefit from using the M3P.5

    M3P claims processing starts January 1, 2025, and requires coordination between Plans, PBMs, and dispensing pharmacies. For members not participating in the M3P, Plans, through their PBMs, must indicate that the patient is likely to benefit from the M3P on approved Part D prescription claims with patient costs that are $600 or more. Receipt of this information from the claim requires the dispensing pharmacy to provide educational materials about the M3P to the patient. While CMS requires pharmacies to distribute M3P information to patients in response to claims messaging, CMS does not require them to provide additional counseling about the program. Pharmacists and pharmacy technicians may, however, choose to educate themselves and their patients about the M3P to provide an elevated patient experience.5

    PAUSE AND PONDER: What quick talking points can you provide to your patients to help them understand the M3P?

    Approved Part D claims for patients who have opted into the program will include instructions for the dispensing pharmacy to send a secondary M3P claim. The secondary M3P claim must use a different Bank Identification Number/Processor Control Number (which pharmacy staff usually refer to as BIN/PCN) combination than the corresponding primary Part D claim. The National Council for Prescription Drug Programs (NCPDP) creates and maintains the standardized format for prescription claims transmission. NCPDP is adding specific transmission codes for PBMs to transmit M3P information to dispensing pharmacies.4 Table 1 describes the types of M3P claims processing information that dispensing pharmacies should expect starting January 1, 2025.  Pharmacists and technicians should consult their employer’s training materials for specific instructions on providing patients with information about the M3P, using NCPDP M3P transmission codes, and submitting secondary M3P claims.

    Table 1. Anticipated M3P Claims Messaging Information

    Patient Status Claim Type Message Type
    Not participating in M3P Approved Part D Claims with ≥ $600 patient cost The member is likely to benefit from participating in the M3P; the pharmacy should provide M3P educational information.
    Not participating in M3P Secondary M3P Claims (if sent accidentally) The member is not participating in the M3P program; the pharmacy should collect the member’s cost share based on the Part D claim.
    Participating in M3P Approved Part D Claims The member is participating in the M3P;  the pharmacy should send a secondary M3P claim.
    Participating in M3P Secondary M3P Claims The corresponding Part D claim is not found. Transmission may have failed or the Part D claim has been reversed; the pharmacy should reprocess the Part D claim and then re-send the secondary M3P claim.
    Participating in M3P Secondary M3P Claims The drug is not covered by Part D and therefore not eligible for M3P; the pharmacy should collect the member’s cost share based on the Part D claim.

     

    Members can start signing up for the M3P as early as October 15, 2024, which is the beginning of open enrollment for 2025 Medicare Part D coverage. They can also sign up any time after their 2025 Part D coverage starts. CMS requires Plans to accept M3P participation requests by mail, telephone, or through a website application.4 CMS does not currently require dispensing pharmacies to process M3P election requests, and pharmacists and pharmacy technicians should direct patients to their Plan to sign up for the M3P.

    Once a member opts into the program, their Plan will issue a monthly M3P invoice for all Part D prescription costs including the deductible and copay/coinsurance amounts. CMS requires Plans to issue M3P invoices separately from monthly premium invoices.4

    Plans can remove members from M3P participation for failure to pay M3P invoices after a 2-month grace period but cannot disenroll members from Part D coverage for failure to pay M3P invoices. Members who are removed from M3P participation for falling behind on M3P payments can restore their M3P participation by paying their past-due M3P balance in full.4 Plans may disenroll members from Part D coverage for failure to pay monthly premium invoices after a 2-month grace period, even if their M3P invoices are paid in full.6 Pharmacists and pharmacy technicians can help M3P patients stay current with their payments by reminding them to pay both M3P and monthly Part D premium invoices. The SIDEBAR explains common terms.

    SIDEBAR: Part D Patient Costs Defined

    Monthly Premium: a monthly payment that maintains enrollment in the Plan; not impacted by deductible, copay, or coinsurance amounts

    Annual Deductible: a yearly dollar amount the patient pays before their Plan starts to contribute to prescription costs

    Copayment (or Copay): a specific, pre-determined dollar amount the patient pays for each prescription after satisfying the deductible

    Coinsurance: an alternative to a copay, the percentage of the total cost the patient pays for each prescription after satisfying the deductible

     

    Distribution of M3P responsibilities

    CMS develops guidance and member-facing documents that Plans and PBMs use when building operational processes. For the M3P, CMS is providing Plans with5

    • Detailed guidance documents that provide M3P requirements and invoice calculation instructions
    • Content for plan mailings including the Annual Notice of Change, Evidence of Coverage, and Explanation of Benefits
    • A fact sheet with educational language for Plan websites and printed materials
    • An election request form
    • Letters to notify members of M3P election, failure to pay, and termination from the program
    • A targeted letter for members who are likely to benefit from participating in the M3P

    CMS is also adding M3P information to the resources and educational materials that they provide directly to Medicare beneficiaries, including the annual Medicare & You Handbook, Medicare.gov, and Medicare Plan Finder.5

    CMS assigns most of the responsibility for the M3P to Plans and holds Plans accountable for meeting all program requirements. Plans are responsible for delivering all aspects of the M3P but must rely on PBMs, vendors, and dispensing pharmacies for certain requirements. Table 2 provides an overview of the main activities that Plans must implement for M3P.4,5

    Table 2. Plan M3P Responsibilities4, 5

    Activity Requirements
    Member education ·       General information during open enrollment, with annual plan mailings, and on their website

    ·       Targeted information prior to and during the plan year for members who are likely to benefit from the M3P

    M3P participation processing ·       Mail, telephone, and web-based options

    ·       Accept M3P elections during open enrollment, before the start of the plan year

    ·       Activate completed M3P elections received during the plan year within 24 hours

    ·       Outreach to gather missing information from incomplete M3P election requests

    ·       Communication to PBM for claims processing

    M3P claims processing ·       Coordination and oversight of their PBM for

    o   Claims notification to pharmacies for members who are likely to benefit from M3P

    o   Processing information and $0 copay/coinsurance for M3P participants

    o   Payment to the dispensing pharmacy for the member’s portion of the drug cost

    M3P Invoices and Payment Collections ·       Monthly invoices based on CMS-required calculations

    ·       60-day grace period, then removal from M3P for failure to pay

    Other ·       Customer service

    ·       Pharmacy and provider education

    ·       Data and reporting

    ·       Oversight of dispensing pharmacies

     

    While Plans hold the most responsibility for M3P, dispensing pharmacies play a large part in the program’s success. CMS requires all pharmacies who accept Part D prescription drug coverage to participate in the M3P. Pharmacists and pharmacy technicians must act on M3P claim information to distribute M3P materials to members and process M3P claims. Pharmacies may need to adjust their claim reversals and reprocessing procedures to ensure that both the primary Part D and the secondary M3P claims are included.  For example, if a patient decides to fill a prescription for less than the original quantity, the pharmacy would need to first reverse both the Part D and M3P claims and then resubmit both claims with the new quantity. CMS also requires pharmacies to re-process claims for members who sign up for M3P after filling but before picking up their prescriptions.4,5

    To benefit from the M3P, Medicare beneficiaries are responsible for reviewing the educational materials provided by CMS, their Plan, and their pharmacy. They also have the opportunity to use the tools provided by their Plan to determine if they would benefit from participating in the M3P. After signing up, members are obligated to pay their M3P invoices on a monthly basis to avoid being removed from the program. Members who sign up for the M3P may decide later to drop out of the program but are still responsible for paying invoices incurred during their M3P participation. 4,5

    Monthly invoice calculations and members most likely to benefit from participating in the M3P

    The monthly invoice calculations required by CMS are complex and typically do not result in equal monthly installments. Members can sign up for the M3P at any time during the year, and the monthly invoice calculation for their first month in the program is different from the invoice calculations for later months. Invoice amounts also vary based on when the member signs up for the M3P and prescriptions purchased at the pharmacy before they entered the program. CMS protects members who participate in the M3P by prohibiting  Plans from adding service/late fees or charging interest on M3P balances.4

    PAUSE AND PONDER: What can you tell a patient who asks how the M3P is different than using a credit card to pay for his prescriptions?

    CMS holds Plans responsible for accurately calculating M3P invoice amounts and answering member questions. Dispensing pharmacies are not required to explain invoice details but may benefit from understanding why not all patients will benefit from participating in the M3P.4

    Figures 2 and 3 provide examples of pharmacy copay/coinsurance amounts compared to M3P invoice amounts for members who sign up for M3P in January. Both example members have the same out-of-pocket prescription costs for the year. The member in Figure 2 is more likely to benefit financially from the M3P because the monthly M3P invoice amount is never higher than what they would have paid at the pharmacy counter. In general, the higher the member’s out-of-pocket prescription costs the earlier in the year, the more likely the  member will benefit financially from using the M3P.4

    All Part D members are entitled to sign up for the M3P, regardless of their drug costs or M3P invoice amounts. Members who do not benefit financially from the M3P, such as the member illustrated in Figure 3, may have personal reasons for signing up for the program. For example, patients who rely on caretakers to pick up their prescriptions from the pharmacy may prefer the convenience of having no cost at the pharmacy counter. Patients may also pay more than their MP3 invoice amounts earlier in the year to reduce invoice amounts later in the year as long as they do not pay more than their total year-to-date copay/coinsurance amounts.4

    Alternatively, patients may have non-financial reasons for not signing up for the M3P. They may not want to receive another monthly bill or may feel that paying for their prescriptions at the pharmacy provides better visibility into their drug costs. Even patients who would benefit financially from using the M3P may be put off by the uneven monthly M3P payment amounts. Patients who sign up for the M3P have the option to leave at any time if they feel they are not benefiting from the program.

    PAUSE AND PONDER: What other non-financial situations may members face where they could benefit from the M3P?

    M3P Resources

    CMS has a number of resources available for anyone looking for more information about the M3P. They provide access to detailed M3P guidance, technical, and related information at https://www.cms.gov/inflation-reduction-act-and-medicare/part-d-improvements/medicare-prescription-payment-plan

    CMS also provides an annual handbook entitled “Medicare and You” designed to educate members about all aspects of Medicare. When the 2025 version of “Medicare and You” is released by CMS in late 2024, it will include educational information about the M3P.5 The “Medicare and You” handbook is available at https://www.medicare.gov/medicare-and-you.

    At the time of this publication, CMS is still developing additional resources, but expects information about the M3P to be available at www.medicare.gov.5

    CMS requires Plans to provide information about the M3P on their websites before October 15, 2024. While the general M3P information included on Plan websites will likely be similar to the information provided by CMS, it will also include Plan-specific instructions and contact information.5

    SUMMARY AND CONCLUSION

    The M3P provides flexibility for Medicare beneficiaries who prefer to receive a monthly invoice instead of paying for their prescriptions at the pharmacy counter. The program requires complex operational changes for Plans, PBMs, and dispensing pharmacies.

    CMS holds Plans responsible for the overall administration of the M3P, but PBMs and dispensing pharmacies have important responsibilities. Pharmacists and pharmacy technicians can help their patients benefit from the M3P by educating themselves and their patients about the program.

     

    Good:

    • Be familiar with your pharmacy’s procedures for processing M3P claims
    • Provide M3P information to patients when prompted by your pharmacy’s dispensing system
    • Refer patients to their Plan for additional information about the M3P

     

    Better:

    • Discuss the overall benefits of the M3P
    • Answer patient questions about how the M3P works
    • Describe the characteristics of patients most likely to benefit from using the M3P

     

    Best:

    • BE COMMUNITY CHAMPIONS! Stay abreast of upcoming changes and take the time to comment on proposed revisions to Medicare
    • Assist patients with decisions about M3P participation
    • Consider appointing one staff member to be your “M3P Expert” who deals with complex patient questions

    Pharmacist & Pharmacy Technician Post Test (for viewing only)

    Demystifying the Medicare Prescription Payment Plan
    Educational Objectives for Pharmacists and Pharmacy Technicians:
    1. Describe the benefits and features of the Medicare Prescription Payment Plan
    2. Outline the responsibilities of Part D Sponsors and dispensing pharmacies under the Medicare Prescription Payment Plan
    3. Discuss the characteristics of beneficiaries most likely to benefit from participating in the Medicare Prescription Payment Plan
    4. Explain the resources available for Medicare Beneficiaries to learn more about the Medicare Prescription Payment Plan.

    1. What can you tell patients who ask about the Medicare Prescription Payment Plan?
    a. It will lower prescription drug costs for millions of Americans
    b. It creates an option to pay for Part D prescriptions through a monthly invoice
    c. The government will make this program available on January 1, 2026

    2. What can members who participate in the Medicare Prescription Payment Plan expect?
    a. They will pay $0 at the pharmacy for their Part D prescriptions
    b. They must meet strict minimum income requirements
    c. They will receive monthly invoices from their pharmacy

    3. Which of the following is an M3P responsibility for dispensing pharmacies?
    a. Provide counseling about the program
    b. Distribute materials in response to claims messaging
    c. Identify patients who are likely to benefit from the program

    4. If a member fails to pay M3P invoices, what could happen?
    a. They could be required to change pharmacies
    b. They could be denied prescription drug coverage
    c. They could be removed from the M3P program

    5. Which of the following is a Medicare Part D Plan responsibility?
    a. Processing M3P participation requests
    b. Allowing a 90-day grace period for failure to pay M3P invoices
    c. Developing guidance and member-facing documents

    6. Which Medicare beneficiaries are most likely to benefit financially from using the M3P?
    a. People who have high drug costs early in the year
    b. People who have low drug costs throughout the year
    c. People who have high drug costs late in the year

    7. What advice can you offer to patients who do not benefit financially from the M3P?
    a. They are not permitted to use the program
    b. They must remain in the program until the end of the plan year
    c. They may choose to join the program for non-financial reasons

    8. Which of the following may patients consider a disadvantage to using the M3P, even for patients who may benefit financially from the program?
    a. Invoice amounts that are not the same every month
    b. Being required to change pharmacies to participate
    c. Risk of losing their prescription coverage if they cannot pay their M3P invoices

    9. Where can beneficiaries learn more about the M3P?
    a. The 2024 “Medicare and You” Handbook
    b. From their Plan Formulary
    c. CMS and Plan websites

    10. When will Medicare Part D Plans have M3P details available on their websites and start accepting M3P member elections?
    a. After patients meet their annual deductible
    b. No later than October 15, 2024
    c. After January 1, 2025

    References

    Full List of References

    References

       

      Centers for Medicare & Medicaid Services. The Inflation Reduction Act Lowers Health Care Costs for Millions of Americans. Accessed April 27, 2024. https://www.cms.gov/priorities/legislation/inflation-reduction-act-and-medicare/lowers-health-care-costs-millions-americans

      Centers for Medicare & Medicaid Services. Fact Sheet: Medicare Prescription Payment Plan. Accessed April 27, 2024. https://www.cms.gov/files/document/medicare-prescription-payment-plan-fact-sheet.pdf

      Kaiser Family Foundation. Explaining the Prescription Drug Provisions in the Inflation Reduction Act. Accessed July 1, 2024. https://www.kff.org/medicare/issue-brief/explaining-the-prescription-drug-provisions-in-the-inflation-reduction-act/
      Centers for Medicare & Medicaid Services. Medicare Prescription Payment Plan: Final Part One Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025, and Response to Relevant Comments. Accessed April 27, 2024. https://www.cms.gov/files/document/medicare-prescription-payment-plan-final-part-one-guidance.pdf

      Centers for Medicare & Medicaid Services. Medicare Prescription Payment Plan: Final Part Two Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025, and Solicitation of Comments. Accessed July 17, 2024. https://www.cms.gov/files/document/medicare-prescription-payment-plan-final-part-two-guidance.pdf

      Centers for Medicare & Medicaid Services. What Happens When a Plan Member Doesn’t Pay Their Medicare Plan Premiums? Accessed April 28, 2024. https://www.cms.gov/outreach-and-education/outreach/partnerships/downloads/11338-p.pdf

      Dealing with Difficult Students: Simple(ish) Solutions to Common Problems

      Learning Objectives

       

      After completing this application-based continuing education activity, pharmacist preceptors will be able to

      • DEFINE types of learning disabilities that preceptors are likely to encounter
      • LIST the information the school of pharmacy should provide to preceptors
      • IDENTIFY accommodation that are appropriate for specific students
      • DESCRIBE reasonable accommodation in experiential education

         

        Release Date: April 20, 2024

        Expiration Date: April 20, 2027

        Course Fee

        Pharmacists: $7

        UConn Faculty & Adjuncts:  FREE

        There is no grant funding for this CE activity

        ACPE UANs

        Pharmacist: 0009-0000-24-027-H04-P

        Session Code

        Pharmacist:  24PC27-WXT24

        Accreditation Hours

        2.0 hours of CE

        Accreditation Statements

        The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit for the online activity ACPE UAN 0009-0000-24-027-H04-P  will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

         

        Disclosure of Discussions of Off-label and Investigational Drug Use

        The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

        Faculty

        Jennifer Luciano, PharmD
        Director, Office of Experiential Education; Associate Clinical Professor
        UConn School of Pharmacy
        Storrs, CT

        Anna Sandalidis, BS
        PharmD Candidate 2025
        UConn School of Pharmacy
        Storrs, CT

        Jeannette Y. Wick, RPh, MBA, FASCP
        Director, Office of Pharmacy Professional Development
        UConn School of Pharmacy
        Storrs, CT

         

         

         

         

         

         

        Faculty Disclosure

        In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

        Jeannette Wick, Anna Sandalidis, and Jennifer Luciano do not have any relationships with ineligible companies

         

        ABSTRACT

        Every student is different. Preceptors may encounter a student who has habits or behaviors that need adjustment. Often, these habits or behaviors are reflective of a lack of professionalism. Preceptors who anticipate certain behaviors and develop strategies to deal with them can usually help students navigate the rotation successfully. It's critical to address poor behaviors the first time they happen, document carefully if the behaviors persist, and involve the school of pharmacy if the behaviors continue. This continuing education activity will describe common challenges and propose effective solutions for dealing with difficult students. It will also discuss student centered learning and present case studies.

        CONTENT

        Content

        INTRODUCTION

        Pharmacist preceptors shape the future of pharmacy by mentoring students during their experiential learning experiences. It is not uncommon for preceptors to encounter challenging situations and difficult student behaviors that can ultimately test a preceptor’s skills and patience. A faculty preceptor once said, “Students don’t usually fail rotations because they don’t know brand and generic drug names; they fail because of behaviors incompatible with the pharmacist’s professional identity. No one becomes a preceptor to hunt for students and force them to go to rounds!”

         

        By addressing diverse behaviors and challenges that preceptors commonly encounter, this activity will empower preceptors to address troublesome behaviors effectively.

         

        PAUSE AND PONDER: What types of difficult behavior have you encountered in the students you precept in the past?

         

        TYPES OF DIFFICULT BEHAVIOR

        Preceptors report a variety of challenging student behaviors during introductory pharmacy practice experiences (IPPE) or advanced pharmacy practice experiences (APPE) rotations. This continuing education activity explores the following behaviors as they relate to experiential education; failure to answer introductory emails, dressing inappropriately, cursing, poor language choices, disrespectful oral or written language, tardiness, and making excuses for unacceptable behaviors.

         

        Failure to Send Introductory E-mail

        Schools of pharmacy typically notify students about their IPPE or APPE rotations several months in advance, often in April for the latter. The timing for reaching out to preceptors may differ for IPPE and APPE students. For example, some schools require IPPE students to contact their preceptors shortly after receiving their site match notification. They may also expect APPE students to introduce themselves and address any site requirements approximately two weeks in advance of the first scheduled day unless the preceptor contacts them sooner. Students should take the initiative and reach out to their preceptors first. This communication serves multiple purposes, including introducing themselves, demonstrating awareness of the start date, confirming the student’s ability to fulfill the expected hourly commitment of the rotation, and addressing any scheduling adjustments. Students spend 120 to 160 valuable hours under the preceptor’s guidance. A student’s failure to initiate or answer introductory emails can significantly impact the student-preceptor relationship and hinder early establishment of effective communication channels.

         

        When students fail to communicate, it opens the door to discuss the importance of good communication in the workplace. Preceptors can use a few techniques to encourage better communication from students1,2:

        • Create an electronic reminder on your calendar that will notify you one week before a student is expected. If you haven’t heard from the student, use the contact information the school provided for the student and send a brief message. Something like, “My calendar indicates you are scheduled for your rotation at (INSERT LOCATION) starting Monday. I haven’t heard from you. Are you still scheduled or has your situation changed?”
        • Consider copying the school’s Office of Experiential Education (OEE) and asking if the preferred contact method has changed.
        • Know that 47% of e-mail is opened or deleted based on the subject line. Be sure to use a specific subject line, like “IMMEDIATE RESPONSE NEEDED: Your April 2024 rotation.” Experts recommend starting with a command and using seven or few words so the subject line will be visible on a phone. Using four or fewer words increases the likelihood e-mail will be opened, so a subject line of “TIME SENSITIVE: IPPE Rotation” might be even better.
        • When the student responds, reply promptly (modeling good communication), providing information like start time, hours, dress code, and other essential information as you would with any student. Ask for a reply confirming the student received the information.
        • If the student does not reply, resend the communication, and copy the OEE. Add a sentence at the start of the communication (and consider highlighting it) that says, “I haven’t heard from you. Is this your preferred method of communication?”
        • When the student reports, discuss the need for prompt responses, underscoring that preceptors are busy and do not have time to track students down.

         

         

        Inappropriate Dress and Hygiene

        Schools of pharmacy and preceptors expect students to adhere to professional dress standards during their experiential rotations. Dressing appropriately can improve the student’s self-perception and confidence and also improves the public’s confidence and perceptions of a pharmacist’s abilities.3 Preceptors can explain to students that dressing professionally also reflects the workplace institutional culture. Dressing appropriately can improve the likelihood of career advancement.4,5 Table 1 lists examples of appropriate and inappropriate attire for pharmacy students.

         

        Table 1. Professional Attire3,6
        Appropriate Attire Inappropriate Attire
        ·       A clean, ironed white lab coat with name tag

        ·       Full length slacks with a collared dress shirts or skirts with blouses or dress shirts, or dresses

        ·        Maintains good hygiene

        ·       Blue jeans, shorts, overalls, sorority or fraternity jerseys, t-shirts, halter tops, tank tops

        ·       Hats, caps

        ·       Tennis shoes, sandals, bare feet

        ·       Excessive jewelry

        ·       May also include revealing clothing, unkept appearance, or lack of attention to personal hygiene

        Consider the case of Ally, a P2 pharmacy student on her first IPPE rotation at a large, well-recognized health system. Ally always reported for her shifts wearing dress pants and a turtleneck of sorts under her white coat. One day, Ally joined her preceptor for a meeting with the organization’s medical directors and the room was quite warm. Ally removed her white coat, which revealed the fact that her top was a crop-top and exposed her torso. Ally had always appeared to dress professionally before but always kept her white coat on.

        While conversations about dress are sensitive and may be uncomfortable, it’s important to address issues early when appropriate. Experiential rotations may be the first time a student has ever needed to dress professionally. It may take some students time to assimilate to professional dress standards.4,5 Providing feedback supports the students ability to make a positive first impression and aids in overall career readiness.

        After the meeting ended, the preceptor (who was also female) privately addressed Ally’s attire. She suggested that Ally dress professionally daily for any occasion with or without her white coat. If the preceptor had been male, he could ask another female pharmacist to speak with Ally. The key is to address these issues in private and with discretion.

        Hygiene is often closely related to attire. Students who have poor hygiene and noticeable body odor often fail to launder, repair, or replace their clothes when they should. Talking with students about hygiene problems is embarrassing for everyone involved. Here, too, it’s often less embarrassing for the student if the person who addresses the issue is of the same gender. The discussion also needs to be conducted in private and with absolute discretion. Some students may have underlying medical conditions that contribute to the problem, like lack of smell or difficulty with executive functioning or organization.7 Preceptors can point out that a lack of proper hygiene can lead to social problems with peers and patients and sometimes increases the likelihood of illness. Clothing like white coats that aren’t washed often harbor bacteria and accumulate odors.8 Students may need very specific direction. For example, the preceptor may need to tell the student that white coats must be washed every week, or that showering and washing hair at least every other day is the expectation. They can also suggest that students establish routines and incorporate hygiene activities into their routines, like showering every evening if students tend to run late in the morning.7

        A growing concern in workplaces is the use of fragrance.9 More than one-third of Americans report scent sensitivity.10 The reason: artificial fragrances can be irritating to individuals who have allergies and asthma. Colognes and perfumes are not the only problem. Products like lotions, soaps, hairsprays, laundry detergent, and dryer sheets designed to reduce static can also trigger allergies and asthma. For individuals who have sensitivities to fragrances, exposure can lead to headache, respiratory distress, itching/burning eyes, runny nose or congestion, and nausea. The end result is presenteeism, meaning they are present in the workplace but unable to perform as well as they might. 9 For this reason, some workplaces have policies indicating that employees may not wear any fragrances while on duty.

        Here, too, the best intervention is to discuss the problem directly with the student as soon as it's noticed. Since about one-third of workplaces include individuals who have scent sensitivities, establishing a fragrance-free policy is prudent. Consistency is important. Site supervisors who ask one employee or student to stop wearing fragrance should make sure that the rule applies to everyone. Again, it’s often more comfortable for students if the person who approaches them is of the same gender.

        PAUSE AND PONDER: What types of difficult behavior might stem from little exposure to professional environments and lack of experience?

        Profane or Poor Language Choices

        Patients often complain about profanity in healthcare, as they expect professionals to remove these words from professional discussions. But it’s a fact that people—all kinds of people—curse. Experts indicate that people use profane words in two ways: (1) in casual conversation, and (2) in anger.11 Students sometimes use profanity or inappropriate language, and in some cases, they are unaware that the words or phrases they choose are offensive, unprofessional, or incomprehensible. Some students simply use words that they grew up hearing and using, and they believe the words are acceptable. These words usually refer to biologic functions. One pharmacist was surprised when she heard her technician talking to a patient about diarrhea using the *s*-word to describe feces. When she approached the technician, the technician said with all sincerity, “That’s what it is! (The *s*-word)!”  And while the *s*-word is unprofessional, students will need to know patient-friendly terms because “feces” is too high level for many patients. (Suggest bowel movement, stool, or even poop.) Students may also be accustomed to using curse words in casual conversation and simply swear habitually. Unfortunately, others may overhear even casual conversations between coworkers and be offended, so using profanities at work (even in casual conversation) should be avoided.11

         

        Using profanity in anger is a different issue.11 Employees and students usually curse in anger when they are frustrated or arguing with someone. Usually, the person is in a heightened emotional state and the conversation is loud. The cursing affects everyone who hears the profanity, and patients are especially likely to be affected. Humans translate loud conflict as a survival threat and it activates the fight or flight response, raising others’ emotional states, too. Such a change can affect the performance of those involved in or witnessing the conflict for the next few hours. It’s possible that the incident could affect patient outcomes.11

         

        Preceptors should consider a  “No Swearing Policy.” Such policies should be enforced with a well-defined managerial plan for disciplinary action or possible termination for employees and specific repercussions for students (discussed below). While swearing, in and of itself, may not constitute serious misconduct, understanding its context and the potential harm it can cause is crucial.

         

        When preceptors observe a student breaching a no swearing policy, they should consider several factors12:

        • Intention: Determine whether the student accidentally used profanity as an outlet for frustration or used swear words to voice abuse or threats.
        • Delivery: Assess the specific words being used, the volume, and the student’s tone when swearing.
        • Context: Examine the circumstances in which an individual swore and the motivations behind it.
        • Workplace Environment: Consider the nature of your workplace, including the type of work being performed and the overall atmosphere.

        With employees, the recourse is corrective or disciplinary action. With students, the recourse is documentation in the next evaluation and if the event is serious enough, failing the student in  the professionalism section of the evaluation (which in some schools precipitates a failing grade for the entire rotation).

         

        It's important for preceptors to recognize when a student’s behavior may be considered unsafe or harmful to themselves, to patients, or other health care personnel. In cases when a student displays behavior that endangers others, preceptors should

        1. Involve the student’s school immediately.
        2. Provide timely, constructive, and actionable feedback. Identifying and sharing concerns as soon as they arise offers students the opportunity to correct the behavior promptly. Students may not receive a tremendous amount of feedback on their professionalism. It’s important to be transparent about a student’s progress or standing in a rotation.
        3. Inform students that they are breaching workplace policies and the types of disciplinary action that may follow.
        4. Document the date, time, and specific details of any concerning behavior. For situations in which students are at risk of a low to failing grades, documenting behaviors with dates can help justify grading decisions and address concerns with the OEE.

           

          Similar steps can be taken when students violate other polices like dress code, attendance, workplace harassment, cell phone use, etc.13,14

           

          Disrespectful Language

          Another type of inappropriate communication is biased language. Clearly, abusive language, hate speech, and racist or sexist remarks are never appropriate, but biased language may occur without the student being cognizant of it.15 Preceptors should address the student immediately and explain why what the student said or how the student said it is inappropriate. Some students may come from environments at home or socially where inappropriate language is normalized. These students may voice opinions that reflect their cultural biases, political persuasion, or religious beliefs, or demean others who believe differently. They may also use language that has been common and accepted by society but has now fallen from favor.15 For example, referring to the technicians as “the girls who run the register,” needs gentle correction. Similarly, labeling patients crazy, drug addict, and senile should prompt preceptors to suggest kinder, gentler terms. These terms have been replaced by mentally ill, person who uses drugs, and person with dementia, respectively. Explaining why negative words may be hurtful can help students develop empathy. It’s also an opportunity to explain how these conditions, like all medical diagnoses, are not the patient’s fault.16,17

          Finally, elderspeak is something pharmacy staff often use unintentionally to demonstrate support for the elderly patient.18 Elderspeak may become obvious as students encounter older adults. It’s a kind of speech adjustment—often called “baby talk” or “pet talk”—that young people may use when talking with an elder. Table 2 provides some examples of elderspeak.18

          Table 2. Examples of Elderspeak18

          • Changing the delivery of verbal information to
            • Raise the pitch and tone
            • Speak in a singsong tempo
            • Exaggerate words
            • Speak more slowly
          • Shortening sentence length
          • Simplifying sentence complexity by using limited (and sometimes condescending) vocabulary
          • Repeating or paraphrasing what the elder just said
          • Using terms like "dear," "honey," “old buddy,” or “young lady”
          • Using statements that sound like questions
            • Ending sentences with a negative question (e.g., You want to take this medicine as directed, don’t you?”)

          In short, elders often find elderspeak condescending and patronizing.18 Elderspeak can have a significant impact on specific patient populations. For example, patients with dementia or Alzheimer’s may experience progressive symptoms of aphasia as they age. Many caretakers and healthcare providers resort to language that is simple and limited to alpha commands, or language that is concise, straightforward, and direct. While elderspeak may help compensate for natural changes in older adults’ cognitive abilities, it may consequently cause older people to question their abilities and reinforce negative stereotypes about aging. Because opportunities for communication using elderspeak are constrained (often can be answered with yes or no or the communication invites a “correct” answer or no answer at all), older adults may perceive elderspeak negatively. It may cause reduced self-esteem, depression, and withdrawal from social interactions. Pointing out the problem when students use elderspeak is often enough to correct the behavior. Some students, however, will need coaching. Some strategies to minimize elderspeak include repeating and paraphrasing what you are saying, simplifying phrases, actively listening, and asking appropriate questions.18,19

           

          It’s essential for students to communicate effectively, maintaining a professional and positive demeanor at all times. Rotations with patient interaction are excellent opportunities to help students communicate their thoughts and feelings effectively. Poor language choices reflect poorly on the student, the school of pharmacy, and the pharmaceutical profession.  

           

          Other Specific Behaviors

          While the list of challenging student behaviors may be endless, this section touches on some of the other most common difficult behaviors preceptors encounter. This includes tardiness, boundary violations like practicing beyond one’s scope, inappropriate cell phone use, lacking accountability, lacking initiative and motivation, sloppy work practices, and gossiping. Employing effective strategies to manage these behaviors foster a more professional and productive educational experience.

           

          Last to Arrive, First to Leave

          Students are expected to be punctual and arrive at their rotations 15 minutes early. These standards are in place to replicate the pharmacist’s obligations and duties. While students aren’t responsible for opening a pharmacy at 8:00 AM, students must demonstrate their ability to be held accountable to such standards in the future. Students must adhere to their agreed scheduling commitments and communicate any delays or absences promptly. Tardiness creates lost productivity. Being 10 minutes late each day is equal to a week's paid vacation by year’s end!  It can also inconvenience others if they need to delay meetings or events.

           

          Students who have chronic tardiness problems usually have time management issues. It’s a habit that's difficult to defeat. Preceptors can use a number of interventions, described in Table 3.20

           

          Table 3. Dealing with Tardiness20,21

          1. Encourage punctuality with a clear policy. Communicate the policy to students when they arrive (and consider putting it in your introductory email) and enforce it consistently.
          2. Send reminders of early meetings or events. Send an e-mail reminder the evening before or 30 minutes before every meeting. Remind participants to be on time. Do not backtrack to fill them in on missed discussions if they are late.
          3. Deal with tardy individuals privately. Meet with the student, revisit company policies, and ask about extenuating circumstances or logistics problems. Clarify the consequences for being late, which may include asking the school to reassign the student.
          4. Describe punctuality as a choice. Convey to students that attendance is not an option, but a critical component of their professional training. They have a choice: To be punctual or the school will have to be notified immediately.
          5. Document, Document, Document. Keep written documentation of all incidents of tardiness, detailing the date and time. This will provide an accurate report to the OEE regarding the student’s behavior.
          6. Keep the pharmacy school involved and aware.

           

          Tardiness doesn’t just affect the student but the entire workplace dynamic. As one professor commented, “When you are late, it makes us ALL late. This is because, even if you think you’re just a student, you have a job here. When you don’t show up on time, you can’t do all the things we count on you.” This statement emphasizes the cascading effects of lateness and the importance of punctuality as just one way to demonstrate professionalism and teamwork.

           

          Addressing Boundary Issues and Protocol Deviation

          Students may fail to adhere to established procedures when the pharmacist is not present. For instance, students may provide patient counseling without the pharmacist present or verify medications without the pharmacist’s supervision to speed up workflow. This is called performing outside the scope of training or practice.22

           

          Some pharmacy employees are tempted to perform outside the scope of training or practice. Sometimes students feel pressured or justified to perform beyond their scope, but doing so violates professional guidelines, risks patient safety, and may violate state or national laws and regulations.22 Pharmacists might also choose to overlook or fail to confront boundary crossing. However, if allowed once, it sets a precedent for the future. Preceptors need to be clear that emergencies and staffing shortages happen, but all employees including students need to work within their scope of practice. Preceptors need to address mismatched expectations (i.e., that a student thinks it’s OK to counsel if the preceptor is busy) and ensure that the workplace has adequate supervision.22

           

          Preceptors can coach students that while they are on rotation and after they are licensed, they need to be aware of exactly what they can and can’t do. Students should watch for key phrases that signal danger which include

          • I’ll just do this first and then (show the pharmacist, call the doctor, convince the patient) later, I’m sure he won’t mind…
          • We do this all the time…
          • I know how to do this, it’s no big deal.

          When they start thinking like that, they need to stop and make sure they are practicing within their scope of practice.

           

          Practicing outside the scope aligns with another ethical concept known as incrementalism. Incrementalism suggests that as individuals repeatedly observe unethical behavior, they perceive it as less wrong, eventually normalizing it or deeming it acceptable. As the mind struggles to detect subtle changes over time, people may engage in unethical behavior more readily through a gradual process of minor infractions, ultimately escalating unethical behaviors. Unethical or challenging behavior typically doesn’t arise as a conscious decision to violate ethical standards; instead, it often occurs incrementally along a slippery slope, in tandem with peer interactions.

           

          Using cell phones at inappropriate times

          Cellphones, tablets, and other electronic devices can help students access pertinent information to better support their pharmacy practice experience. However, engaging with these devices in ways not related to their practice, such as unnecessary texting or browsing on social media, is inappropriate.

           

          Social media encompasses Internet-based tools that facilitate networking and collaboration, and real-time sharing of information, photos, videos, and more. Social media can be referred to as “social networking” or “Web 2.0.”23 These platforms can have positive and negative consequences on a student’s performance. While cell phones can be an indispensable tool for communicating and information access, misuse, or excessive use, can also be a source of distraction. When social media is excessive, it can lead to social media addiction (which is not yet a recognized medical condition). As with substance use, social media addiction can negatively impair physical and psychological health and cause behavioral disorders such as depression, anxiety, and mania. Researchers have not identified a threshold that would suggest what levels of social media use is considered to have poor outcomes. It’s clear poor management of social media use presents many concerning consequences on students’ academic performance and interpersonal relations 24-26

           

          As the technology landscape is always changing, consequences are unpredictable. Some practical solutions to supporting a student’s management of social media use can include:

           

          1. Set clear expectations: Early on, practice settings need to communicate and enforce guidelines about cell phone use. A simple approach is to set parameters in the syllabus.
          2. Suggest time management tools: Encourage students to use timers to manage their engagement with social media effectively. In the settings app on most phones, students can set a time limit that alerts the user when the time has been met.
          3. Be informative: Preceptors can encourage students to join online medical communities to access news articles, expert insights, and stay up to date on research and trends. Some students may simply have never thought to do so. Examples of social networking sites available for pharmacists include the following:
          • ASHP Connect (connect.ashp.org )
          • APhA (www.pharmacist.com)
          • The Pharmacist Society (www.pharmacistsociety.com)
          • LinkedIn
          1. Connect with students: Preceptors might also share readings, blogs, or podcasts that relate to the experiential rotation with students. As a supplement, following up on these materials can also exercise a student’s communication skills and their proficiency in relaying medical information.

           

          Lack of accountability and dishonesty

          At times, it may be necessary to address a student’s challenging behavior by discussing it privately. Many reactions can emerge from such conversations. Honesty and accountability should be prioritized – students should openly acknowledge their actions or lack thereof. As aspiring licensed pharmacists, they must uphold principles of integrity and accountability from the early stages of their advanced pharmacy practice experiences. Lack of accountability and dishonesty are character flaws that preceptors should consider quite serious.

           

          Let's talk about a student, Jeff, who started his IPPE rotation in a chain pharmacy location. Jeff's school of pharmacy has experienced recurring issues with him. He often fails to respond to emails in a timely manner if at all. Staff in the experiential education office has to nag at him constantly to update records about vaccinations, license renewals, and similar necessary documentation. He is often flippant about why OEE needs any of this information. On the first day of his rotation, his  preceptor asked if he was up to date with all of his vaccinations and licensure renewals, to which he responded, “Of course. I wouldn't be here if I wasn't!” Over the first few days that Jeff worked at the store, the preceptor noticed some incongruities in several of Jeff’s explanations. He had unusual explanations for tardiness, was very defensive when he didn't know the answer to a question, and he was caught using the photocopier for personal purposes even after he had been told not to.

           

          Several days later, the person who was responsible for tracking documentation in the OEE called and asked to speak with Jeff. She had heard that Jeff reported to this site even though the school had told him not to until his vaccinations were current. Jeff took the phone off to a corner of the pharmacy and spoke in hushed tones. When he was done, he told the preceptor that unfortunately he had an emergency and had to leave, and he would let him know when he would return. When the preceptor expressed concern, Jeff said that he had not submitted his vaccination documentation. When pressed further, Jeff confessed that he actually had failed to receive his vaccinations.

           

          Dishonesty is unacceptable in a professional setting. When encountering similar situations, the preceptor should consider the following:

          • Preceptors should report dishonesty to the OEE as soon as they notice it. Often, preceptors think that this may be a one-off instance of a student’s bad judgement, or preceptors think they may not understand something. Usually, however, this is a behavior that the school of pharmacy has been tracking and other people have noticed also.
          • Documentation is critical. It needs to be thorough and clear. Preceptors should document what they saw or heard, how they disproved or came to realize that the information was dishonest, and when exactly it happened. They should not wait till the final evaluation to make note of the problems. It should occur in the very first evaluation and it's acceptable to do an immediate interim evaluation.
          • If the preceptor decides to pass a student who showcased moments of dishonesty on a rotation, they should document in writing that they are passing the student, but they experienced professionalism problems during the rotation.
          • At some schools that use a pass-fail system, professionalism violations are an immediate “fail.” We don't want people who have this magnitude of dishonesty entering the profession.

           

          PAUSE AND PONDER: What kinds of behaviors would improve with discussion and direction, and what kind of behaviors would improve with more practice?

           

          Inability to take initiative and unwillingness to participate in activities

          Some students may appear frustrated, bored, underprepared, and distracted. This lack of engagement may manifest in communication styles aimed at minimizing interactions or diverting attention away from meaningful conversations. An essential component of professional development is the student’s capacity to engage proactively in various learning activities.

           

          A particularly concerning sign is a student’s lack of motivation, which may be evident in their reluctance to engage in self-directed learning or displaying disinterest in the rotation site, assigned activities, or patient care. To address this issue, Table 4 outlines several coaching strategies designed to re-engage students lacking motivation.

          Table 4. Strategies to Engage Students Lacking Motivation27,28

          • Discuss your observations regarding their disinterest and lack of motivation with the student.
          • Encourage the student to create a personal success plan, including:
          • Self-assessment of performance areas needing improvement, as identified by the preceptor
          • Development of a concrete, actionable plan for improvement
          • Engagement in critical reflection
          • Revisit the learner’s professional and rotational goals to realign the students focus
          • Consider setting mutual goals with the student, focusing on how to use discretionary time during the rotation to meet their unique needs and interests.

          Students may distance themselves for several reasons. This could be due to finding a topic uninteresting, lacking understanding of situational expectations, or facing difficulties engaging with an interprofessional team or among cross-generational groups. By allowing students the opportunity to receive feedback and create their own success plan, they can incorporate a self-directed learning process. This approach provides a scaffold in developing essential self-awareness skills.

           

          Consider Sally, who was two weeks in her rotation at Rosemary Hospital. Her preceptor, Dr. Unconfrontational (“Dr. U”), observed that Sally was unengaged, asked no questions, and kept disappearing in the break room for long stretches of time. Five days into the rotation, Dr. U asked Sally if she had read the assigned chapter the evening before. She said she did. When he asked questions about its content, she couldn’t answer. He needed to take a phone call, and she slipped away. He found her in the break room with the book open to the chapter (but she seemed to just stare at the pages). Dr. U was disappointed that Sally wasn’t interested in what he considered the most fascinating—but not the most difficult—part of his specialty. He decided that it was easier to stop assigning reading to Sally because she seemed uninterested. At the rotation’s end, he passed her with a C.

           

          Cases like this demonstrate that precepting can be difficult and students can be puzzling. Although it’s hard to tell if Sally read the chapter, her behavior suggests she did not. The way that Dr. U interacted with Sally provides little information about the root of the problem. Dr. U could have done a number of things when he noticed Sally’s lack of enthusiasm29-31:

          • He could have educated himself about disengagement. It’s usually not directed at the preceptor. It could be poor self-esteem, difficult home situations, or the need to work after hours to support oneself. It may be that the student doesn’t see the assignment as challenging. Or, the student may be bored and need more—rather than less—work.
          • He could have spent time asking Sally about her interests and what she hoped to learn in his rotation. While getting to know her, he could have asked if she had concerns or obligations outside of the rotation that he should know about. Ice-breaking activities are critical with students and should reveal students’ talents, passions, questions, and challenges. Asking questions like, “How do you learn best?” or “Would you rather read about a topic, watch a video, or do both?” can also provide good information.
          • He could have examined his own expectations to make sure they were SMART (specific, measurable, achievable, realistic, and time-tagged). Was he asking too much?
          • He could have asked her what she learned in pharmacy school related to his specialty, and what she liked and disliked about it.
          • He could provide “hooks” to start her thinking about what’s coming next. This is the practice of providing just a little bit of attention-grabbing information about a topic. Preceptors can make a controversial statement (“Some people believe that gargling with bleach kills COVID. We’ll talk about how to respond to that kind of talk next week.”), asking a provocative question (“Why do you think that more than half of patients don’t take their medication? Do you think that statistic is accurate?”), or telling a good story (“I keep this x-ray on the bulletin board because it reminds me of a child who had nausea, vomiting, diarrhea, and low copper levels. It all came down to those things you see in his gut! Anyway…think about that and we’ll talk about it next week)
          • He could have asked her to develop three goals for the rotation, and three sub-goals for each of the main goals so she could plan her own learning. If she couldn’t do this activity (which would explain much about why she is disengaged), he could work with her to develop goals.
          • He could have asked her to create a deliverable as she read the chapter. Asking her to write down 10 interesting facts or use sticky notes to mark the pages she found most interesting and least comprehensible would have added an interactive element to the assignment.
          • He could have asked her if she has had any experience with patients or family members who have diagnoses related to his field. This often provides some real-world relevance to learning.

           

          Sloppiness

          Health professionals including pharmacy students are held to rigorous standards of cleanliness, organization, and adherence to site-specific protocols. These protocols are not merely procedural formalities but are fundamental to maintaining quality standards and preventing pharmacy errors.

           

          Pharmacy students, through their education and practical experiences, should be well-versed in these high standards. In compounding labs, for instance, faculty emphasize meticulous attention to detail and stringent adherence to procedures. As future pharmacists, they will prepare or verify medications that are often ingested orally, where the risk of contamination carries potentially severe consequences. Table 5 shares examples of how a student may exhibit sloppy behavior.

          Table 5. Examples of the Sloppy, Disorganized, and Nonadherent Student

          • Poor medication management: This can include incorrect labeling, improper storage of drugs, or disorganized inventory management. These practices can lead to medication errors, altered drug metabolism, or even possible harm to patients.
          • Lack of attention to detail: This can manifest in several ways such as making calculation errors, misinterpreting prescriptions, or failing to recognize important patient information. Again, this is a patient safety issue.
          • Failure to clean up: Leaving behind clutter and the detritus of pharmacy work for others to clean not only disrupts workflow but also reflects a lack of professionalism and responsibility.
          • Improper waste disposal: Disregarding proper guidelines for drug disposal of expired or unused medications, sharps, and other waste can pose environmental and safety repercussions.
          • Improper recycling practices: In hospital and community pharmacy settings, waste bins are often color-sorted for proper disposal. For example, disposing patient information in a regular trash bin instead of its designated bin violates HIPAA regulations.

          Addressing these issues in educational settings is imperative for students to be aware of their habits and actions. This involves reinforcing the importance of these standards early, modeling these behaviors, and holding students accountable when necessary.

          Gossiping

          During rotations, some students may seamlessly connect with other staff members. In some cases, students may observe instances when coworkers engage in gossip and complaints about the workplace and colleagues. While it might be tempting to indulge in such discussion, setting boundaries is crucial when displaying leadership. This includes no gossiping or destructive criticism, and showing empathy when other coworkers present difficult behaviors.  Students should be embedded in the healthcare team with a healthy sense of belonging. As students practice mirroring the pharmacist’s actions, they learn to act as mediators in workplace conflict.

           

          One way to discuss gossip with students is to ask them if they know what Socrates said about repeating information.32 This Greek philosopher said that before speaking, people need to ask themselves three questions about the information they plan to convey: Is it true, is it kind, and is it necessary? These questions are filters. Asking these questions guides the honest person to engage in ethical thinking and decision-making. Taking a few minutes to shift the discussion from the juicy tidbit of gossip to the related and more important topic of truth, kindness, and necessity can (but doesn’t always) help people who gossip develop some insight into their behavior. Emphasizing that these questions help individuals develop nurturing, trusting, empathetic relationships is key. This technique is useful with students and coworkers and can often start the process of reducing gossiping.32

           

          LEARNING THEORY TO ENHANCE ROTATIONS

          Canadian psychologist Albert Bandura is widely recognized for introducing the concept of social cognitive theory.33 He postulated that learning of any type occurs through observation, imitation, and modeling with influence from the learner’s attention, motivation, attitudes, and emotions. It means that the environment interacts with the individual’s cognitive makeup as learning occurs. Preceptors can use his tenets to help students engage and learn. Bandura’s observational learning theory moves through four key cognitive processes33,34:

          1. Attention: Learning starts with an individual’s engagement and focus on a particular behavior or task. The ability to imitate a behavior hinge on the accessibility of role models, behavior complexity, and perceived value of behavior. Ultimately, students need to perceive a model, or their preceptor, as someone worth imitating.
          2. Retention: Students should register and retain information that they observe from their model preceptor. Learners retain information in a symbolic form of imagery and verbal elements. When preceptors perform actions repeatedly, they enhance the student’s retention.
          3. Motor reproduction: As students are assigned to new tasks or behaviors associated with being a pharmacist, they will use clues from imagery and verbal elements to guide their actions. Frequent motor reproduction exposes students to new situational contexts and empowers them to adapt and refine their behaviors in future interactions. Role models who demonstrate positive behaviors subtly influence others’ actions and responses.
          4. Motivation, reinforcement and punishment: Attention, retention, and motor reproduction all contribute to the ability to imitate a behavior. To stimulate positive reinforcement of behavior, the motivation and will to perform is often based on the rewards and punishment that result from modeling those actions.

           

          Preceptors who understand another theory—that of unconscious learning—will also be able to assess students based on their past experiences and present materials appropriately. It describes the acquisition, access, and application of knowledge without deliberate and controlled attention. It’s the opposite of studying for an exam. It’s basically the “learn by doing” model, students are unaware it’s happening, and it, too, has four stages.35,36

           

          1. In the first stage, unconscious incompetence, students are unaware of how little they know about a subject. These are entry level students who have little experience. They may think they know more than they actually do.
          2. In the second stage—conscious incompetence—students are able to recognize knowledge deficits. Preceptors can think of this as the point where students experience that AH-HA! moment of enlightenment.
          3. Learning begins to accelerate and coalesce in the third stage—conscious competence. Students will begin to see patterns and store that information. An example would be learning the top 200 drugs after processing prescriptions or orders, rather than just memorizing them.
          4. In the fourth stage, students develop unconscious competence. A task or process becomes second nature. Preceptors will not need to remind students to complete steps. Students will simply do the right thing.

           

          Learning barriers can contribute to student difficulties, so understanding learning theory can assist preceptors to support students and reduce difficult behaviors. Exposure to a variety of situations in the workplace will help students learn unconsciously.36 Fear and anxiety are barriers to unconscious learning (and contributors to difficult behaviors), so creating a learning environment that is comfortable (and maybe even fun) can speed the process. So can asking students to take a few moments and visualize processes and procedures before starting.36

           

          In the unconscious incompetence stage, preceptors will need to look for signs that students are recognizing they don’t know what they don’t know.37 Having students repeat processes until they can do them without error is essential. Asking students how they think they are doing may stimulate some self-awareness. Encouraging them to periodically question what they think they know is also good.37 These steps break down learning barriers gradually.

           

          When students reach conscious incompetence, preceptors need to be observant. It’s the step where students, frustrated with their deficits, may want to give up. Preceptors who provide encouragement and additional practice can help them move on. Students need positive feedback to progress to the last step of unconscious competence, or mastery.

           

          PAUSE AND PONDER: Think about a student whose behavior was difficult to address in the past. After taking this continuing education activity, how would you have addressed the issues differently?

           

          CONCLUSION

          When students are on rotations, they are in certain respects on their own and need oversight from preceptors and the preceptors’ team. Students benefit from preceptors who engage with their students. Oversight and feedback are needed consistently during this crucial time because preceptors want their students to succeed in the profession and the workplace. Pharmacy preceptors who explore the effectiveness of managing tardiness and use strategies to reinforce accountability and motivation will find the precepting experience more fulfilling. A thorough understanding and application of social cognitive theory and stages of learning will enhance a preceptors response to difficult student behaviors. They can use the interventions they develop to build better pharmacy student experiences. Before giving up on the student, they should ask for help from the pharmacy school’s OEE and reach out to people with good supervisory skills.

           

          Why does early intervention on the preceptor’s part to correct difficult student behaviors matter? Developing good workplace behaviors is critical to prepare students for the rigors and responsibilities of the pharmacy workplace. Precepting students is a phenomenal opportunity to practice life-long learning and working mantras.

           

           

           

          Pharmacist Post Test (for viewing only)

          POST TEST QUESTIONS

          Dealing with Difficult Students: Simple(ish) Solutions to Common Problems

          Educational Objectives
          1. DEFINE types of student behaviors and common challenges preceptor’s encounter
          2. EXPLAIN the underlying factors and learning needs that contribute to difficult student behaviors
          3. APPLY the principles of student-centered learning to develop appropriate responses to difficult students
          4. ANALYZE case studies and develop strategies for difficult student behaviors

          1. Why is dressing appropriately important for students on rotation in a community pharmacy setting?
          A. Community pharmacies usually enforce dress codes strictly.
          B. It can improve the student’s self-perception and confidence.
          C. It ensures that students bathe and groom regularly.

          2. Why should a preceptor intervene when a student addresses an older patient as “honey” or “sweetie”?
          A. Elderspeak usually signals conflict and activates the fight or flight response, creating fear and anxiety among people who are nearby.
          B. Elderspeak is demeaning to older people and may cause them to question their abilities and reinforce negative stereotypes about aging.
          C. Elderspeak is usually reserved for speaking to children as it describes using endearments, so children feel more relaxed.

          3. Why might a student use poor word choices that may be considered profane for biologic functions?
          A. They may have grown up in a home where those words were used exclusively and not realize that most people consider the words profane.
          B. The problem isn't the student; The problem is that the preceptor doesn't understand that English is changing and some words are more acceptable now.
          C. The student probably perceives that the patient will be more comfortable with common slang and needs to be corrected.

          4. A student is on his first rotation in a hospital setting. He has no experience other than a few weeks working in a chain pharmacy. The preceptor observes the student using a procedure that may be acceptable in a chain pharmacy but it's not acceptable in a hospital pharmacy. What step of unconscious learning does this reflect?
          A. unconscious incompetence
          B. conscious incompetence
          C. conscious competence

          5. A student reports for her rotation wearing a white coat that is clean and pressed but smells like a popular laundry additive that adds a strong scent to the fabric. Two employees at this location are extremely allergic to strong scents. Select the statement that is TRUE.
          A. All health care facilities have policies that prohibit the use of scents.
          B. The preceptor’s introductory e-mail should have said not to use fragrance.
          C. More than one-third of Americans report scent sensitivity.

          6. Why might a student be tempted to perform outside the scope of work appropriate for an intern?
          A. The student might feel pressured to do more than she should.
          B. The pharmacy school might not have explained scope of work.
          C. State law might be vague about an intern’s scope of work.

          7. A student has prepared inadequately on several occasions and presented work that is sloppy and incomplete. The preceptor asks the student to create a personal success plan. What is one possible component to such a plan?
          A. A face-to-face discussion with the preceptor
          B. Engagement in critical reflection about motivation
          C. A letter to the pharmacy school documenting deficits

          8. You overhear a student discussing information about one employee with one of your other employees. You know that the information is untrue and mean-spirited. You pull the student aside and counsel him about gossip. What question would help the student develop insight?
          A. Is it true, is it kind, and is it necessary?
          B. Where did you get that information?
          C. Why would say something like that?

          9. Which of the following is an example of a “hook” to increase student engagement?
          A. Ensuring you make only uncontroversial statements
          B. Asking questions that student will surely be able to answer
          C. Telling a story about materials to be covered next week***

          10. Your current APPE student tends to arrive 15 minutes late every day and seems to disappear about 10 minutes before the close of business. Which of the following is the BEST approach?
          A. Clarify the store's hours and that the student needs to arrive and leave on time, explain why it's necessary to be on time, and document if the problem persists
          B. Document the problem on the first offense, explain why it's necessary to be on time, clarify the store's hours and that only paid employees can arrive late
          C. Notify the school of pharmacy immediately that the student is a problem and needs to be reassigned to a different rotation site because she is too difficult

          11. Which of the following statements is the best strategy for dealing with difficult students?
          A. Preceptors should address problems only if they reoccur since most times, students simply are ignorant of certain rules.
          B. Preceptors should address problems as soon as they see them using kind corrective action and positive reinforcement.
          C. Preceptors should realize that when they have difficult students, the problem is usually a mismatch with the rotation site.

          References

          Full List of References

          REFERENCES
          1. Non-Responders: How to Deal With Colleagues Who Don’t Answer Their Email. Walden University. Accessed March 19, 2024. https://www.waldenu.edu/online-masters-programs/ms-in-industrial-and-organizational-psychology/resource/non-responders-how-to-deal-with-colleagues-who-dont-answer-their-email
          2. Zucker R. How to Follow Up with Someone Who’s Not Getting Back to You. Harvard Business Review. January 13, 2021. Accessed March 19, 2024. https://hbr.org/2021/01/how-to-follow-up-with-someone-whos-not-getting-back-to-you
          3. Naughton CA, Schweiger TA, Angelo LB, Lea Bonner C, Dhing CW, Farley JF. Expanding Dress Code Requirements in the Doctor of Pharmacy Program. Am J Pharm Educ. 2016;80(5):74. doi:10.5688/ajpe80574
          4. Cardon PW, Okoro EA. Professional characteristics communicated by formal versus casual workplace attire. Bus Comm Q. 2009;72(3): 355–360. doi: 10.1177/1080569909340682
          5. Furnham A, Chan PS, Wilson E. What to wear? The influence of attire on the perceived professionalism of dentists and lawyers. J Appl Soc Psychol. 2013;43(9):1838-1850. doi:10.1111/jasp.12136
          6. Rickles NM. UConn School of Pharmacy Student Handbook. University of Connecticut School of Pharmacy
          7. McClure C. Autism and Poor Hygiene: The Smelly Truth to Overcome. My Autism Mind. July 13, 2023. Accesse March 19, 2024. https://myautismmind.com/poor-hygiene/
          8. Chan CK, Lam TY, Mohanavel L, et al. Knowledge, attitude, and practice of white coat use among medical students during clinical practice (LAUNDERKAP): A cross-sectional study. Am J Infect Control. 2024;52(1):35-40. doi:10.1016/j.ajic.2023.06.022
          9. Rádis-Baptista G. Do Synthetic Fragrances in Personal Care and Household Products Impact Indoor Air Quality and Pose Health Risks?. J Xenobiot. 2023;13(1):121-131. Published 2023 Mar 1. doi:10.3390/jox13010010
          10. Steinemann A. International prevalence of fragrance sensitivity. Air Qual Atmos Health. 2019;12(8):891–897. doi: 10.1007/s11869-019-00699-4.
          11. Thompson R. The Profanity Problem. January 24, 2022. Accessed August 27, 2023. https://www.workingnurse.com/articles/the-profanity-problem/
          12. Raptis G. My Employee is Swearing in the Workplace. What can I do?. Updated April 11, 2022. Accessed February 15, 2024. https://legalvision.com.au/my-employee-is-swearing-in-the-workplace-what-can-i-do/
          13. Chunta KS, Custer NR. Addressing unsafe student behavior. AJN, American Journal of Nursing. 2018;118(11):57-61. doi:10.1097/01.naj.0000547667.08087.51
          14. Raptis G. My employee is swearing in the workplace. what can I do? LegalVision. April 11, 2022. Accessed September 9, 2023. https://legalvision.com.au/my-employee-is-swearing-in-the-workplace-what-can-i-do/.
          15. Morgan K. Why swearing could have a place in the office. May 16, 2021. Accessed August 27, 2023. https://www.bbc.com/worklife/article/20210514-why-swearing-could-have-a-place-in-the-office
          16. Szalavitz M. Why We Should Say Someone Is A 'Person With An Addiction,' Not An Addict. NPR. June 11, 2017. https://www.npr.org/sections/health-shots/2017/06/11/531931490/change-from-addict-to-person-with-an-addiction-is-long-overdue
          17. Senile: Why Not to Use the Term and How You Can Age Well. Healthline. Accessed August 27, 2023. https://www.healthline.com/health/senior-health/senile
          18. Simpson J. Elderspeak – Is it helpful or just baby talk? Merril Center. Accessed September 1, 2023.https://merrill.ku.edu/elderspeak-it-helpful-or-just-baby-talk
          19. Torres-Soto K. The Effects of Elderspeak on the Mood of Older Adults with Dementia: A Preliminary Report. Order No. 13885707 ed. Minnesota State University, Mankato; 2019. Assessed August 31, 2023. https://www.proquest.com/dissertations-theses/effects-elderspeak-on-mood-older-adults-with/docview/2247140946/se-2
          20. DeLonzor D. Taming Tardiness. SHRM. August 18, 2020. Accessed October 1, 2023. https://www.shrm.org/resourcesandtools/hr-topics/people-managers/pages/taming-tardiness.aspx
          21. Edwards P. HR in Practice: Addressing Employee Tardiness. MedEsthetics. August 25, 2016. Accessed October 1, 2023. https://scholar.google.com/scholar?as_ylo=2019&q=tardiness+healthcare+worker+punctuality&hl=en&as_sdt=0,7
          22. Doobay-Persaud A, Evert J, DeCamp M, et al. Extent, nature and consequences of performing outside scope of training in global health. Global Health. 2019;15(1):60. Published 2019 Nov 1. doi:10.1186/s12992-019-0506-6
          23. Ventola CL. Social media and health care professionals: benefits, risks, and best practices. P T. 2014;39(7):491-520.
          24. Azizi, S.M., Soroush, A. & Khatony, A. The relationship between social networking addiction and academic performance in Iranian students of medical sciences: a cross-sectional study. BMC Psychol 7, 28 (2019). https://doi.org/10.1186/s40359-019-0305-0
          25. Bhandarkar AM, Pandey AK, Nayak R, Pujary K, Kumar A. Impact of social media on the academic performance of undergraduate medical students. Med J Armed Forces India. 2021;77(Suppl 1):S37-S41. doi:10.1016/j.mjafi.2020.10.021
          26. Lahiry S, Choudhury S, Chatterjee S, Hazra A. Impact of social media on academic performance and interpersonal relation: A cross-sectional study among students at a tertiary medical center in East India. J Educ Health Promot. 2019;8:73. Published 2019 Apr 24. doi:10.4103/jehp.jehp_365_18
          27.Davis LE, Miller ML, Raub JN, Gortney JS. Constructive ways to prevent, identify, and remediate deficiencies of "challenging trainees" in experiential education. Am J Health Syst Pharm. 2016;73(13):996-1009. doi:10.2146/ajhp150330
          28. Briceland LL, Caimano RC, Rosa SQ, et al. Exlporing the impact of engaging student pharmacists in developing individualized experiential success plans
          29. Barkley EF. 7 Ways to Use “The Hook” to Grab Students’ Attention. Wiley Network. Accessed January 16, 2024. https://www.wiley.com/en-us/network/education/instructors/teaching-strategies/7-ways-to-use-the-hook-to-grab-students-attention
          30. Chipchase L, Davidson M, Blackstock F, et al. Conceptualising and measuring student disengagement in higher education: A synthesis of the literature. Int J Higher Ed. 2017;6(2):31-42.
          31. [No author.] A Gentle Nudge: How Teachers Can Address Disinterested Students. Accessed January 15, 2024. https://blog.planbook.com/disinterested-students/
          32. Is it True, Is It Kind, or Is It Necessary Quote: Origin and Explanation. QUOTELYFE. Accessed January 16, 2024. https://quotelyfe.com/is-it-true-is-it-kind-or-is-it-necessary-quote-origin-and-explanation/
          33. Fuente J de la, Kauffman DF, Boruchovitch E. Editorial: Past, present and future contributions from the social cognitive theory (Albert Bandura). Frontiers in Psychology. Published online August 7, 2023. Accessed September 8, 2023.
          34. Incrementalism. Ethics Unwrapped. November 5, 2022. Accessed September 7, 2023. https://ethicsunwrapped.utexas.edu/glossary/incrementalism.
          35. Kuldas S, Ismail HN, Hashim S, Bakar ZA. Unconscious learning processes: mental integration of verbal and pictorial instructional materials. Springerplus. 2013;2(1):105. doi: 10.1186/2193-1801-2-105.
          36. Griffen M. Unconscious Incompetence and the Four Stages of Learning. Medium. January 13, 2014. Accessed January 31, 2023. https://mattangriffel.medium.com/unconscious-incompetence-ad5583abf646
          37. Cherry K. What Is the Dunning-Kruger Effect? A cognitive bias that causes an overestimation of capability. verywellMind. November 5, 2022. Accessed January 31, 2023. https://www.verywellmind.com/an-overview-of-the-dunning-kruger-effect-4160740

          Exploring Implicit Bias and Its Impact in Pharmacy

          Learning Objectives

           

          After completing this application-based continuing education activity, pharmacists will be able to

          ·       DEFINE different types of bias and how they are formed
          ·       RECOGNIZE what bias may look like in the pharmacy setting
          ·       IDENTIFY how bias can impact patient care
          ·       APPLY methods to address and mitigate bias in the workplace

           

          After completing this application-based continuing education activity, pharmacy technicians will be able to:

          ·       DEFINE different types of bias and how they are formed
          ·       RECOGNIZE what bias may look like in the pharmacy setting
          ·       IDENTIFY how bias can impact patient care
          ·       ILLUSTRATE methods to address and mitigate bias in the workplace

           

           

             

            Release Date: March 20, 2024

            Expiration Date: March 20, 2027

            Course Fee

            FREE

            There is no funding for this CE.

            ACPE UANs

            Pharmacist: 0009-0000-24-017-H04-P

            Pharmacy Technician:  0009-0000-24-015-H04-T

            Session Codes

            Pharmacist:  24YC17-TKF38

            Pharmacy Technician:  24YC17-FTK43

            Accreditation Hours

            2.0 hours of CE

            Accreditation Statements

            The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit for the online activity ACPE UAN 0009-0000-24-017-H04-P/T will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

             

            Disclosure of Discussions of Off-label and Investigational Drug Use

            The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

            Faculty

            Jessica Bylyku
            PharmD Candidate 2024
            UConn School of Pharmacy
            Storrs, CT

             

            Jeannette Y. Wick RPh, MBA, FCCP
            Director Office Pharmacy Professional Development
            UConn School of Pharmacy
            Storrs, CT

            Faculty Disclosure

            In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

            Neither Ms. Wick nor Ms. Bylyku have any relationships with ineligible companies.

             

            ABSTRACT

            Implicit bias is an important buzzword in healthcare. It has received much attention in the past few years because many researchers have documented its pervasive existence among healthcare providers. Implicit bias involves consciously or unconsciously thinking of some patient groups (or some coworkers) as less important than others, less deserving of care, or simply “less than.” Related concepts include second victim phenomena and imposter syndrome. Good research documents that many people from disenfranchised groups experience implicit or explicit bias when they visit pharmacies. Educational institutions have started to develop programs to educate pharmacists about potential implicit bias before they graduate. Yet most pharmacy personnel who work in clinical contexts have not had such education and need to understand the basic concepts of implicit bias. Pharmacy staff who take time to examine their own attitudes can improve care in influential ways and become significantly more enlightened. This continuing education activity provides basic education on implicit bias and refers readers to evaluation tools.

            CONTENT

            Content

            INTRODUCTION

            Can you solve this riddle?

            A father and son are involved in a car crash. The son is rushed to the hospital. As the son is about to enter surgery the surgeon says, “I can’t operate—that boy is my son!”

            People answer this question in a variety of ways, revealing different implicit biases. Some answers include 1) the boy has two fathers or 2) the father was actually a priest or 3) the whole thing was a dream. Researchers asked this question to two focus groups, one consisting of 197 college students from Boston University and the other, 103 children from Brookline Summer camps.1 Only 14% of college students and 15% of children answered correctly with the “mom’s the surgeon."1 A majority of people didn’t guess that the surgeon was the boy’s mother until a few tries, revealing the implicit bias that females are not meant to be doctors or surgeons. 

            TYPES OF BIAS 

            Implicit biases are unconscious mental processes that create unintentional automatic associations and reactions.2 Implicit bias is more than a stereotype, which is a fixed set of characteristics associated with a particular social group. Implicit bias occurs when people harbor biases unconsciously. A person can develop negative feelings or attitudes towards another person by failing to connect to another person’s identities. The other person may then become part of an “out-group.”2 This is not to say that those with shared identities hold no bias towards each other; some women think that women cannot be surgeons, for example. It’s important to look at other factors that cause implicit bias. Besides obvious differences in identities, social norms can influence biases and media outlets, public policy, and even education may magnify bias.2 People may not often express implicit biases out loud because of their hidden, unconscious nature. Implicit biases contribute to a person’s explicit biases.

            Explicit biases include peoples’ conscious preferences, beliefs, and attitudes, and people may communicate them outright.2 For example, people may express explicit biases verbally and expose their prejudicial opinions. Prejudice—a biased response towards a social group and its members based on preconceptions3—may lead to irrational hostility directed towards an individual or group.  

            In-Group vs Out-Group

            Social psychologists have long known that people define themselves in terms of social groups and often malign or disparage others who don't fit into their social groups. People who are part of the “in-group” feel they belong to that group because of social perceptions. People part of the in-group generally have positive views of each other and perceive that the group is composed of individual people.4 In direct comparison, in-group members view people in the “out-group” negatively because they do not belong to the in-group. People in the in-group characterize the out-group as a homogeneous collective rather than individuals. Thus, it becomes easy for members of the in-group to label the out-group as “all the same” rather than treat them like individuals.4

            Simply put, in-vs-out group labeling becomes a case of “us-vs-them" with those in the in-group being “us” and those in the out-group being “them.”4 This tendency explains why hostility can exist between certain groups based on factors like political parties, race, or sexual orientation. This concept of “othering” people is fundamental to understanding how bias can influence personal opinions. Healthcare workers must be mindful of their opinions to ensure biases do not interfere with patient care.

             

            Differentiating Stereotypes, Microaggressions, and Discrimination

            Stereotypes are a fixed set of attributes associated with a particular group.2 Stereotypes are often untrue or unfair generalizations about people who may appear or identify a certain way. Stereotypical beliefs can lead to displays of microaggression, discrimination, and harmful judgment. Some common examples of stereotypes include

            • People who wear glasses are smart
            • Boys are stronger than girls
            • People with tattoos are dangerous
            • Men are better drivers than women

            Microaggressions are physical or verbal acts that subtly express stereotypical thoughts. A 2010 study tracked high school students (N = 342) over their four-year progression and found that students had experienced 21 different types of microaggressions at least once.5 Some examples of reported microaggressions included5

            • Teachers assuming a Black student was poor or illiterate
            • Hispanic and Asian students were asked to teach “native words” even if they only spoke English
            • Students of color being called on to speak on behalf of their race

            Discrimination is the result of implicit or explicit biases. It causes unfair treatment of individuals and communities based on general policies, practices, or norms.2

            PAUSE AND PONDER: What kinds of implicit bias have you observed in your workplace?

            Consider this example: Kate was shopping at the rear of a beauty store when suddenly, someone robbed the cashier located at the front of the store. She rushed home and immediately called her friends Mark and Sylvia to share what she had experienced. Mark asked what the robber looked like. Sylvia says, “I didn’t see him. He was probably Black. They usually are.” This demonstrates a stereotype about Black people. Her comments are the microaggressions in this case. Sylvia’s racial bias is what contributed to this reaction.

             BIAS SUBGROUPS

            Bias comes in many forms and is not limited to particular set of individuals. It can affect any group. Common biases are based on6

            • Beauty
            • Educational background
            • Gender
            • Race/Ethnicity
            • Religion
            • Sexual orientation
            • Socioeconomic background

             

            Unconscious biases are more difficult to identify given that people rarely verbalize them, but they still play crucial roles in affecting behavior and judgment. Bias is a large umbrella term that can further be broken down into subgroups and sub-definitions. Table 1 lists some common categories of unconscious or implicit bias. The SIDEBAR discusses recency bias, a type of bias that can have significant influence on providers’ and patients’ healthcare decisions.

            Table 1. Major Biases Present in Everyday Life6

            Affinity bias Unconscious preference for people with whom you share qualities or interests
            Ageism Negative feelings towards others based on their age
            Attribution bias Related to how you infer the reasons that others act as they do and misunderstand motivations; individuals may attribute their own accomplishments to skill, but assign no fault to their failures; they may be less generous in their thinking when examining others’ behaviors
            Beauty bias Belief that attractive people are more successful, competent, and qualified than unattractive people; physical appearance is used to judge competency
            Confirmation bias Searching for information that backs the opinion an individual holds and rejecting information that contradicts that opinion
            Conformity bias Others’ views influence an individual’s views; this concept is related to peer pressure and acceptance seeking

             

            SIDEBAR: RECENCY BIAS7,8

            Recency bias affects cognitive decision-making by favoring recent events over historic events to estimate future events. Recency bias is also defined as the tendency to base thinking on what comes easily to mind based on recent events.

            For example, an employer is conducting employee evaluations and greets an employee who consistently meets performance goals and expectations. However, the employer chooses to deny the employee a promotion based on a recent mistake. Despite consistent success, a recent error influenced the employer’s decision.

            In healthcare settings, some examples of recency bias include

            • Rejecting older evidence that disproves new (mis)information
            • Emphasizing recent information and failing to consider the entire evidence set
            • Seeking new information rather than older, more voluminous, and more consistent facts

             

            ETIOLOGY OF BIAS

            Science offers some explanation as to how and why biases form in the human mind. The amygdala and the prefrontal cortex (PFC) are most involved in forming bias.9 The amygdala, a small structure located in the temporal lobe of the brain, is responsible for receiving direct information from all the body’s sensory organs.3 It is the part of the brain that generates responses to stimuli, whether that be arousal, attention, or fear.3 The amygdala controls the body’s fight-or-flight response, which is activated in situations that are frightening like walking down a dark alleyway, hearing unfamiliar sounds, or seeing unfamiliar people.3,10

            Several neuroimaging studies have shown that activity in the amygdala heightens when people view pictures that trigger biases. For instance, when people see facial images of those from a different ethnic background than that of their own, the amygdala is activated more so than seeing people who look similar to them.3,10

            The PFC processes cues and is involved with contingency-based learning, decision-making, and evaluation.3 Essentially, the PFC communicates with the amygdala to signal that visual or auditory cues may not be a danger at all; it effectively regulates or “calms” immediate amygdala activation based on situational surroundings.9,10 The PFC functions to help the brain adjust to fit the environment’s social norms.

             

            Influences of Bias

            Social attitudes and expectations that reinforce stereotypes and microaggressions change the way the brain processes behavior. That said, implicit bias is not intrinsic (or hard-wired), meaning although it may exist in the unconscious parts of the brain, it can be “un-wired.”10 Experiments involving children who had diverse friend groups show less reactive amygdala activation, meaning their brains did not automatically associate negative reactions based on skin color.9

            What does this have to do with bias? It suggests that bias is not inherently present in children from birth and develops in adolescence.9 The social, physical, and economic environment in which people are raised affects brain development and ultimately alters individual implicit biases.

             

            Identity, Individuality, and Intersectionality

            People use their social identity to compartmentalize themselves into specific groups or categories. In 1974, sociologist Henri Tajfel first proposed the social identity theory that suggested social identity derives from the “knowledge of membership” in a group (or groups), and that membership in those groups creates individual significance and value.11 Social identity defines how individuals characterize their own traits. Common identities include things like12

            • Disability
            • Ethnicity
            • Gender or sex
            • Nationality
            • Political party
            • Race
            • Religion
            • Economic status

            Personal identities are adjectives used to describe oneself, like smart, tall, or funny.12

            Social identity is dynamic in that it can develop in various ways.10 For example, society classifies people born in the early 1980s to mid-1990s as being part of the millennial generation. Although membership requires nothing other than birth at a specific time, others group millennials into a category (their generation) that has over time acquired certain characteristics typical of group members. Individuals can also develop identity through conscious choices, like choosing to go into a healthcare profession or going to school to be a writer.10 People are not usually limited to one identity, but rather possess multiple social identities that work to influence a person’s experiences in life.12 For example, a White man fits into categorical groups of (1) White person and (2) male sex, yet his life experience may differ depending on if he is born into higher socioeconomic class, identifies as heterosexual, or has a disability.

             

            Society’s cultural norms shape identities.13 As attitudes towards cultures (or groups) change over time, societal standards change as well. Certain identities may have more value and importance than others because society emphasizes those differences. Identities may also shift importance based on the context in which a person lives. A White American living in North America might think about national identity only infrequently. However, if that person takes a job in China, national identity might suddenly feel like a significant part of individual identity, because it will likely impact how others see the person and how the person interprets experiences.12

             

            Social identity overlaps strongly with intersectionality, or the multifaceted interplay of social identities, systems of power, and oppression of certain groups.13 As mentioned above, social identities exist in various combinations that make individuals unique. Intersectionality allows us to see how different identities may affect one another, and how that in turn relates back to concepts of bias, discrimination, and stereotypes.13

             

            Bias within groups can affect intersectionality. For example, studies show that people of color who also identify as part of a sexuality minority experience internalized stigma related to gender and/or sexual orientation within their racial groups; these people experience what is called intersectional minority stress.14 Individuals experiencing discrimination in both racial and gender or sexuality identities are more vulnerable to poor health outcomes given the increased bias and discrimination they face.14

             

            A public health researcher from the University of Michigan introduced the “weathering” hypothesis, which suggests that Blacks experience health deterioration as a result of chronic social and economic stressors or political marginalization.15 Some studies have explored and validated this hypothesis. A recent study found that the COVID-19 mortality rate was 2.1 times higher for Black Americans than that of White Americans.16 The researchers indicate that weathering from chronic and toxic stress magnified COVID-19’s effects in people of color. People of color are more likely to suffer job loss as a result of the COVID-19 outbreak, which in turn affects health insurance coverage and thus contributes to poorer health outcomes. Regardless, even those who possess employment and health insurance are more likely to receive inferior care due to the implicit biases present in healthcare. This study emphasizes the concept of “weathering” in a way that is relevant in our world today.16

            PAUSE AND PONDER: How might implicit biases in your workplace affect patient care and outcomes?

            Bias and social identity are entwined. Social identities stem from a person belonging to a group, whether that be an “in-group” or “out-group.” Figure 1 provides examples of the groups, such as middle class or documented citizens. A person can belong to more than one group. Society tends to label certain groups as more valuable than others, which leads to re-enforcement of certain biases. People tend to conform to societal standards, and placing oneself into these groups creates the foundation for bias, stereotypes, and prejudice to occur. It is still important to recognize that while our personal and social identities place us into groups with shared attributes, we are still unique individuals.

             

            Image showing how different aspects of personalities impact levels of power 

            SOURCE: Adapted from James R Vanderwoerd ("Web of Oppression"), and Sylvia Duckworth ("Wheel of Power/Privilege")

             

            Institutional Bias

            “Power tends to corrupt, and absolute power corrupts absolutely.”

            – Lord Acton, British Historian

             

            All people have unconscious or conscious biases. Ultimately, biases result from social identities’ influence on the brain and our environment. But what happens when a collection of individuals with a shared bias comes together? Biases can become discrimination. While prejudice is the pre-conceived notion about someone based on bias, discrimination is conscious, intentionally disparate treatment.17

             

            Institutional bias, known also as structural bias, ties many issues that arise from discrimination together. Institutional bias—the established laws, customs and practices that methodically reflect and produce group-based inequities in any society—involves policies and practices that are discriminatory beyond that of the individual level.18 Even in an ideal situation wherein individuals do not possess a certain bias or prejudice towards a group of people, discrimination may still occur because the institutions in which they are involved may have biased practices in place.18

             

            Nearly every type of social institution exhibits some form of bias against groups of people. Examples of institutions include18

            • Education
            • Environmental management
            • Healthcare
            • Law/Criminal justice
            • Military
            • Politics
            • Politics
            • Retail and housing market
            • Workforce

            Some people allege that individual and institutional bias may not co-exist, but that belief is a bit contradictory. Since the civil rights movement, individual expression of stereotypes and prejudice against Black people in the United States has declined. However, racial discrimination is still widespread and may be as prevalent as it was before the civil right movement in some areas. In 2007, the legal system incarcerated Black people at a rate four times higher than White people in the U.S.18 Although other factors may contribute to this disparity, institutional racism is still prevalent regardless of individuals’ attitudes or bias towards Black people.18

             

            Power and legitimacy also influence institutional biases.18 Groups in power are more likely to control institutional bias since they are most likely to control the institutions and create policy.18 Legitimacy is a word used to describe the perception that a policy that is detrimental to the oppressed group is fair or somehow justified.18

             

            For example, the housing market enables implicit associations between minorities and the risk they present to the value of the neighborhood in which they live or seek to live. As a result, the perception influences certain housing and lending practices for minority applicants.19 Another example is more nuanced. Adults younger than 21 cannot purchase or drink alcohol in the United States; one may argue that this is a form of bias against this age group. However, given the shared societal attitude that teens and young adults should not drink alcohol due to its potential to cause impairment, few people fight against this bias.18

             

            While some biases are widely accepted, others are clearly not. For example, some immigrants don’t qualify for high level positions within companies. Members of immigrant groups are more likely to take low-level, undesirable positions. As a result, they tend not to stay at that company for long, increasing turnover and decreasing ambition within their fields.18 A similar predicament is the standardized college admission tests; depending on their exam score, students may not qualify for admission to certain schools, perpetuating the idea that they are not smart enough to be admitted.18 Standardized tests fail to take into account students’ different backgrounds; some students benefit from simply being in a higher socioeconomic status with resources available to ensure success.

             

            IMPLICATIONS OF BIAS

            Negative attitudes have the potential to affect decision making and health outcomes across various healthcare settings. In 2021, the three largest motivations for hate crimes in the U.S. were race, sexual orientation, and religion.20 Maternal mortality rates in the U.S. by race are disproportionate. Black women die during childbirth nearly three times more often than White or Hispanic women.21 These discrepancies are due to institutional biases and existing racism toward Black women in healthcare. The Centers for Disease Prevention and Control adds that implicit bias prevents people of color from having fair opportunities for economic, physical, and emotional health.22 As part of the healthcare workforce, pharmacists and pharmacy technicians should be able to identify how implicit biases can adversely impact relationships with patients and customers.

            PAUSE AND PONDER: Which interventions described in this CE might help you and your coworkers
            have frank discussion about bias and discrimination?

            Recent research shows people have self-reported experiences of discrimination in healthcare. These instances frequently occur in the following groups of people23:

            • LGBTQ (lesbian, gay, bisexual, transgender, queer)
            • Low socioeconomic status
            • Older adults
            • Overweight or obese
            • Poor health
            • Racial/ethnic minorities
            • Uninsured
            • Women

             

            Patterns of bias and discrimination towards marginalized groups becomes evident. As a result, these individuals can feel perceived discrimination, which is anticipation of unfair treatment they may receive due to their characteristics.23 These groups are more likely to have high stress and mental health disorders such as anxiety, depression, and substance abuse.23 Table 2 lists examples of studies that highlight implicit biases related to healthcare.

            Table 2. Studies that Highlight Implicit Biases Related to Healthcare24-28

            A study (N = 142) of emergency response situations showed that White bystanders were slower to provide help to Black victims than the speed at which White bystanders helped White victims. White participants helped 88% of White victims compared to 58% of Black victims. “Help Time” was ~120 sec for Black victims compared to ~40 sec for White victims.
            A review (N = 7070) found Black and Latino patients are less likely to receive medication, especially opioids, to alleviate acute pain in the emergency department than White patients (OR 0.60 [95%-CI], 0.43-0.83).
            Asian Americans (N = 521) reported feeling like their doctors do not involve them in shared decision making, do not listen to their concerns, and spend less time with them. They were also less likely to receive counseling on mental health or lifestyle issues compared to White patients (N = 3205) in the survey.
            An analysis found doctors perceived Black patients (N = 618) to be less educated, less likable, less intelligent, and nonadherent to medical advice and medication therapy. Physicians were less likely to agree that Black patients vs. White patients are `the kind of person they could be friends with’ (34% of White vs. 27% of Black patients).
            A survey (N = 316) showed transgender or gender nonconforming people worry about discrimination when they use pharmacy services; 41.6% reported discrimination associated with such services, and 52.5% reported pharmacists as having very little or no competency in providing gender-affirming care.

             

            Gender-Diverse Care and Ageism

            An emerging topic is gender-diverse care. The Human Rights Campaign Foundation and the American Pharmacist Association (APhA) released a joint pharmacy resource guide for gender diverse care. The guide includes key terms, inclusive communication, staff training and other essential points of patient centered care for gender diverse patients.29 It is accessible for free at https://www.thehrcfoundation.org/professional-resources/transgender-pharmacy-guide

            Nicole Avant, PharmD, BCACP, founder, owner, and consultant at Avant Consulting Group, presented key studies on implicit bias during a session at the 2022 National Community Pharmacy Association Annual Convention. They include30

            • Black women are more likely to die after being diagnosed with breast cancer.
            • Patients of color (POC) receive fewer cardiovascular interventions and fewer renal transplants than White patients.
            • POC who have diabetes are more likely to undergo leg amputation.

             

            Poor provider-based interactions negatively impact the quality of care and the desire to seek medical help. This fosters mistrust of healthcare and healthcare workers, like pharmacists and pharmacy technicians. Poor interactions can significantly delay treatment-seeking, which worsens health complications by creating avoidable increases in emergency healthcare use and increasing health disparities. The SIDEBAR provides an example of poor care.

             

            SIDEBAR: A Health Professional’s Observation31

            Joanne Whitney is a retired pharmacy professor who has shared her experiences when interacting with healthcare providers.

            • She went to the emergency room for a urinary tract infection (UTI) and severe pain. She asked for hydromorphone (Dilaudid) since it had helped her before, but a young physician told her that they don’t prescribe opioids to “those who seek them.”
            • Her pain continued for eight hours. She states, “When older people come in like that, they don’t get the same level of commitment to do something to rectify the situation. It’s like ‘Oh, here’s an old person with pain. Well, that happens a lot to older people.’”
            • She also told the physician the prescribed antibiotic was incorrect for her UTI, but the provider disregarded her concern despite her pharmacy background.

             

            The prejudice in this case is the notion that older people are unpleasant and difficult to treat. Discrimination occurs when healthcare providers do not manage older adults’ needs appropriately or treat them less favorably than younger patients.

            Her experience emphasizes ageism in healthcare settings. More than half a million Americans aged 65 and up encountered ageism during the COVID-19 pandemic.

            Ageism can be explicit in some healthcare settings. In 2021, an advocacy group for older adults filed a lawsuit in Idaho over the state’s crisis guidelines for hospitals that were overwhelmed with COVID-19 patients. The protocol stated staff should triage and treat younger patients before older adults because “they have more years left” to live.32

            Other examples of ageism prevalent in healthcare today include

            • Assuming older patients who talk slowly are cognitively compromised
            • Rushing patients, not listening to their concerns
            • Only speaking to the patient’s family member
            • Ignoring or minimizing pain complaints

             

            Racism in Pharmacies

            A 2021 U.S. Qualtrics Survey found that nearly 20% of people perceived racial discrimination in community pharmacy settings.23 Of those people, one-third of them felt they had to be particularly careful about their appearance to receive “good service” and avoid harassment.23 On average, people visit doctors and specialists a handful of times but can visit their community pharmacies up to 35 times a year. The study showed that perceived discrimination significantly affects healthcare. One third of respondents stated they tried to avoid certain pharmacies, and 17% reported switching pharmacies.  Switching pharmacies may seem like an adequate temporary solution, but in actuality fragments medical records, increases the likelihood that pharmacists will miss potential drug interactions, and compounds adherence issues.23

             

            Thus, healthcare providers must be cognizant of their biases and avoid acting on them when interacting with patients in pharmacy settings. Pharmacy workers should strive to be fair and aware of their personal implicit biases. They should also be conscientious and deliberate when interacting with patients. Management must ensure adequate training is in place for pharmacists and technicians to create a welcoming, inclusive atmosphere. If it is not, pharmacy employees should suggest it is needed.

             

            Becoming conscious about implicit biases should begin during the education of future pharmacists. Six PharmD programs surveyed students (N = 357) using the Harvard Race Implication Test.33 The test determines implicit associations by measuring the time it takes a person to connect two concepts, i.e. (Black/White to good/bad). The survey found that pharmacy students exhibited preference for White patients and moderately negative implicit and explicit bias towards Black patients.33 Although many pharmacy schools have already incorporated the concepts of cultural competence, increasing awareness of how implicit biases negatively affect patient interactions should be a focus area.

             

            Bias Affecting Decision-Making Processes 

            Implicit bias has been associated with several downstream effects. Consider “second victim” effect. The term “second victim” describes healthcare professionals and the unanticipated emotional impact they feel after making a medical or clinical error.34 Medical errors are one of the top leading causes of death in the U.S.35 The first victim is the patient who experiences the medical error. The second victim—the person who made the errors—feels distress and personal responsibility after an unexpected adverse patient outcome or error. This directly impacts the healthcare professional’s career and life.34 In many cases, implicit bias is not a factor in second victim effect, but sometimes it is. For example, consider a provider who has an implicit bias towards Black women. The provider fails to intervene aggressively when a patient, a Black woman, is experiencing pain and hemorrhaging due to complications during childbirth. The patient soon becomes unconscious from blood loss. The patient unfortunately dies. The patient’s family files a complaint with the hospital regarding the provider’s lack of standard care during her birthing process. The provider is then afflicted by second-victim effect.

             

            Many second victims suffer from job-related emotional and physical stress, and their additional feelings of powerlessness and insecurity can prompt them to leave the profession.34 Lack of support for coworkers and management contributes to the second victim phenomenon, and coworkers and managers may be less likely to support the second victim if they have biases against that person for some reason.34 The second victim’s self-blaming negative feelings could influence future decision making.

             

            Nearly half of healthcare professionals experience second victim effect at least once in their careers.34 This effect may lead to changes in clinical judgment and inadvertently affect patient care. It is important to recognize when it occurs. To combat second victim phenomenon’s negative effects, mindfulness-based interventions have shown efficacy in reducing stress and burnout.34 Also, psychological first aid fosters resilience in healthcare professionals by establishing formal support teams within health institutions.36 This includes education about normal responses to traumatic events, active listening skills, understanding the importance of nutrition and rest, and clarifying when to seek help.36

             

            Interprofessional Bias

            Interprofessional collaboration is an important part of managing and delivering quality patient care. Biases about other professions can create conflict within the team, which has negative consequences for communication, decision-making, and trust.37 Implicit biases influence a person’s actions unconsciously and can intrude in various cultural and structural settings. For example, individuals may have preferences for certain specialties or simply certain people over others. Their implicit biases can influence decisions, like who rounds on an inpatient hospital team. The traditional hierarchy of physicians as team “leaders” can create tension within a group that must work with (as equals), but not for (as subordinates), that physician.37

             

            Research shows that biases adversely affect the quality of healthcare delivered to patients. A systematic review on implicit biases in interprofessional collaboration found that biases between professions were predominately negative.37 The review mentioned the concept of internalization, which describes how people internalize biases towards their profession towards their own self and behaviors.37 For example, physicians mostly saw themselves as leaders while nurses consistently perceived themselves as powerless and lacking authority. As such, physicians exhibit behaviors such as authoritatively shutting down communication in case conferences, whereas non-physician professionals tended to be silent, less engaged, or chose to skip team meetings. Bias internalization influenced which professions voiced their opinions and inhibited the team’s overall growth.37 Consequently, these healthcare teams developed feelings of disrespect and mistrust, which impedes patient care. Another study found that when team members perceived they were not consulted about a decision, they exhibited defensive posturing and frustration in meetings.38

             

            Imposter Syndrome

            Imposter syndrome is defined as self-doubt about intellect, skills or accomplishments among high achieving individuals.39 Imposter syndrome and disorders such as depression and anxiety are often comorbid.39 Many healthcare professionals strive for perfection, but those with imposter syndrome tend to associate their success with random chance as opposed to their own intelligence.39 Imposter syndrome tends to be more common in marginalized groups (e.g., minority races) in high pressure settings due to underrepresentation in the field; poor representation and pressure exacerbate imposter syndrome.39 It may also be a result of lifelong bias and discrimination, which can affect professionals in their clinical roles as well.

             

            Interestingly, a study of pharmacy residents (N = 720) found higher Clance Imposter Scale scores correlated with the number of hours worked per week and prior mental health treatment, factors associated with high stakes learning environments.40 This study validates other studies done with various medical professionals and demonstrates the connection between highly focused academic and healthcare areas and the increased likelihood of imposter syndrome.40

            Imposter syndrome, like the second victim effect, can affect clinical judgement in healthcare professions. It may promote certain biases when they normally would not be due to those feelings of inadequacy, and thus mistakes occur.

             

            Bias in the Pharmacy

            Pharmacists hold crucial positions in healthcare, especially since they engage with diverse groups of patients regardless of the setting in which they work. Pharmacists can stimulate broader efforts to address health disparities, especially as their scope of practice widens.41 Social determinants of health (SDOH) are the social and structural conditions in which people are born, live, and work.42 Figure 2 shows the key SDOH.

            Image showing the 5 social determinants of health: education access and quality, healthcare access and quality, neighborhood and built environment, social and community context, and economic stability

            Source: Healthy People 2030, U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Retrieved July 28, 2023, from https://health.gov/healthypeople/objectives-and-data/social-determinants-health

             

            A 2016 review of pharmacy literature highlighted issues stemming from SDOH affecting pharmacies. These factors are known to influence health outcomes, and pharmacy workers need to be aware when SDH may affect the population they serve. The study showed the following knowledge gaps among pharmacists41:

            • Mental illness
            • Substance/drug abuse with prescription and illicit drugs
            • Those at risk for HIV/AIDS or hepatitis C infection

             

            Although pharmacists provide care to groups that suffer from effects of SDH, they may not understand entirely or have access to information that could expose SDH. More education on cultural competency is needed within pharmacy.41

             

            Bias can influence the pharmacy workforce. Perhaps one of the most relevant examples of bias in pharmacy workers concerns opioid use disorder (OUD). The U.S. has battled the opioid crisis for more than two decades.43 Those who suffer with OUD are often stigmatized. Pharmacists and pharmacy technicians frequently interact with patients who are diagnosed with such disorders. The lack of knowledge and understanding surrounding OUD underscores biases that exist towards people with OUD.

             

            A small study that examined pharmacy technicians’ attitudes (N = 46) using focus groups found that participants had negative perceptions of patients using opioids. Pharmacy technicians reported “ever-present” negative feelings (meaning they persisted over time) toward patients with OUD, even if they did not know opioid’s indication for a particular person.43 The researchers asked pharmacy technicians to recount their experiences with patients who recieved opioids. Figure 3 highlights their perceptions.43

            Figure 3. Comments from Pharmacy Staff about Patients with OUD43

            Image showing quotes from pharmacy technicians regarding patients with OUD

             

            A multitude of reasons may explain why participants felt this way. Their experiences may be tied to aggressive encounters between healthcare professionals and patients who use opioids and negative media portrayals of opioid use.43 The study went into further detail on early refills, a situation where patients want to fill a prescription when their fill histories indicate it’s too early. Most technicians stated they tried to be compassionate and non-judgmental in these situations to overcome the stigmas associated with opioid prescriptions.43

             

            The discussion further explained that the negative perception of patients who take opioids compromises quality of care because it is difficult to reverse formed opinions. The National Institute on Drug Abuse stresses the importance of accurate, complete medication histories and reporting to prescription drug monitoring programs to create healthier patient-provider relationships in the pharmacy.43

             

            Another study focused on pharmacy personnel responses to expedited partner therapy (EPT) in the management of sexually transmitted infections. EPT effectively prevents chlamydia and gonorrhea infections for partners of patients already infected.44 Providers can give patients diagnosed with chlamydia or gonorrhea prescriptions for the partner without having to name the partner. EPT is protected by law in 41 states and supported by numerous organizations including44

            • American Academy of Pediatrics
            • American Academy of Family Physicians
            • American Congress of Obstetricians and Gynecologists
            • Society of Adolescent Health and Medicine

             

            The study (N = 50) found pharmacists refused to fill 58% of EPT prescriptions, and suburban pharmacists were more likely to refuse than city pharmacists.44 Refusal was more likely if the pharmacists were older than the patient and if patients were White. Pharmacists most commonly cited lack of name on the prescription as the reason for refusal, even if the law does not require a partner name. This indicates a general lack of knowledge about EPT among study participants, which may have contributed to their decisions.44

             

            A literature review on weight management programs found implicit and explicit weight bias exists within the pharmacy profession. Weight management programs can vary, and pharmacies offer some in conjunction with prescription medications and nonpharmacologic lifestyle interventions.45 The review found stigmatizing language in the screening processes for weight management programs. It is unclear to what extent weight biased communication exists between pharmacists to patients.45 The stigma that surrounds obesity affects other related health problems, like diabetes or cardiovascular concerns, and can weaken the pharmacist-patient relationship.45

             

            ADDRESSING BIAS

            Implicit biases are present in all people, but the importance lies not in the existence of bias, but how to overcome it. Several strategies address biases, the most important being education in pharmacy school curriculums. Many studies use the IAT to measure implicit bias. The test is free to the public and can be found here: https://implicit.harvard.edu/implicit/

            Learners should note that this is not just one test, but a series of different tests.

             

            The IAT measures the time it takes for the individual to match concepts in categories to descriptive words, like race, skin tone, and weight to good, bad, or other stereotypical language.46,47 An individual’s underlying beliefs drive responses time, thus measuring the strength of the association between concepts (a person, image, etc.) and evaluations (good, bad). Researchers recommend incorporating the IAT in curriculums prior to before direct patient exposure.46

             

            Other interventions that may be helpful in pharmacy education and other pharmacy settings include44

            • Practicing mindfulness (directing active, open attention to the present to examine one’s thoughts and feelings without judging them). Mindfulness reduces the likelihood of activating implicit biases and enhances the ability to control biases in patient care situations.
            • Self-awareness/self-reflection training: After completing the IAT, individuals can reflect on identified biases.
            • Activating goals: Healthcare workers can identify goals that promote fairness and equality for patients and coworkers.
            • Stereotype replacement: Individuals who collect information that is opposite of cultural stereotypes can replace stereotypical thoughts with non-biased thoughts.
            • Case studies observing implicit bias: Analyzing case studies where implicit bias was involved helps people recognize how to approach situations differently.
            • Individuating: This action challenges people to see others for their individual traits as opposing to grouping them by their stereotypical components.
            • Perspective-taking: This “walk a mile in their shoes” activity asks individuals to assume the perspective of a stigmatized or marginalized member to build empathy.

             

            The University of Utah Pharmacy Residency program implemented an implicit bias awareness and action seminar with four training modules and a pre- and post-test survey. After training, pharmacy residents indicated higher comfort and confidence addressing personal biases and were better able to identify biases of others.47 While not accessible to the public, this shows that implementing training programs makes a difference in future of pharmacy delivered care.

             

            Conclusion

            Implicit biases have overall negative effects on patient care, which is detrimental to patients and those that harbor the implicit biases. Pharmacists and pharmacy technicians who are aware of and take steps to address their implicit biases will improve the way they treat patients and each other as colleagues.

             

            Pharmacist Post Test (for viewing only)

            Exploring Implicit Bias and Its Impact in Pharmacy
            POST-TEST Pharmacists
            Learning Objectives
            After completing the continuing education activity, pharmacists will be able to
            • DEFINE different types of bias and how they are formed
            • RECOGNIZE what bias may look like in the pharmacy setting
            • IDENTIFY how bias can impact patient care
            • APPLY methods to address and mitigate bias in the workplace

            1. You are a 52-year-old clinical pharmacist who works with an interprofessional team. The doctor is a 33-year-old resident who has just started working at the hospital. He does not ask for your input, yet you have caught several prescribing errors he made. He also ignores your questions. He has openly stated that he thinks pharmacists “don’t know what they are talking about.” What potential bias may be occurring?
            a. Age bias
            b. Interprofessional bias
            c. Confirmation bias

            2. Which strategy could potentially help mitigate implicit biases in pharmacy education or clinical settings?
            a. Behavioral therapy
            b. Anonymous reporting
            c. Self-awareness training

            3. Which of the following statements best describes an explicit bias?
            a. “Women who have children are not serious about professional careers.”
            b. “Pharmacists and doctors have more clinical education than nurses do.”
            c. “Patients of color receive fewer primary care interventions than White patients.”

            4. Which of the following statements is CORRECT regarding the etiology of bias?
            a. The amygdala processes cues and “calms” the PFC to adjust to social norms.
            b. Neuroimaging studies do not associate amygdala activity and bias.
            c. Bias triggers amygdala activity and affects decision-making processes.

            5. How does bias negatively impact marginalized pharmacy customers?
            a. Patients struggle to fill medications due to shortages.
            b. Patients feel they have to be careful of their appearance.
            c. There is not really bias towards patients in pharmacy.

            6. A new pharmacy resident was paged to attend a stroke code and unfortunately, the patient died because the resident did not know which medication to give at the moment. This was the fifth unsuccessful stroke code this month, and the resident is troubled. He starts drinking more after his work shift to help cope with the feelings of loss. After several months, he is diagnosed with depression. He is often late to work and his supervisors counsel him several times. What is the resident experiencing?
            a. The resident is experiencing second victim syndrome.
            b. The resident does not like his job or his bosses.
            c. The resident is experiencing imposter syndrome.

            7. Which choice correctly defines social identity and intersectionality?
            a. Social identity is the relationship between intersectionality and systems of power; intersectionality is the process of being placed into a group
            b. Social identity and intersectionality are different terms for the same concept, and researcher tend to use the two interchangeably in studies and review articles
            c. Social identity relates to being placed in an “out-group” or “in-group”; intersectionality is the relationship between social identities and power systems

            8. How does the Implicit Association Test (IAT) work?
            a. It measures how fast White responders help Black victims in emergencies.
            b. It measures the strength of participants’ personal beliefs towards minorities.
            c. It measures how quickly participants associate concepts to categories.

            9. Which of the following statements about bias internalization is TRUE?
            a. Internalized bias has no impact on teamwork, and affects only the individual.
            b. Internalized bias has no impact on individual, and affects only the whole team.
            c. A bias toward a group of people can be internalized and applied to one’s self.

            10. A recently pharmacy graduated has been hired to work on your team. You notice that the new pharmacist tends to hand off minority patients who need a language interpreter to other coworkers. You bring this up to your supervisor, who asks for your suggestions. Which statement is the best intervention?
            a. The supervisor should call a team meeting and directly address the new pharmacist in front of everyone to hold that person accountable.
            b. The team should review case studies similar to the minority patients so the new pharmacist can feel more comfortable working on those cases.
            c. The manager should fire the new pharmacist because recent graduates should know how to manage all cases, even when an interpreter is needed.

            Pharmacy Technician Post Test (for viewing only)

            Pharmacy technician post-test

            After completing the continuing education activity, the pharmacy technician will be able to:
            • define different types of bias and how they are formed
            • recognize what bias may look like in the pharmacy setting
            • identify how bias can impact patient care
            • illustrate understanding of strategies that mitigate bias

            1. A female technician has worked in a retail pharmacy for several years. She notices the pharmacist always asks for the male technicians to help her put away the order, despite her being there much longer than they have. When she asks the pharmacist why she doesn’t ask for her help, the pharmacist says, “Oh, I just thought it was too heavy for you.” Which statement best describes this case?
            a. Male technicians are better and more efficient workers than female technicians.
            b. The pharmacist does not like working with the female technician.
            c. The pharmacist’s thinking that females are not as strong as males is gender bias.

            2. Which statement correctly identifies the differences between explicit and implicit bias?
            a. Implicit biases are unconscious; explicit biases are conscious.
            b. Explicit biases are harsher than implicit biases.
            c. Implicit biases do not have anything to do with explicit biases.

            3. You work in a retail pharmacy and a patient drops off a new prescription for Suboxone. When the patient comes to pick up the medication, you notice he is defensive when you ask to see an ID for verification purposes. What is one possible reason for their reaction?
            a. The patient feels you may be judging him for his prescription.
            b. The patient is offended and thinks you are calling him old.
            c. The patient does not have his ID with him at the moment.

            4. A female inpatient pharmacy technician is working with a male pharmacy resident to perform a medication history review. The tech notices the resident tends to rush through the interactions with older patients and will only speak to the family if they are present in the room. The tech has overheard this resident state he thinks the nurses should take medication histories since residents have “more important jobs than nurses.” With regard to the pharmacy resident, which bias may negatively affect patient care the most?
            a. Affinity bias
            b. Interprofessional bias
            c. Age bias

            5. Which statement is a microaggression?
            a. A doctor says “Black women are at higher risks for maternal mortality.”
            b. A faculty member says, “Most Black students are poor or illiterate”
            c. A patient says, “I want to speak with to the doctor I saw last month.”

            6. An APRN is concerned with a medication dose and asks to speak to the pharmacist. When finished with the call, the pharmacist turns to you and says, “APRNs are so incompetent. They never know how to send things over the right way.” Which statement describes the bias the pharmacist is displaying?
            a. The pharmacist shows interprofessional bias towards the APRN.
            b. The pharmacist in this example is not showing any explicit bias.
            c. The pharmacist shows unprofessional bias towards the APRN.

            7. How can practicing mindfulness help reduce biases in healthcare settings?
            a. It reduces the likelihood of activating implicit biases and enhances the ability to control biases in patient care.
            b. It helps healthcare providers take on the perspective of stigmatized or marginalized group members to build empathy.
            c. It is designed to let healthcare providers develop goals that promote fairness and equality among coworkers.

            8. Over the course of your career in pharmacy, you come to realize that your initial belief that patients who are prescribed multiple refills of opioids are abusing them is wrong. What is this an example of?
            a. Stereotype
            b. Interprofessional Bias
            c. Ageism

            9. Which statement describes how the brain plays a role in forming bias?
            a. The amygdala and PFC both process social cues that turn to bias most of the time.
            b. The PFC is triggered by sensory information while the amygdala processes cues.
            c. The amygdala is triggered by sensory information while the PFC processes cues.

            10. Which is an example of how implicit biases can influence institutional bias?
            a. A Black male is unable to cast his vote at the ballots because he forgot his ID at home
            b. A young Hispanic female is denied pain medication because the doctor thinks she’s exaggerating her pain
            c. A disabled male athlete does not qualify for a sporting event because he places last in the competition

            References

            Full List of References

            References

               

              1. Barlow R. Bu research: A Riddle reveals depth of gender bias: BU Today. Boston University. Published January 16, 2014. Accessed April 10, 2023. https://www.bu.edu/articles/2014/bu-research-riddle-reveals-the-depth-of-gender-bias/
              2. Vela MB, Erondu AI, Smith NA, Peek ME, Woodruff JN, Chin MH. Eliminating Explicit and Implicit Biases in Health Care: Evidence and Research Needs. Annu Rev Public Health. 2022;43:477-501. doi:10.1146/annurev-publhealth-052620-103528
              3. Amodio DM. The neuroscience of prejudice and stereotyping. Nat Rev Neurosci. 2014;15(10):670-682. doi:10.1038/nrn3800
              4. Ashcraft D, Treadwell T. Chapter VII: The Social Psychology of Online Collaborative Learning: The Good, the Bad, and the Awkward. In Orvis K, Lassiter A, eds. Computer-Supported Collaborative Learning: Best Practices and Principles for Instructors. IGI Global; 2008:11-15. doi.org/10.4018/978-1-59904-753-9.ch007
              5. Sparks SD. Fighting Subtle Bias: Classroom Biases Hinder Students’ Learning. Published October 27, 2015; Accessed April 10, 2023. https://www.edweek.org/leadership/classroom-biases-hinder-students-learning/2015/10
              6. Murphy N. Types of Bias. CPD Online College. Published November 10, 2021. Updated May 27, 2022. Accessed April 10, 2023. https://cpdonline.co.uk/knowledge-base/safeguarding/types-of-bias/
              7. Phillips-Wren G, Power DJ, Mora M. Cognitive bias, decision styles, and risk attitudes in decision making and DSS. J Decision Syst. 2019;28(2):63-66. doi: 10.1080/12460125.2019.1646509
              8. Salim A, Johnson WE. How Bias and Perception Impact Complicance.https://assets.hcca-info.org/Portals/0/PDFs/Resources/Conference_Handouts/Compliance_Institute/2019/304_Bias%20and%20Perception.pdf
              9. Weichselbaum C, Banks K. Racism on the Brain. Fron Young Minds. 2021;9:1-8. doi:10.3389/frym.2021.608843
              10. Agarwal P. What Neuroimaging Can Tell Us about Our Unconscious Biases. Published April 12, 2020. Accessed April 12, 2023 https://blogs.scientificamerican.com/observations/what-neuroimaging-can-tell-us-about-our-unconscious-biases/
              11. Everett JAC, Faber NS, Crockett M. Preferences and beliefs in ingroup favoritism. Fron Behav Neurosci. 2015;9:1-21. doi:10.3389/fnbeh.2015.00015
              12. Leading Effectively Staff. Understand Social Identity to Lead in a Changing World. Published February 7, 2023. Accessed April 10, 2023. https://www.ccl.org/articles/leading-effectively-articles/understand-social-identity-to-lead-in-a-changing-world/
              13. Kearney, DB. Universal Design for Learning (UDL) for Inclusion, Diversity, Equity, and Accessibility (IDEA). Module 4.2 Positionality and Intersectionality. eCampus Ontario; 2022. Accessed April 10, 2023. https://ecampusontario.pressbooks.pub/universaldesign/
              14. Sarno EL, Swann G, Newcomb ME, Whitton SW. Intersectional minority stress and identity conflict among sexual and gender minority people of color assigned female at birth. Cultur Divers Ethnic Minor Psychol. 2021;27(3):408-417. doi:10.1037/cdp0000412
              15. Geronimus AT, Hicken M, Keene D, Bound J. "Weathering" and age patterns of allostatic load scores among blacks and whites in the United States. Am J Public Health. 2006;96(5):826-833. doi:10.2105/AJPH.2004.060749
              16. Johnson-Agbakwu, C.E., Ali, N.S., Oxford, C.M. et al. Racism, COVID-19, and Health Inequity in the USA: a Call to Action. J. Racial Ethn Health Disparities. 2022;9: 52–58.
              17. López L, Betancourt JR. Racial and Ethnic Disparities in Health Care. In: Loscalzo J, Fauci A, Kasper D, Hauser S, Longo D, Jameson J. eds. Harrison's Principles of Internal Medicine, 21e. McGraw Hill; 2022. Accessed April 10, 2023. https://accesspharmacy.mhmedical.com/content.aspx?bookid=3095§ionid=263343935
              18. Henry, P. Institutional Bias. In: Dovidio JF, Hewstone M, Glick P, Esses VM, eds. Handbook of Prejudice, Stereotyping, and Discrimination. Sage; 2010:426-440
              19. Olinger J, Capatosto K, McKay MA, et al. Challenging Race as Risk: How Implicit Bias Undermines Housing Opportunity in America. Ohio State University; 2017:1-85. Accessed July 20, 2023. https://kirwaninstitute.osu.edu/research/challenging-race-risk-implicit-bias-housing
              20. FBI. Number of Victims of Hate Crime in The United States in 2021, by Motivation. Statista. Published March 13, 2023, Accessed April 10, 2023. https://www.statista.com/statistics/737648/number-of-hate-crime-victims-in-the-us-by-motivation/
              21. Hoyert DL. Maternal mortality rates in the United States, 2020. NCHS Health E-Stats. 2022. doi.org/10.15620/cdc:113967
              22. Working Together to Reduce Black Maternal Mortality. CDC. Updated April 3, 2023. Accessed April 10, 2023. https://www.cdc.gov/healthequity/features/maternal-mortality/index.htm
              23. Baffoe JO, Moczygemba LR, Brown CM. Perceived discrimination in the community pharmacy: A cross-sectional, national survey of adults. J Am Pharm Assoc. 2022;63(2):518-528. doi:10.1016/j.japh.2022.10.016
              24. Kunstman JW, Plant EA. Racing to help: Racial bias in high emergency helping situations. J Pers Socl Psych. 2008;95(6)1499-1510. doi.org/10.1037/a0012822
              25. Lee P, Le Saux M, Siegel R, et al. Racial and ethnic disparities in the management of acute pain in US emergency departments: Meta-analysis and systematic review. Am J Emerg Med. 2019;37(9):1770-1777. doi:10.1016/j.ajem.2019.06.014
              26. Ngo-Metzger Q, Legedza AT, Phillips RS. Asian Americans' reports of their health care experiences. Results of a national survey. J Gen Intern Med. 2004;19(2):111-119. doi:10.1111/j.1525-1497.2004.30143.x
              27. van Ryn M, Burke J. The effect of patient race and socio-economic status on physicians' perceptions of patients. Soc Sci Med. 2000;50(6):813-828. doi:10.1016/s0277-9536(99)00338-x
              28. Lewis NJW, Batra P, Misiolek BA, Rockafellow S, Tupper C. Transgender/gender nonconforming adults' worries and coping actions related to discrimination: Relevance to pharmacist care. Am J Health Syst Pharm. 2019;76(8):512-520. doi:10.1093/ajhp/zxz023
              29. Human Rights Campaign Foundation, APhA. Providing Inclusive Care and Services for the Transgender and Gender Diverse Community: A Pharmacy Resource Guide. Published March 2021. Accessed April 10, 2023. https://www.thehrcfoundation.org/professional-resources/transgender-pharmacy-guide#overview
              30. Hippensteele A. Expert: 'we all hold implicit biases' that may contradict explicit beliefs, impact patient health. Pharmacy Times. Published October 2, 2022. Accessed April 10, 2023. https://www.pharmacytimes.com/view/expert-we-all-hold-implicit-biases-that-may-contradict-explicit-beliefs-impact-patient-health
              31. Graham J. 'they treat me like I'm old and stupid': Seniors decry health providers' age bias. KFF Health News. Published October 20, 2021. Accessed April 10, 2023. https://kffhealthnews.org/news/article/ageism-health-care-seniors-decry-bias-inappropriate-treatment/
              32. Boone R. Civil rights complaint targets Idaho Health Care Rationing. AP News. Published September 24, 2021. Accessed April 10, 2023. https://apnews.com/article/coronavirus-pandemic-business-discrimination-race-and-ethnicity-idaho-4a152d4f4f809bfb6588b9025c400d6b
              33. Santee J, Barnes K, Borja-Hart N, et al. Correlation Between Pharmacy Students' Implicit Bias Scores, Explicit Bias Scores, and Responses to Clinical Cases. Am J Pharm Educ. 2022;86(1):8587. doi:10.5688/ajpe858
              34. Miller CS, Scott SD, Beck M. Second victims and mindfulness: A systematic review. J Pat Saf Risk Manag. 2019;24(3):108-117. doi:10.1177/2516043519838176
              35. Coughlan B, Powell D, Higgins MF. The Second Victim: a Review. Eur J Obstet Gynecol Reprod Biol. 2017;213:11-16. doi:10.1016/j.ejogrb.2017.04.002
              36. Everly GS. Psychological first aid to support healthcare professionals. J Pat Saf Risk Manag. 2020;25(4):159-162. doi:10.1177/2516043520944637
              37. Sukhera J, Bertram K, Hendrikx S, et al. Exploring implicit influences on interprofessional collaboration: a scoping review. J Interprof Care. 2022;36(5):716-724. doi:10.1080/13561820.2021.1979946
              38. Simpson A. The impact of team processes on psychiatric case management. J Adv Nurs. 2007;60(4):409-418 doi:10.1111/j.1365-2648.2007.04402.x
              39. Huecker MR, Shreffler J, McKeny PT, Davis D. Imposter Phenomenon. In: StatPearls. Treasure Island (FL): StatPearls Publishing; September 9, 2022.
              40. Sullivan JB, Ryba NL. Prevalence of impostor phenomenon and assessment of well-being in pharmacy residents. Am J Health Syst Pharm. 2020;77(9):690-696. doi:10.1093/ajhp/zxaa041
              41. Wenger LM, Rosenthal M, Sharpe JP, Waite N. Confronting inequities: A scoping review of the literature on pharmacist practice and health-related disparities. Res Social Adm Pharm. 2016;12(2):175-217. doi:10.1016/j.sapharm.2015.05.011
              42. CDC. Social Determinants of Health. Centers for Disease Control and Prevention. Published 2022. https://www.cdc.gov/about/sdoh/index.html
              43. Cernasev A, Desselle S, Hohmeier KC, Canedo J, Tran B, Wheeler J. Pharmacy Technicians, Stigma, and Compassion Fatigue: Front-Line Perspectives of Pharmacy and the US Opioid Epidemic. Int J Envir Res Pub Health. 2021; 18(12):6231. doi:10.3390/ijerph18126231
              44. Borchardt LN, Pickett ML, Tan KT, Visotcky AM, Drendel AL. Expedited Partner Therapy: Pharmacist Refusal of Legal Prescriptions. Sex Transm Dis. 2018;45(5):350-353. doi:10.1097/OLQ.0000000000000751
              45. Murphy AL, Gardner DM. A scoping review of weight bias by community pharmacists towards people with obesity and mental illness. Can Pharm J (Ott). 2016;149(4):226-235. doi:10.1177/1715163516651242
              46. Prasad-Reddy L, Fina P, Kerner D, Daisy-Bell B. The Impact of Implicit Biases in Pharmacy Education. Am J Pharm Educ. 2022;86(1):8518. doi:10.5688/ajpe8518
              47. Terry K, Nickman NA, Mullin S, Ghule P, Tyler LS. Implementation of implicit bias awareness and action training in a pharmacy residency program. Am J Health Syst Pharm. 2022;79(21):1929-1937. doi:10.1093/ajhp/zxac199

              All “Prior Authorizations” are Not Created Equal: A Guide to Medicare Part D Prescription Drug Coverage

              Learning Objectives

               

              After completing this application-based continuing education activity, pharmacists will be able to

              • Describe the different types of prescription drug coverage available to Medicare patients
              • Explain the patient costs associated with Medicare Part D prescription drug coverage
              • Demonstrate use of a patient’s Medicare Part D formulary to determine the appropriate type of coverage determination
              • Identify prescriptions that Medicare Part D does not cover

               

              After completing this application-based continuing education activity, pharmacy technicians will be able to:

              • Describe the different types of prescription drug coverage available to Medicare patients
              • Explain the patient costs associated with Medicare Part D prescription drug coverage
              • Identify the types of coverage determinations available for Medicare Part D prescriptions
              • Outline the timeframes involved in Medicare Part D coverage determination and appeal decisions

               

                 

                Release Date: March 15, 2024

                Expiration Date: March 15, 2027

                Course Fee

                Pharmacists:  $7

                Pharmacy Technicians: $4

                There is no funding for this CE.

                ACPE UANs

                Pharmacist: 0009-0000-24-015-H04-P

                Pharmacy Technician:  0009-0000-24-015-H04-T

                Session Codes

                Pharmacist:  24YC15-XTK93

                Pharmacy Technician:  24YC15-KFV48

                Accreditation Hours

                2.0 hours of CE

                Accreditation Statements

                The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit for the online activity ACPE UAN 0009-0000-24-015-H04-P/T will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

                 

                Disclosure of Discussions of Off-label and Investigational Drug Use

                The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

                Faculty

                Lori R. Donnelly, PharmD
                Consultant
                BluePeak Advisors
                Chardon, OH

                Faculty Disclosure

                In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

                Dr. Donnelly is a consultant with Blue Peak Consultancy that assists those with government healthcare concerns. Any conflict of interest has been mitigated.

                 

                ABSTRACT

                Millions of Americans are enrolled in Medicare Part D, with hundreds of specific Part D plans available across the country. The Centers for Medicare & Medicaid Services (CMS) regulates Part D coverage. Part D plans must submit their plan costs and formularies, including formulary restrictions, to CMS for annual approval. Patient costs for Part D coverage vary based on the specific choice of plan and the benefit phase. All Part D plans must provide a process for requesting coverage of prescription medications that are not on the formulary or on the formulary with restrictions. Pharmacists and pharmacy technicians are valuable resources and can advise Part D patients and prescribers about prescription costs and the options available for non-covered medications.

                CONTENT

                Content

                INTRODUCTION

                As of April 2023, more than 51 million Americans were enrolled in prescription drug coverage through Medicare, with the number of enrollees steadily increasing every year.1 Private insurance companies contracted by the Centers for Medicare & Medicaid Services (CMS) provide Medicare prescription drug coverage. Although specific plans’ details differ, CMS requires that all plans offer certain features.

                Pharmacists and pharmacy technicians can assist patients in navigating these features to maximize their prescription benefits. This continuing education activity will review the types of Medicare prescription drug coverage, associated patient costs, formulary structure, and the options available when a patient’s Part D plan does not cover a medication.

                MEDICARE AND PRESCRIPTION DRUG COVERAGE

                CMS provides “Original Medicare” to most Americans aged 65 and older. Original Medicare includes2:

                • Part A: Most Americans are eligible for Medicare Part A at no additional cost, as long as they or their spouses have paid sufficient Medicare taxes. Medicare Part A includes coverage for inpatient hospital stays, hospice, and skilled nursing facility care.
                • Part B: Medicare Part B is optional and usually requires additional fees. Part B coverage includes outpatient and home health care, preventive services, and durable medical equipment.

                CMS contracts with private insurance companies to provide prescription drug coverage. Individuals enrolled in Original Medicare may purchase a standalone Part D Prescription Drug plan (PDP) for outpatient prescription drug coverage.

                Rather than using CMS coverage, individuals may purchase Medicare-approved private insurance called Medicare Advantage (MA), also known as Part C. With this arrangement, the MA Plan supersedes Medicare Part A and Part B for most coverage. MA plans often have lower patient costs and extra benefits compared to Original Medicare but may have fewer covered hospitals and physicians.2 Medicare Advantage Prescription Drug (MAPD) plans are MA plans that include prescription drug coverage and eliminate the need for a separate PDP.

                 

                SIDEBAR: Patient Costs Defined

                Monthly Premium: a monthly payment that maintains enrollment in the plan; not impacted by deductible, copay, or coinsurance amounts

                Annual Deductible: a yearly dollar amount the patient pays before insurance starts to contribute

                Copayment (or Copay): a specific, pre-determined dollar amount the patient pays for each prescription, office visit, or other type of care after satisfying the deductible

                Coinsurance: an alternative to a copay, the percentage of the total cost the patient pays for each prescription, office visit, or other type of care after satisfying the deductible

                 

                Medicare plans are associated with various costs to the enrollee (see SIDEBAR: Patient Costs Defined). Individuals with income higher than a predefined threshold pay a higher premium for their Part B coverage due to Medicare’s Income Related Monthly Adjustment Amount (IRMAA). IRMAA does not change any of the other costs associated with Medicare coverage. CMS may also issue a late enrollment penalty (LEP) to people who do not sign up for Part D (from either a PDP or MAPD) as soon as they become eligible for Medicare. Once assigned, CMS adds the LEP to the patient’s monthly Part D premium for the remainder of their enrollment in Part D, regardless of which Part D plan they choose. Even people not actively taking prescription medications should consider choosing a Part D plan with a low monthly premium and/or no annual deductible to avoid incurring LEP.2

                Individuals and couples with incomes and assets less than an annual threshold set by CMS may qualify for a Low Income Subsidy (LIS), also known as “extra help.” For people who qualify, the LIS reduces or eliminates the Part D monthly premium, deductible, and copay/coinsurance. CMS automatically enrolls most qualified patients into extra help, but a manual application process is also available. Pharmacy personnel should refer patients to 1-800-MEDICARE or https://www.medicare.gov/basics/costs/help/drug-costs to see if they qualify for LIS.3

                Once a patient decides between Original Medicare or MAPD coverage, the next step is choosing a specific plan. CMS provides a comprehensive platform, called Medicare Plan Finder (MPF) for patients to shop and compare costs for PDP and MAPD plans. Patients can enter their medication list and see detailed cost information for each prescription. MPF also includes information about participating pharmacies and Star Ratings, a system CMS uses to measure each Part D plan’s performance in the areas of customer service, member experience, drug safety, and drug pricing accuracy. CMS rates plans on a scale of one to five stars, with five stars indicating the highest level of performance.4

                The MPF tool is located at www.medicare.gov/plan-compare.

                It is not necessary for pharmacy personnel to distinguish between MAPD and PDP coverage before processing prescription claims. The member’s prescription drug card provides the details needed to submit pharmacy claims to either type of Part D plan. If the member’s prescription drug card is not available, CMS provides a process known as an E1 transaction that returns Part D coverage information using basic demographic information. Pharmacists and technicians should consult their employer’s training materials for specific instructions on submitting an E1 transaction.5

                The Part D Coverage Cycle

                The Part D coverage cycle runs January to December each year. Regardless of when an individual reaches each phase of coverage, summarized in Figure 1, they start over in the deductible phase each year on January 1st. Only “True Out-of-Pocket” (TrOOP) costs as defined by CMS go toward the thresholds to move patients through each of the four coverage phases. Patient costs excluded from TrOOP are6

                • Medications not covered by the Part D plan
                • Prescriptions obtained at non-participating (i.e., out-of-network [OON]) pharmacies, except those specifically allowed under the Part D plan’s rules
                • Costs reimbursed by an organization other than the Part D plan

                Wheel showing Medicare coverage timeline sections

                PAUSE AND PONDER: Some patients with lower prescription costs do not complete their annual deductible until November or December. They are surprised when their out-of-pocket costs increase again in January. How would you explain the increase?

                 

                Patients with higher prescription costs may also be subject to the coverage gap, commonly known as the “Donut Hole” (see SIDEBAR: Explaining the Donut Hole). The coverage gap occurs when a patient’s prescription drug costs exceed a defined threshold under Medicare Part D. In the coverage gap, a patient’s out-of-pocket cost for brand name prescriptions may increase. 7 Patients with very high prescription drug costs may reach the end of the coverage gap to enter catastrophic coverage, where they pay nothing out of pocket. The Inflation Reduction Act of 2022 removed patient costs from the catastrophic phase starting in 2024 and eliminated the coverage gap starting in 2025.8

                 

                SIDEBAR: Explaining the Donut Hole

                Have you ever wondered why the Medicare Part D coverage gap is called the “Donut Hole?”

                Imagine a giant donut, a circle with a hole in the middle, big enough to drive through. Half of the donut is plain, but the other half has frosting and sprinkles. In January, you start driving in a straight line through the plain half of the donut, toward the frosted half. Your drug costs determine your speed.

                The plain half of the donut represents the annual deductible and initial coverage phases where you are subject to normal coverage amounts.

                If high drug costs cause you to drive faster, you exit the plain half of the donut and enter the donut’s hole before the end of the year. You are now driving where there is no donut, and you must pay more than the normal amount for brand name drugs.

                If your drug costs are high enough that you speed to the other side of the hole before the end of the year, then you enter the frosting and sprinkles half of the donut. Frosting and sprinkles represent the additional Part D contributions in the catastrophic phase and you pay nothing out of pocket.

                Unfortunately, your car has only a 365-day warranty, so when January comes, you must start all over at the plain side of the donut.

                 

                An annual bidding process determines the specific costs for each Part D plan. Each year, CMS sets limits and thresholds for certain aspects of Part D coverage but allows flexibility within these parameters for both PDP and MAPD plans. Insurance companies submit bids that demonstrate how their plans comply with CMS’s annual limits and thresholds. The financial information that contributes to each plan’s annual bid is highly complex, and CMS can either accept or reject each bid.

                As part of the annual bidding process, CMS defines standard prescription drug coverage. For a “basic” Part D plan, a bid must either match or be financially equivalent to the CMS definition of standard coverage. Table 1 provides the 2023 and 2024 standard benefit parameters, as defined by CMS.9

                 

                Table 1. Limits and Thresholds for 2023 and 2024 Medicare Part D Plans9

                2023 2024
                Annual Deductible Limit $505 $545
                Initial Coverage Limit (starts the coverage gap) $4660 total drug costs $5030 total drug costs
                Out-of-Pocket Limit (ends the coverage gap and starts catastrophic phase) $7400 patient cost $8000 patient cost

                 

                Insurance companies may also offer “enhanced” Part D plans with coverage that is more robust than the defined standard. Most plans with enhanced coverage have higher monthly premiums compared to basic plans but offer corresponding advantages such as reduced deductibles, lower copays/coinsurance, and lower costs in the coverage gap.

                Individuals should choose their Part D plans carefully because they can only sign up or change Part D plans during certain periods2:

                • During the 3-month initial enrollment period that starts 1 month before and ends 1 month after an individual’s 65th birthday; coverage starts the month after initial enrollment
                • During the annual open enrollment period that runs from mid-October to early December each year; coverage starts on January 1 of the following year for people who enroll during annual open enrollment
                • During the Medicare Advantage open enrollment period that runs from January through March each year; during this time, CMS only allows certain types of changes
                • During special enrollment periods for qualifying events such as relocation or the loss of employer or Medicaid coverage. Natural disasters that disrupt the initial or annual enrollment period may also create special enrollment periods

                Prescription Coverage Under Medicare Parts A and B

                Original Medicare provides prescription drug coverage under very limited circumstances and CMS prohibits Part D from covering anything covered under Medicare Parts A or B.

                Medicare Part A covers hospice care, including medications related to the hospice diagnosis. Hospice providers receive payment for these medications from CMS and are responsible for paying the pharmacy. Medicare Part D is prohibited from covering medications related to any hospice diagnosis.10

                Medicare Part B provides the only coverage options for some items, such as diabetic testing supplies and certain vaccines. Coverage for other items may fall under Part B or Part D, depending on the specific circumstances. Table 2 compares Part B and Part D coverage for the most common examples.10

                Table 2. Medicare Part B and Part D Coverage of Common Products

                Product(s) Part B Coverage Part D Coveragea
                Nebulizer Solutions (such as albuterol sulfate and ipratropium bromide) For patients residing at home. For patients residing in a long-term care facility.
                Influenza, Hepatitis B, Pneumonia, and Coronavirus (COVID-19) Vaccines Yes No
                Immunosuppressants (such as cyclosporine and mycophenolate mofetil) When used to prevent rejection of a Medicare-covered transplant. When used for a medically accepted indication other than a Medicare-covered transplant.
                Oral Anti-Cancer Drugs (such as cyclophosphamide and methotrexate) When used to treat cancer. When used to treat a medically accepted indication other than cancer.
                Oral Anti-Emetic Drugs (such as ondansetron and promethazine) When used to treat or prevent chemotherapy-related nausea and vomiting. When used to treat or prevent medically accepted indications other than chemotherapy-related nausea and vomiting.
                Insulin When used in an insulin pump. When not used in an insulin pump.
                Diabetic Testing Supplies (such as test strips and lancets) Yes No
                Insulin Injection Supplies (such as needles and alcohol swabs) No Yes
                aCoverage may be subject to formulary restrictions.

                 

                Part D plans are responsible for rejecting pharmacy claims for medications that may be covered under Part A or Part B. Pharmacy personnel should refer to claim reject messaging and redirect the claim appropriately.

                 

                Other Prescription Drug Coverage

                Most people who qualify for Medicare are covered by some combination of Parts A, B, C, and D as described above. However, other prescription drug coverage options are available under special circumstances:

                • Employer Group Waiver plans (EGWPs): Employers may choose to provide prescription drug coverage for their retirees by contracting with a Part D plan for EGWP coverage. Retirees with EGWP plans that start as soon as they become eligible for Medicare are exempt from LEP. When providing an EGWP plan for their retirees, employers may also add additional benefits paid either through Part D or by the employer themselves.11
                • Medicare Supplemental Insurance (Medigap): Medigap coverage helps with costs not covered by Medicare Parts A and B, such as copays and deductibles. Certain Medigap plans also help with skilled nursing facility or hospice costs and emergency care while traveling outside of the United States. Individuals who enrolled in Medigap prior to 2006 may have prescription drug coverage included, but those who are newer to Medigap should purchase separate Part D coverage to avoid LEP.12
                • Employer Coverage: Individuals who are actively employed (not retired) may have coverage through their employer to replace Medicare or use Medicare as secondary coverage. Covered employees are exempt from the LEP if the employer coverage is equivalent to at least a basic Part D plan.2
                • Consolidated Omnibus Budget Reconciliation Act (COBRA): People who have recently separated from an employer may be eligible for COBRA. Individuals enrolled in COBRA may still be subject to LEP because COBRA is usually not equivalent to Medicare coverage.2
                • Medicaid: People with low incomes who qualify for both Medicaid and Medicare receive the LIS and have Part D coverage with reduced patient costs. In most cases, Medicare pays first and Medicaid helps with remaining costs.2
                • Manufacturer Discount Programs: Many drug manufacturers provide coupons, discount cards, and patient assistance programs to help cover their products’ cost. Federal law prohibits using these manufacturer payments in combination with Medicare prescription drug coverage.13 Medicare patients may choose manufacturer coupons or patient assistance programs for certain prescriptions only when they do not use their Part D coverage.
                • Prescription Discount Cards: Unlike manufacturer discounts, which are limited to products produced by that manufacturer, prescription discount cards offer discounts on a wide range of medications. Also known as “cash cards”, prescription discount cards reduce the cash price of prescriptions, but are not used in combination with insurance, including Medicare.14 Patients who choose a prescription discount card cannot use it in combination with their Part D coverage for the same medication.

                MEDICARE PART D FORMULARIES

                CMS requires Part D plans to maintain a list of covered drugs, called a formulary. CMS reviews each Part D formulary to ensure sufficient coverage under each drug class. The copay or coinsurance for each medication on the formulary is determined by its “tier.” Medications on lower tiers generally cost less than drugs on higher tiers.15 CMS allows some flexibility on how Part D plans define their formulary tiers, so tier structure differs between plans. Figure 2 provides an example of a formulary tier arrangement.

                Image showing Tier 1-5 of covered medications, where tier 1 has the lowest copay and tier 5 has the highest copay

                 

                Drug Placement and Formulary Restrictions

                Specialty medications are high-cost prescription products used to treat complicated medical conditions. CMS limits the patient cost portion for these medications and Part D plans typically place all specialty mediations into designated formulary tiers.10

                CMS requires that Part D plans cover adult vaccines (excluding those covered under Part B) recommended by The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices at no cost to the patient, regardless of formulary tier or benefit phase.16

                In 2023, CMS began setting a maximum copay for insulin products covered under Part D. Currently, the maximum copay is $35 for a one-month supply and is subject to change on an annual basis. Insulin copays may be lower if a Part D plan includes specific insulin products on a formulary tier where the monthly copay is lower than the CMS maximum. A similar program exists for insulin used in an insulin pump and covered under Part B.16

                Part D plans may put restrictions on formulary medications to ensure appropriate coverage and to control costs. CMS reviews the restrictions and will not allow overly restrictive formularies. Plans may place four types of restrictions on formulary medications10:

                • Quantity Limit: Quantity limit restrictions define the maximum number of dosage units allowed for a specific time period.
                • Step Therapy: Step therapy restrictions require patients to first try a different medication, usually a lower cost alternative, before the prescribed medication.
                • Prior Authorization: Prior authorizations require patients to meet specific criteria, which may be as simple as providing the diagnosis or more complicated (e.g., specific lab tests, involvement of a specialist physician).
                • Drug Utilization Review (DUR): May be “hard edits” that require a coverage determination or “soft edits” that require the dispensing pharmacist to obtain clinical information and enter a set of codes into the prescription claim.

                CMS defines six drug classes—those used to treat disorders where changes or interruptions in therapy involve higher risk—as “protected class.” CMS requires that Part D formularies include most medications within these classes with at least one medication on a preferred tier and no restrictions. Plans are not, however, required to include all variations of each medication (i.e., brand name and generic or immediate and extended-release versions). The six protected classes are10

                • immunosuppressants (used to prevent organ transplant rejection)
                • antidepressants (used to treat depression)
                • antipsychotics (used to treat mental health disorders)
                • anticonvulsants (used to treat seizure disorders)
                • antiretrovirals (used to treat human immunodeficiency virus)
                • antineoplastics (used to treat cancer)

                CMS allows plans to add medications and make other positive changes to their formulary throughout the year but restricts medication removal and other negative changes until the following January. This restriction protects patients from losing coverage for their prescriptions during the time when they cannot switch to a different Part D plan. Marketplace removal, safety concerns, and the availability of a new generic are examples of situations when CMS would allow removal of a medication from a Part D formulary during the year.

                Part D plans must provide patients with ongoing access to their formulary information. Most Part D plans post formularies online and only provide paper copies upon request. Patients can also see the formulary status for their specific medications when comparing Part D plans using the MPF website.

                 

                COVERAGE DETERMINATIONS AND APPEALS

                Patients and pharmacy personnel commonly generalize the term “prior authorization” to describe any situation that requires insurance approval before insurance covers a prescription. Under Medicare Part D, this is known as the coverage determination process. Part D patients may use the coverage determination process to request approval for a non-formulary medication or a formulary medication with restrictions.

                Who hasn’t been frustrated after contacting a prescriber to change a non-formulary prescription to a formulary medication, only to have the formulary medication require prior authorization? Part D plans usually include messaging within rejected claims to help determine which type of coverage determination is needed. When faced with a prescription rejection, pharmacists and pharmacy technicians who understand the nuances of the coverage determination process are equipped to advise their Part D patients on the best course of action.

                Several specific types of coverage determinations are available and each type of coverage determination has specific criteria for approval.16,17 Table 3 provides a summary of coverage determination types, their uses, and the information required for approval.

                Table 3. Types of Coverage Determinations and Their Uses16,17

                Medication Status Coverage Determination Requirements for Approval
                On the formulary, but dosing regimen requires more than the formulary allowance or requires tablet splitting Quantity Limit Exception The quantity allowed by the plan’s formulary is not effective in treating the patient’s condition or requires tablet-splitting to achieve the prescribed dosing regimen.
                On the formulary with step therapy restrictions Step Therapy Exception

                 

                The patient tried the step medication and either did not achieve therapeutic effect or experienced an adverse outcome.
                Step Therapy The patient is likely to experience an adverse outcome if they must first try the step medication.
                On the formulary with prior authorization or “hard” DUR restrictions Prior Authorization

                 

                The patient meets the Part D plan’s specific criteria for the prescribed medication.
                On the formulary with a “soft” DUR restriction None DUR “soft edits” may require dispensing pharmacists to contact prescribers and obtain clinical information, but do not require a coverage determination.
                Sometimes by Medicare Part B Prior Authorization Why the patient’s situation warrants coverage under Part D for the prescribed medication.
                On the formulary, but the patient cannot afford the copay/coinsurance Tier Exception The required number of lower tier drugs for the same condition are less effective or likely to result in an adverse outcome.

                 

                Not available for specialty or non-formulary medications and cannot provide a brand name medication at the generic cost.

                Not on the formulary Non-formulary Exception

                 

                The required number of formulary alternative medication(s) were ineffective or likely to result in an adverse outcome.

                Patients should consult their specific plan information to find out how many alternatives are required for tier or non-formulary exceptions.

                Part D plans will only approve a coverage determination request if the product is medically necessary and if the information submitted by the prescriber meets the plan’s criteria. Prescribers may submit information over the phone, by fax, or by mail. Most Part D plans also have an electronic portal to accept information from prescribers. Dispensing pharmacists are only permitted to supply information in place of the prescriber under limited circumstances, such as prior authorizations to determine Part B versus Part D coverage.

                Approval and Denial Parameters

                For exception requests that meet approval criteria, CMS requires Part D plans to maintain the approval at least through the end of the year. Part D plans may approve prior authorizations for a shorter time only if clinically appropriate and approved by CMS as part of the annual formulary approval process.

                Part D plans will deny requests with incomplete information and requests that do not meet approval criteria. Part D plans will also deny any type of coverage determination if the medication is being used for a non-medically accepted indication. Medically accepted indications are uses approved by the United States Food and Drug Administration or listed in one of the references that CMS defines as approved compendia10:

                • American Hospital Formulary Service Drug Information
                • DRUGDEX Information System
                • Peer-reviewed medical literature (only allowed for biologics and anti-cancer chemotherapy medications)

                Common examples of medications prescribed for non-medically accepted indications include the use of fentanyl lollipops/lozenges for non-cancer pain and hydroxychloroquine for coronavirus disease 2019 (COVID-19). Federal and state laws may allow prescriptions for non-medically accepted indications, but patients cannot use their Part D coverage to pay for them. Part D plans must block medication coverage if the determination process reveals a non-medically accepted indication, even for previously covered medications, quantities less than the predetermined limit, and any tier cost after a tier exception request.10 Pharmacists are not required to confirm medically accepted indications before dispensing prescriptions because CMS considers this a plan responsibility. As a result, Part D plans will often reject claims and require a prior authorization for medications commonly prescribed for non-medically accepted indications. Pharmacists and pharmacy technicians can assist patients and prescribers by communicating rejected claim information and explaining the CMS requirement for medically accepted indications. 10

                In addition to medications covered under Part A or B, CMS specifically excludes certain types of medications from Part D coverage10:

                • Products used for weight loss or weight gain
                • Fertility medications
                • Cosmetic and hair growth products
                • Treatments for the symptomatic relief of cough and colds
                • Non-prescription medications
                • Prescription vitamins, except prenatal and fluoride products
                • Erectile dysfunction treatments

                Bulk powders and inert excipients used for compounded prescriptions are also excluded from Part D coverage. Compounds may contain other ingredients that are covered with or without restrictions under Part D. When pharmacies bill some of a compound’s ingredients to Part D, CMS prohibits them from charging patients for the non-Part D portion.10

                Patients cannot obtain Part D coverage for excluded medications using the coverage determination process. Employers may cover some of these medications and manufacturer coupons or prescription discount cards may help make these products more affordable for individuals without employer coverage.

                PAUSE AND PONDER: Generic sildenafil is prescribed for both erectile dysfunction (excluded from Part D coverage) and pulmonary hypertension (eligible for Part D coverage). Can a dispensing pharmacist distinguish between the two to bill Part D for the appropriate product?

                Part D plans may dismiss requests that are inappropriate, unnecessary, or filed incorrectly. CMS requires Part D plans to provide written notification and a reason for the dismissal to the patient and prescriber. 17

                If the patient or prescriber decides that a request is unnecessary, they can withdraw the request before a decision is issued. Withdrawing a request does not prevent the patient or prescriber from submitting a later request for the same medication.17

                When a Part D plan denies a coverage determination, CMS requires them to send the specific reason(s) for the denial to the patient and the prescriber. Part D plans may choose to also send a copy of this information to the dispensing pharmacy.17 Depending on the reason for the denial, the patient or prescriber may choose to appeal the Part D plan’s decision.

                Appeal requests must be within 60 days of the denial, unless good cause is established for missing the 60-day deadline. If the Part D plan denies the appeal, beneficiaries have up to four additional opportunities to appeal through entities outside of their Part D plan. After the second level, higher levels of appeal are only available if the drug cost meets a specific threshold set by CMS.18 Figure 3 outlines the five levels of appeal available to Part D patients.

                Image showing timeline of insurance coverage denials and appeals

                A patient or prescriber can request a re-opening instead of the next level appeal if they feel that a coverage determination or appeal decision is in error. Part D plans may also initiate a re-opening if they identify a decision error.

                Direct Member Reimbursements

                Patients who pay for a covered Part D prescription without using their Part D Insurance may be eligible for reimbursement from their Part D plan through a process called Direct Member Reimbursement (DMR). To qualify for DMR, the prescription must meet the Part D plan’s coverage requirements and not be covered by any other type of insurance or discount card. Prescriptions obtained at an OON pharmacy must meet the Part D plan’s OON rules to qualify for reimbursement.19

                Pharmacies should submit Part D prescriptions to the patient’s Part D plan whenever possible because a DMR reimbursement may not result in a full refund of the cash price.

                 

                Timeframes

                Part D plans must offer both standard and expedited timeframes for coverage determination and appeal requests (listed in Table 4). Expedited requests are available when the standard timeframe could result in a significant adverse outcome. DMR requests do not qualify for expedited timeframes because the patient has already received the medication.17

                Table 4. Plan Timeframes for Medicare Part D Requests16

                Request Level Request Urgency Request Type Required Timeframe
                Initial Coverage Determination Standard Quantity Limit Exception

                Step Therapy Exception

                Tier Exception

                Non-Formulary Exception

                72 hours from supporting statement but no longer than 14 days from request received

                 

                Initial Coverage Determination Expedited Quantity Limit Exception

                Step Therapy Exception

                Tier Exception

                Non-Formulary Exception

                24 hours from supporting statement but no longer than 14 days from request received

                 

                Initial Coverage Determination Standard Prior Authorization

                Step Therapy (non-exception)

                72 hours from request received
                Initial Coverage Determination Expedited Prior Authorization

                Step Therapy (non-exception)

                24 hours from request received
                Initial Coverage Determination N/A Direct Member Reimbursement 14 days from request received
                First Level Appeal Standard Quantity Limit Exception

                Step Therapy Exception

                Tier Exception

                Non-Formulary Exception

                Prior Authorization

                7 days from request received
                First Level Appeal Expedited Quantity Limit Exception

                Step Therapy Exception

                Tier Exception

                Non-Formulary Exception

                Prior Authorization

                72 hours from request received
                First Level Appeal N/A Direct Member Reimbursement Notification of Decision: 14 days from request received

                Payment (if approved): 30 days from request received

                 

                Part D plans may automatically apply the expedited timeframe if the clinical information submitted for the coverage determination indicates that waiting may harm the patient’s health. Alternatively, Part D plans may downgrade an expedited request if they determine that the patient’s health will not be harmed by using the standard timeframe. CMS requires Part D plans to notify the patient if a request is downgraded from expedited to standard.17

                All Part D timeframes are based on calendar hours/days and include weekends and holidays. Timeframes start as soon as the Part D plan receives a non-exception coverage determination or any type of valid appeal request, regardless of how much clinical information is included with the request. For exception requests, the timeframe starts as soon as the Part D plan receives clinical information from the prescriber to support the request (known as the prescriber’s supporting statement). When a supporting statement is missing from an exception request, CMS allows up to 14 days for plans to obtain it.17 The following examples demonstrate Part D timeframes over weekends and holidays:

                • A patient requests a standard prior authorization on Friday afternoon, December 23. The prescriber’s office is closed for the three-day holiday weekend. The plan must deny the request in 72 hours (on Monday afternoon), even though the prescriber’s office was not available to provide information during that timeframe.
                • A different patient requests a standard non-formulary exception the same day. Their prescriber’s office is also closed for the three-day holiday weekend but contacts the plan with the supporting information on Tuesday morning. Since this is an exception request, 72 hour timeframe starts on Tuesday morning and the plan has until Friday morning to complete the request.

                When clinical information is incomplete, CMS requires that Part D plans make reasonable efforts to contact the prescriber and obtain the missing information. Once the timeframe has started, making outreach attempts and waiting for additional information does not extend the request timeframe. The Part D plan will deny the request if they do not receive sufficient clinical information by the end of the allotted timeframe.17

                PAUSE AND PONDER: It’s late Friday afternoon and your patient is anxious to request a prior authorization for her medication. The physician’s office is closed for the weekend. Could requesting an expedited coverage determination at this point cause more of a delay?

                When a Part D plan does not process a request within the required timeframe, they must send the request to the IRE as an “auto-forward.” This is the same IRE that processes Part D second-level appeals. Part D plans must notify patients in the event of an auto-forward. CMS monitors Part D plans’ timeliness and issues penalties for excessive numbers of auto-forwards.

                How to Submit Requests

                CMS requires that Part D plans accept coverage determination requests via phone, fax, or mail. For appeals, plans must accept both standard and expedited requests via fax or mail. Verbal requests by phone are required for expedited appeals but optional for standard appeals.17 Many plans also choose to accept electronic requests via an online portal.

                Patients should follow the instructions from their specific Part D plan for requesting a DMR. Part D plans usually require hard copies of payment receipts, so most patients file DMR requests by mail.

                CMS does not permit Part D plans to require a specific form to submit a coverage determination, appeal, or DMR request.17 Although optional, using a form provided by the plan usually streamlines the process and reduces the risk of submitting incomplete information.

                CMS does not allow dispensing pharmacists or pharmacy technicians to request a Part D coverage determination or appeal on behalf of the patient. Only the patient, the patient’s appointed representative, the prescriber, or the prescriber’s staff can request a coverage determination or appeal. Only patients or their appointed representative can request a DMR.17

                The handout entitled “Medicare Prescription Drug Coverage and Your Rights” that dispensing pharmacies supply to patients when prescriptions cannot be filled under their Part D plan provides additional instructions for submitting requests.17,20

                CONCLUSION

                Medicare patients have many choices available for their prescription drug coverage. CMS requires that all Part D plans conform to a set of common standards while allowing specific plans to offer a wide range of benefit options.

                Pharmacists and pharmacy technicians with a basic understanding of Part D coverage options, patient costs, formulary structure, and the coverage determination and appeals process can help patients maximize the benefit from their Part D plan. Although CMS does not allow them to initiate coverage determinations and appeals, pharmacy personnel can advise Part D patients and their physicians on the most effective next steps when faced with a non-covered prescription.

                Pharmacist Post Test (for viewing only)

                All “Prior Authorizations” are Not Created Equal: A Guide to Medicare Part D Prescription Drug Coverage

                Pharmacists Post-test

                After completing this continuing education activity, pharmacists will be able to
                1. Describe the different types of prescription drug coverage available to Medicare patients.
                2. Explain the patient costs associated with Medicare Part D prescription drug coverage.
                3. Demonstrate use of a patient’s Medicare Part D formulary to determine the appropriate type of coverage determination.
                4. Identify prescriptions that Medicare Part D does not cover.

                1. Which of the following is the correct description for the type of Medicare coverage?
                A. Medicare Part A: Covers outpatient and home health care, preventative services, and durable medical equipment.
                B. Medicare Part B: Offered by private insurance companies for prescription drug coverage.
                C. Medicare Part C: Offered by private insurance companies to provide Part A and Part B coverage.

                2. What is an appropriate combination of coverage?
                A. Medicare Part A + Medicare Part B + Medicare Part D
                B. Medicare Part A + Medicare Part B + MAPD
                C. Employer Coverage + Medigap + MAPD

                3. A patient who is turning 65 next month asks you about delaying Part D coverage because she only takes two prescriptions that are very low cost using a prescription discount card. What is the possible risk of this approach when she eventually signs up for Part D coverage at a later date?
                A. She may pay higher monthly premiums due to the coverage gap.
                B. She may pay higher annual deductibles due to the late enrollment penalty.
                C. She may pay higher monthly premiums due to the late enrollment penalty.

                4. It’s January and a patient who paid a $10 copay for his prescription last month now has to pay 100% of the cost. What is the most likely explanation?
                A. He is paying the annual deductible
                B. He is in the coverage gap
                C. His Part D plan doesn’t cover his medication

                5. A patient who takes several expensive medications experiences a sharp increase in her out-of-pocket costs around midyear. What is the most likely explanation?
                A. She has entered the deductible phase
                B. She has entered the coverage gap phase
                C. She has entered the catastrophic coverage phase

                6. A patient’s Part D Plan is rejecting a prescription for apixaban. You locate its formulary online and find that dabigatran is listed, but not apixaban. What type of coverage determination does this patient need from this Part D Plan?
                A. Step Therapy
                B. Non-formulary
                C. Prior Authorization

                7. A patient’s Part D Plans is rejecting a prescription for alirocumab. You locate the formulary online and find that alirocumab is on the formulary but is not covered unless simvastatin has been tried first. What type of coverage determination does this patient need from this Part D Plan?
                A. Step Therapy
                B. Prior Authorization
                C. Tier Exception

                8. A Part D patient is struggling to afford his medication, even after the Part D Plan approved a non-formulary exception. What is their best option for lowering costs?
                A. Talk to the prescriber about switching to an alternative on a lower formulary tier.
                B. Ask their Part D Plan for a tier exception.
                C. Find a manufacturer discount coupon to cover their Part D copay.

                9. A Part D patient presents a prescription for a highly advertised diabetic medication and confides in you that she is not diabetic but hoping the medication will help with weight loss. Her Part D Plan requires prior authorization to establish medically accepted indication. What coverage option is available to them?
                A. Part D after prior authorization approval
                B. Manufacturer discount program
                C. Medicare Advantage

                10. A Medicare Part D Plan is rejecting claims for your patient’s diabetic test strips and lancets. What do you recommend as the next course of action?
                A. Call the Part D Plan and request a coverage determination.
                B. Pay out of pocket and ask the Part D Plan for direct member reimbursement.
                C. Compile the documentation required to submit the claims to Part B.

                Pharmacy Technician Post Test (for viewing only)

                All “Prior Authorizations” are Not Created Equal: A Guide to Medicare Part D Prescription Drug Coverage

                Pharmacy Technician Post-test

                After completing this continuing education activity, pharmacy technicians will be able to
                1. Describe the different types of prescription drug coverage available to Medicare patients.
                2. Explain the patient costs associated with Medicare Part D prescription drug coverage.
                3. Identify the types of coverage determinations available for Medicare Part D prescriptions.
                4. Outline the timeframes involved in Medicare Part D coverage determination and appeal decisions.

                1. Which of the following is the correct description for the type of Medicare coverage?
                A. Medicare Part A: Covers outpatient and home health care, preventative services, and durable medical equipment.
                B. Medicare Part B: Offered by private insurance companies for prescription drug coverage.
                C. Medicare Part C: Offered by private insurance companies to replace Part A and Part B coverage.

                2. What is an appropriate combination of coverage?
                A. Medicare Part A + Medicare Part B + Medicare Part D
                B. Medicare Part A + Medicare Part B + MAPD
                C. Employer Coverage + MAPD

                3. A patient who is turning 65 next month asks you about delaying Part D coverage because she only takes two prescriptions that are very low cost using a prescription discount card. What is the possible risk of this approach when she eventually signs up for Part D coverage at a later date?
                A. She may pay higher monthly premiums due to the coverage gap.
                B. She may pay higher annual deductibles due to the late enrollment penalty.
                C. She may pay higher monthly premiums due to the late enrollment penalty.

                4. It’s January and a patient who paid a $10 copay for his prescription last month now has to pay 100% of the cost. What is the most likely explanation?
                A. He is paying the annual deductible
                B. He is in the coverage gap
                C. His Part D plan doesn’t cover his medication

                5. A patient who takes several expensive medications experiences a sharp increase in her out-of-pocket costs around midyear. What is the most likely explanation?
                A. She has entered the deductible phase.
                B. She has entered the coverage gap phase.
                C. She has entered the catastrophic coverage phase.

                6. Which of the following combinations of coverage determinations may be required for a single prescription?
                A. Non-formulary + Quantity Limit
                B. Quantity Limit + Prior Authorization
                C. Tier Exception + Non-formulary

                7. Which type of reject requires a Part D coverage determination?
                A. Non-formulary
                B. Refill too soon
                C. DUR soft edit

                8. Which of the following is the correct description for a type of coverage determination under Medicare Part D?
                A. Non-formulary exceptions: Used to request larger quantities of a medication
                B. Tier Exceptions: Used to request a lower copay for a medication
                C. Prior Authorization: Used to request a non-formulary medication

                9. A patient called her Part D plan yesterday morning to request an urgent appeal for their medication. This afternoon, she has not received a response and the claim is still rejecting. How much longer might she have to wait for a response?
                A. The appeal is already out of timeframe because it has been longer than 24 hours
                B. 6 more days, for a total of 7 days
                C. 2 more days, for a total of 3 days

                10. You are working on a prescription that the Part D Plan is rejecting due to a quantity limit. The patient is not out of medication, so you advise him to call and ask for a standard quantity limit exception. How long should the patient expect to wait for the Part D Plan to make a decision?
                A. 24 hours after the patient calls their Part D Plan to request the coverage determination
                B. 24 hours after their prescriber provides clinical information to the Part D Plan
                C. 72 hours after their prescriber provides clinical information to the Part D Plan

                References

                Full List of References

                References

                   

                  1. Centers for Medicare & Medicaid Services. Medicare Enrollment Dashboard. Accessed August 28, 2023. https://data.cms.gov/tools/medicare-enrollment-dashboard
                  2. Centers for Medicare & Medicaid Services. Medicare & You Handbook. Accessed September 5, 2023. https://www.medicare.gov/medicare-and-you
                  3. Centers for Medicare & Medicaid Services. Help with Drug Costs. Accessed September 6, 2023. https://www.medicare.gov/basics/costs/help/drug-costs
                  4. Centers for Medicare & Medicaid Services. Explore Your Medicare Coverage Options. Accessed September 13, 2023. www.medicare.gov/plan-compare
                  5. RelayHealth. Medicare Eligibility Verification Transaction. Accessed December 28, 2023. https://medifacd.mckesson.com/e1/
                  6. Centers for Medicare & Medicaid Services. Medicare Prescription Drug Benefit Manual Chapter 5: Benefits and Beneficiary Protections. September 20, 2011. Accessed September 5, 2023. https://www.cms.gov/medicare/prescription-drug-coverage/prescriptiondrugcovcontra/downloads/memopdbmanualchapter5_093011.pdf
                  7. Centers for Medicare & Medicaid Services. Costs in the Coverage Gap. Accessed September 6, 2023. https://www.medicare.gov/drug-coverage-part-d/costs-for-medicare-drug-coverage/costs-in-the-coverage-gap
                  8. Kaiser Family Foundation. Changes to Medicare Part D in 2024 and 2025 Under the Inflation Reduction Act and How Enrollees Will Benefit. Accessed December 27, 2023. https://www.kff.org/medicare/issue-brief/changes-to-medicare-part-d-in-2024-and-2025-under-the-inflation-reduction-act-and-how-enrollees-will-benefit
                  9. Centers for Medicare & Medicaid Services. Announcement of Calendar Year (CY) 2024 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies. March 31, 2023. Accessed September 6, 2023. https://www.cms.gov/files/document/2024-announcement-pdf.pdf
                  10. Centers for Medicare & Medicaid Services. Medicare Prescription Drug Benefit Manual Chapter 6 – Part D Drugs and Formulary Requirements. January 15, 2026. Accessed August 23, 2023. https://www.cms.gov/medicare/prescription-drug-coverage/prescriptiondrugcovcontra/downloads/part-d-benefits-manual-chapter-6.pdf
                  11. Centers for Medicare & Medicaid Services. Medicare Prescription Drug Benefit Manual Chapter 12 – Employer/Union Sponsored Group Health plans. November 7, 2008. Accessed September 5, 2023. https://www.cms.gov/regulations-and-guidance/guidance/transmittals/downloads/dwnlds/r6pdbpdfpdf
                  12. Centers for Medicare & Medicaid Services. Learn How Medigap Works. Accessed October 25, 2023. https://www.medicare.gov/health-drug-plans/medigap/basics/how-medigap-works
                  13. Office of Inspector General. Special Advisory Bulletin, Pharmaceutical Manufacturer Copayment Coupons. September 2014. Accessed September 5, 2023. https://oig.hhs.gov/documents/special-advisory-bulletins/878/SAB_Copayment_Coupons.pdf
                  14. Dr Christina Polomoff discusses the complex world of medication discount cards. Am J Manag Care. April 13, 2021. Accessed September 5, 2023. www.ajmc.com/view/dr-christina-polomoff-discusses-the-complex-world-of-medication-discount-cards
                  15. Centers for Medicare & Medicaid Services. What Medicare Pat D plans Cover. Accessed September 7, 2023. https://www.medicare.gov/drug-coverage-part-d/what-medicare-part-d-drug-plans-cover
                  16. Centers for Medicare & Medicaid Services. Final Contract Year (CY) 2024 Part D Bidding Instructions. April 4, 2023. Accessed September 6, 2023. https://www.cms.gov/files/document/final-cy-2024-part-d-bidding-instructions.pdf
                  17. Centers for Medicare & Medicaid Services. Parts C&D Enrollee Grievances, Organization/Coverage Determinations, and Appeals Guidance. August 3, 2022. Accessed September 10, 2023. https://www.cms.gov/medicare/appeals-and-grievances/mmcag/downloads/parts-c-and-d-enrollee-grievances-organization-coverage-determinations-and-appeals-guidance.pdf
                  18. Centers for Medicare & Medicaid Services. Medicare Appeals. Accessed August 23, 2023. https://www.medicare.gov/Pubs/pdf/11525-Medicare-Appeals.pdf
                  19. Centers for Medicare & Medicaid Services. Medicare Prescription Drug Benefit Manual Chapter 14 – Coordination of Benefits. September 17, 2018. Accessed September 11, 2023. https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Chapter-14-Coordination-of-Benefits-v09-14-2018.pdf
                  20. Centers for Medicare & Medicaid Services. Medicare Prescription Drug Coverage and Your Rights. Accessed September 12, 2023. https://www.cms.gov/outreach-and-education/outreach/partnerships/downloads/yourrightsfactsheet.pdf

                  Accommodating Disabilities in Experiential Education: Easier Than it Seems, Full of Reward

                  Learning Objectives

                   

                  After completing this application-based continuing education activity, pharmacist preceptors will be able to

                  • DEFINE types of learning disabilities that preceptors are likely to encounter
                  • LIST the information the school of pharmacy should provide to preceptors
                  • IDENTIFY accommodation that are appropriate for specific students
                  • DESCRIBE reasonable accommodation in experiential education

                    Education for disabled children. Handicapped kid on wheelchair in kindergarten. Equal opportunities, preschool program, special needs. Vector isolated concept metaphor illustration

                     

                    Release Date: December 10, 2023

                    Expiration Date: December 10, 2026

                    Course Fee

                    Pharmacists: $5

                    UConn Faculty & Adjuncts:  FREE

                    There is no grant funding for this CE activity

                    ACPE UANs

                    Pharmacist: 0009-0000-23-059-H04-P

                    Session Code

                    Pharmacist:  23PC59-ACA37

                    Accreditation Hours

                    1.0 hours of CE

                    Accreditation Statements

                    The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit for the online activity ACPE UAN 0009-0000-23-059-H04-P  will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

                     

                    Disclosure of Discussions of Off-label and Investigational Drug Use

                    The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

                    Faculty

                    Jennifer Luciano, PharmD
                    Director, Office of Experiential Education; Associate Clinical Professor
                    UConn School of Pharmacy
                    Storrs, CT

                    Neha Patel
                    2025 PharmD Candidate
                    UConn School of Pharmacy
                    Storrs, CT

                    Jeannette Y. Wick, RPh, MBA, FASCP
                    Director, Office of Pharmacy Professional Development
                    UConn School of Pharmacy
                    Storrs, CT

                     

                     

                     

                     

                     

                     

                    Faculty Disclosure

                    In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

                    Jeannette Wick, Neha Patel, and Jennifer Luciano do not have any relationships with ineligible companies

                     

                    ABSTRACT

                    From time to time, preceptors need to address the needs of students who have disabilities, be they visible or invisible. Students’ disabilities may include chronic diseases, physical limitations, or difficulty with processing information. This continuing education activity introduces various types of disabilities that preceptors may encounter and suggests a stepwise process to develop accommodation plans. It discusses information that preceptors will need or want to have on hand, and potential sources to obtain the information. It also describes the various stakeholders and the accommodation process and the potential benefits for the entire workplace.

                    CONTENT

                    Content

                    INTRODUCTION

                    Some pharmacy students have visible or invisible disabilities that require accommodation (a change or adaptation to adjust a situation to meet the student’s unique needs). Anecdotally, faculty at the University of Connecticut School of Pharmacy report that between 5% and 12% of students in a typical class in the last 10 years need accommodation. In terms of physical disabilities, institutions of higher learning have almost always built or altered existing buildings to accommodate students with disabilities with ramps, elevators, wide doors, and similar structural changes. Preceptors who work in larger organizations may have support teams that address or have already addressed physical disabilities. Those who work in smaller organizations or older buildings may be intimidated by the need to accommodate but will find that the law requires “reasonable” accommodation.

                     

                    Pharmacy preceptors are more likely to encounter students who have chronic disease (e.g., asthma, autoimmune syndromes, diabetes, etc.) or learning disabilities, including those who are neurodivergent (the SIDEBAR explains the concept of neurodiversity). While taking classes, pharmacy schools often (and are legally required to) provide accommodation for students with learning disabilities (see Table 1). They may provide double time or access to a quiet room during exams, permission to take breaks during class, or notetakers to help them depending on the disability type. Students with learning disabilities acquire, organize, retain, comprehend, or use verbal or nonverbal information differently than others. They have impaired perception, thinking, remembering, or learning processes.1

                    Table 1. Types of Learning Disabilities1-7

                     

                    Learning disability Description
                    Anxiety disorder Anxiety that does not go away and can worsen over time. Symptoms can interfere with daily activities such as job performance, schoolwork, and relationships. Subtypes of anxiety disorders include generalized anxiety disorder, panic disorder, social anxiety disorder, and various phobia-related disorders.
                    Attention deficit hyperactivity disorder Causes an ongoing pattern of inattention and/or hyperactivity that interferes with functioning and/or development.
                    • Inattention may manifest as difficulty staying on task, sustaining focus, and staying organized; these problems are not due to insubordination or lack of comprehension.
                    • Hyperactivity manifests as involuntary constant movement, even when it is inappropriate, or excessive fidgeting, tapping, or talking. Adults with ADHD are often extremely restless or talkative.
                    • Impulsivity is acting without thinking or difficulty with self-control. It may include a desire for immediate reward or inability to delay gratification. It may manifest as interrupting others or making key decisions while ignoring long-term consequences.
                    Autism spectrum disorder (ASD) A neurologic and developmental disorder that affects how people interact with others, communicate, learn, and behave. Autism is known as a “spectrum” disorder because its wide variation in presentation and symptom severity.

                    People with ASD often have:

                    ·       Difficulty with communication and interaction with other people

                    ·       Restricted interests and repetitive behaviors

                    ·       Symptoms that affect their ability to function in school, work, and other areas of life

                    Dysgraphia A neurological disorder characterized by writing disabilities that appear as distorted or incorrect writing (inappropriately sized and spaced letters, or wrong or misspelled words despite focused instruction).
                    Dyscalculia Causes consistent failure to achieve in mathematics marked by difficulties with counting, working memory, visualization; visuospatial, directional, and sequential perception and processing; retrieval of learned facts and procedures; quantitative reasoning speed; motor sequencing; perception of time; and the accurate interpretation and representation of numbers when reading, copying, writing, reasoning, speaking, and recalling.
                    Dyslexia Impairs a person’s ability to read. Although varies by individual, common characteristics include difficulty with
                    • Phonological processing (the manipulation of sounds)
                    • Rapid visual-verbal responding
                    • Spelling

                     

                    SIDEBAR: Emerging Terminology and Necessary Understanding: Neurodiversity8-11

                     

                    Neurodiversity refers to the diversity of all people, but is often used in the context of autism spectrum disorder (ASD), neurological or developmental conditions, and learning disabilities. It is neither a medical term nor a diagnosis; it’s a descriptor used to replace the tendency to think of behaviors as normal or abnormal or to marginalize certain people based on their behaviors. When thinking about neurodiversity, it’s critical to remember that there is no one right way of thinking, learning, and behaving, and all differences are not necessarily deficits. Neurodiversity is not preventable, treatable, or curable. It’s the result of normal variation in the human genome. The term is used to promote equity and social justice for people who are members of a neurologic minority.

                     

                    Students who are neurodivergent experience and interact with the world around them in many different ways. Common characteristics among students who are neurodivergent include eye contact, facial expressions, and body language that are different than many other people’s.

                     

                    Students may or may not disclose (or even know) they are neurodivergent. When students do, it is important for preceptors to acknowledge neurodiversity and ask directly about a person’s preferred communication style and accommodations, many of which are described in the text of this continuing education activity. Many of the accommodations for people who are neurodiverse also help other students and employees who do not fall into neurologic minority categories, including

                    • Offering or allowing individuals to make small adjustments to the workspace
                    • Avoiding sarcasm, idioms, euphemisms, and implications
                    • Providing concise instructions
                    • Posting information about due dates and meetings as far in advance as possible
                    • Treating all people with respect

                     

                    Preceptors should foster environments that are conductive to neurodiversity, and to recognize and emphasize each person’s individual strengths and talents while also providing support for their differences and needs. It’s also helpful to know that many large companies are now adjusting their hiring processes to attract people who are neurodivergent. They’ve found that although some people have trouble navigating the hiring process, their unique abilities are valuable, increase the company’s productivity, and often lead to remarkable product and process improvements.

                     

                     

                    This continuing education activity is designed to help preceptors who encounter pharmacy students with disabilities develop workable plans. Preceptors should start by acknowledging a critical fact: accommodation isn’t special treatment. Accommodation levels the playing field so student pharmacists (and employees) can learn and do their best work.

                     

                     

                    PAUSE AND PONDER: You’re a preceptor for your state university. In April, the experiential education office notifies that you have one student per month from June through April. Shortly after, a staff member from the experiential education office calls and tells you that the student scheduled for August needs accommodation. What should you expect going forward, and what is the best time to plan?

                     

                    Providing Reasonable Accommodation

                    Institutions of higher learning usually have entire departments that develop policies, document the student’s type and degree of disability, and develop student-specific accommodation plans. When students who have disabilities go on clinical rotations, rotation sites may have no processes or policies to provide the same accommodation. Preceptors may not know how to cater to their needs. Often, practice sites need only to make minor adjustments to their environments, policies, and procedures. Once the organization makes the changes, the policies will be ready for future students! A PRO TIP is that an astute student who has disabilities may be willing to help edit and adjust policies; this insight can be valuable. However, the student may not want to help as this can be an added burden that other students don’t have.

                     

                    Five basic principles help schools ensure that clinical rotation sites provide reasonable accommodation for students on clinical rotations1,11,12:

                     

                    • Before going on rotation, it is critical for the school to document the student’s disability with a reliable diagnosis. The school’s department for students with disabilities usually does this.
                    • All parties will need to work together to identify elements of the student’s disability that would cloud the preceptor’s ability to assess the student’s competence. Any accommodation should mitigate those elements.
                    • Preceptors should work with the school to develop accommodation tailored to the specific rotation site and tasks to be accomplished at that site.
                    • Three hundred sixty-degree communication is essential. Preceptors, students, school and rotation site administration, and disability service staff must collaborate and communicate.
                    • Throughout the whole process, all parties must protect the student’s privacy.

                     

                    Students with disabilities are subject to a great deal of stigma not only from the outside world but also from preceptors. Ideally, schools should match these students with rotation sites and preceptors with prior experience accommodating students with disabilities.13 However, this may not always be possible. In ideal situations, preceptors are sympathetic and the relationship between the student and preceptor is open, non-judgmental, friendly, and relaxed. These characteristics set the stage for students to disclose their learning needs without fear of discrimination.14

                     

                    The school, however, must identify sites and preceptors based on the student’s accommodation needs without disclosing student-specific accommodation descriptions. Open and honest communication between students, the experiential education team, and representative(s) of the school’s disabilities office before they develop the rotation schedule can prevent problems later.13 Once the school confirms the student’s sites, it can share very basic student-specific details with the preceptor but only the student can share specific health information.1 In other words, the school can communicate the accommodation the student needs, but not the underlying diagnosis; that is private and only the student may disclose it.

                     

                    A challenge for students with physical disabilities is needing accommodation through multiple sites, which requires significant coordination and planning. A solution is providing multiple rotations at a single site where accommodation is available. When this solution is available, students can acclimate once.13 This can provide the best possible experience for the student, providing a level of comfort in the environment; conversely, this solution may force disabled students to stay at one site while their peers rotate from site to site and experience different healthcare teams. In institutions without pre-existing policies, schools would benefit by working with preceptors and the sites to develop guidelines for accommodating students. For students with physical disabilities, guidelines should address different types of mobility devices, physical dimensions of hospital facilities, safety requirements of the pharmacies, and access to particular areas.13 The preceptor should do this before the student begins working at the site. It would be unfortunate if a student arrived at a site only to find it was inaccessible.

                     

                    Step-by-Step to Accommodation

                    Using a stepwise approach on site helps preceptors ensure that they provide reasonable accommodation to students.

                     

                    1. Raising awareness among the clinical team regarding disabilities, accommodation, and inclusive learning environments is a prudent first step. The team is able to do this by reviewing the literature, laws, and regulations. The Americans with Disabilities Act (ADA) Titles I, II, and III and the Rehabilitation Act (see Table 2) are the constellation of laws that prohibit discrimination and govern accommodation in pharmacy experiential education.15 Individual states may also have additional laws that protect disabled students.

                     

                    Table 2. Federal Laws and Regulations that Protect Students with Disabilties15

                    Law/regulation Description
                    Americans with Disabilities Act (ADA)
                    Title 1: Employment ·       Prohibits discrimination in recruitment, hiring, promotions, training, pay, social activities, and other privileges of employment.

                    ·       Restricts questions that can be asked about an applicant’s disability before a job offer is made

                    ·       Requires that employers make reasonable accommodation for known physical or mental limitations of otherwise qualified individuals with disabilities, unless it results in undue hardship.

                     

                    Title II: Public sector ·       Requires state and local governments to give people with disabilities an equal opportunity to benefit from their programs, services, and activities

                    ·       Requires reasonable modifications to policies, practices, and procedures where necessary to avoid discrimination, unless doing so would fundamentally alter the nature of their service

                    ·       Does not require actions that would result in undue financial and administrative burdens

                    ·       Indicates governmental agencies must communicate effectively

                    Title III: Private sector ·       Explains public accommodation in businesses and nonprofits must not discriminate, exclude, segregate, or provide unequal treatment

                    ·       Requires businesses and nonprofits to make  reasonable modifications to polices, practices and procedures and communicate effectively with people with hearing, vision, or speech disabilities

                    ·       Requires employers to remove barriers and meet other access requirements.

                    Rehabilitation Act of 1973
                    Section 504 Prohibits programs or activities that receive federal funding from discriminating against disabled people.

                     

                    One area that all employers and employees need to understand is that accommodation can include variations on the workspace or equipment needed to complete various tasks, how work is assigned and communicated, the specific tasks, and the time and place that the work is done.16

                     

                    1. Establishing essential learning activities and outcomes for students helps all students, not just those with learning or physical disabilities. This means specifying essential functions, minimum competencies, expectations, and procedures that all students must be able to perform by the end of the rotation.15 Preceptors should note that accommodating a student’s needs does not mean lowering expectations.1 A PRO TIP here is that sometimes a student can meet the expectation with only small changes in the preceptor’s style. For students who have information processing issues, asking questions and then pausing for five seconds to allow the student to answer is better than rapid fire questions.1 (This is actually an approach that all preceptors and teachers need to use more in all situations. Pausing benefits everyone, including people who are not native English speakers.)

                     

                    1. The rotation site should make reasonable accommodation based on a reliable diagnosis that the student has documented via the school’s office of student disabilities. The pharmacy school’s office will also provide documentation of the requested accommodation to preceptors; students who have disabilities should not make the requests to preceptors on their own; they may, however, provide the accommodation letter and any information they want to share with the preceptor and copy the school’s director of experiential education if that is the school’s policy. One area that can be difficult for preceptors is the student’s healthcare appointments.1 A PRO TIP is to ask the student at the beginning of the rotation if you need to be aware of any scheduled appointments. Preceptors should also be very clear that the student must notify them of unanticipated appointments as soon as possible (or even before they call to schedule the appointment). If students miss time at rotations, they are responsible for making up the time.

                     

                    Documenting and discussing reasonable accommodation with the individual student who has a disability may be an uncomfortable or unfamiliar task for preceptors but will avoid problems later. Preceptors should meet with students to discuss exactly what they need in relation to their experiential outcomes (using the aforementioned list of specifying essential functions, minimum competencies, expectations, and procedures), asking questions such as1,15

                    • What limitations do you anticipate experiencing on the rotation?
                    • What tasks will you find problematic?
                    • What have you done in the past to reduce or eliminate these limitations?
                    • Do you anticipate needing us to make any modifications while you are here?
                    • What will you do if you encounter an unanticipated obstacle?

                     

                    Here’s another PRO TIP: Knowing a few ways to accommodate disabilities will help preceptors help the student. For example, a student who has severe anxiety will find many rotations difficult and threatening. A preceptor can suggest that the student observe or “preview” activities before requiring interaction, especially if the site is fast-paced or chaotic. Allowing the student to arrive early may also help. Students who are challenged organizationally may benefit from one (not multiple) outline of what to expect every day.1

                     

                    1. The student should self-assess and document how the disability affects each general competency and how accommodation could mitigate each concern.1 Figure 1 describes the process of preceptors choosing accommodation.

                     

                     

                     

                    The preceptor and student should develop an accommodation plan together and document it in writing. An ideal plan would list the intervention or accommodation and how it supports the student, those involved in creating the accommodation, and the parties responsible for any financial costs (discussed below). 11 For example, in a pharmacy setting where a great deal of business is conducted over the phone using headphones, a student who has difficulty hearing may need a phone amplifier. If the student wears hearing aids, headphones may interfere with her ability to hear. The plan should also include specific days/times for periodic check-ins so the student and preceptor can assess whether the intervention/accommodation meets the students’ needs and is still reasonable for the site.11

                     

                    A PRO TIP for preceptors is to stay abreast of technology changes.16 If students have difficulty reading or writing—these are students with dyslexia or dysgraphia—many programs now have read-aloud or voice-to-text programs that are remarkably accurate. Some calculators will talk. Encourage students to use them. Asking students to listen to their work using a read-aloud program will also help them catch errors.

                     

                    PAUSE AND PONDER: You meet with your new APPE student and learn that he has serious visual impairment. He indicates he needs to use assistive devices (supplemental lighting, a magnifier). How would you initiate a discussion about who will secure these devices?

                     

                    The last step, which overlaps with the previous steps to some extent, is providing reasonable accommodation. Readers may read the term “reasonable accommodation” and wonder what is considered reasonable. Accommodation should not pose an undue financial or administrative hardship to the practice site.15 The law would not consider an accommodation reasonable if it decreased quality or posed safety issues to patients or imposed undue financial or administrative burden on the institution. It would also be unreasonable to change curricular elements or alter course objectives substantially. Preceptors might reach out to the school’s experiential education office who can contact the university’s legal department to determine whether a specific accommodation is reasonable. Or, preceptors can contact their own legal representatives. Preceptors and students need to communicate openly and honestly to determine reasonable accommodation together. Table 3 describes some examples of reasonable accommodation.

                     

                    Table 3. Examples of Reasonable Accommodation in Clinical Experiential Learning8,15-17

                     

                    Student Limitation Accommodation
                    Anxiety ·       Embrace the learning experience and don’t be too hard on students when they make an error. Provide feedback and guidance for them to improve.

                    ·       Plan the days and weeks, setting achievable goals, and prioritizing tasks.

                    ·       Offer counseling services and other resources to support the student.

                    Concentration difficulties ·       Use organization techniques that help students manage time and stay on track.

                    ·       Ask students if using a highlighter to emphasize assignments that are priorities will help.

                    ·       Step away from busy workplaces to provide directions in a quieter location.

                    ·       Develop or have the student develop checklists for common tasks.

                    Distractibility ·       Provide or allow students to use their own noise-canceling headphones or give them a private room to work.

                    ·       Provide a quiet space away from noise and busy office traffic and a “Do Not Disturb” sign so students can work without interruption.

                    ·       Avoid allowing or encouraging multitasking. Have students complete one thing at a time.

                    Dyslexia ·       Encourage use of appropriate read-aloud and voice-to-text software.

                    ·       Explain and provide a list of common or site-specific acronyms and other jargon.

                    Neurodiversity ·       Sound sensitivity: offer a quiet break space, communicate expected loud noises (like fire drills), offer noise-canceling headphones.

                    ·       Tactile: allow modifications to the usual work uniform

                    ·       Movement: allow the use of fidget toys, allow extra movement breaks, offer flexible seating

                    ·       Use a clear communication style:

                    o   Avoid sarcasm, euphemisms, and implied messages.

                    o   Provide concise verbal and written instructions for tasks, and break tasks down into small steps.

                    ·       Inform people about workplace etiquette, and don’t assume someone is deliberately breaking the rules or being rude.

                    ·       Try to give advance notice if plans are changing and provide a reason for the change

                    ·       Don’t make assumptions – ask a person’s individual preferences, needs, and goals.

                    ·       Be kind, be patient

                    Poor organization ·       Set aside 15 minutes at the end of the day to plan the next day’s work.

                    ·       Have students and all employees return important shared items to the same place each time they use them.

                    ·       Consider a color-coding system for assignments or shelving.

                    ·       Keep things visible on shelves, bulletin boards, or other places; avoid storage in drawers or closets.

                    ·       Attach important objects physically to the place they belong.

                    Processing disorders ·       Provide both written and oral instructions.

                    ·       Follow-up important conversations with a brief e-mail

                    ·       Ask the student to make notes and provide them to you for review.

                    ·       Use the teach-back method; ask the student to repeat the information back so you can be sure you covered everything (and they heard the key messages)

                     

                    Emphasis on Planning Ahead

                     

                    Before rotations start, students with disabilities and preceptors should complete a practice walk-through at the rotation site to identify, modify, and make necessary adjustments.13 The experiential team must also understand the student’s career aspirations. Frank discussion will help all involved with rotation planning. The experiential team and the preceptor can address the students’ and preceptors’ concerns, needs, and goals in advance. Also, the person coordinating this process should identify and discuss costs and financial resources for the accommodation plan with all parties involved and determine who is responsible for the costs. This creates clear expectations. 13

                     

                    If during the check-in or at any time a situation changes, the plan needs revision to find a more acceptable or effective reasonable accommodation or an urgent concern arises, the student or the preceptor should contact the school immediately.13

                     

                    CONCLUSION

                    Preparing and executing accommodation can be challenging. Preceptors who develop skills in this area help student pharmacists develop communication, collaboration, and planning skills they will use and improve all during their careers. Preceptors also assess the actual barriers associated with the student’s disability in a controlled environment and help students learn how to mitigate the challenges associated with their disabilities in future employment. A PRO TIP is to keep in mind that many employees have disabilities or have slightly different learning styles. Learning how to accommodate them from students and schools of pharmacy will benefit your entire work force. It may even help you!

                     

                     

                     

                     

                    Pharmacist Post Test (for viewing only)

                    1. A student has been diagnosed with attention deficit hyperactivity disorder (ADHD), a type of learning disorder. Which of the following BEST describes ADHD?
                    A. A disorder characterized by writing disabilities that appear as distorted or incorrect writing
                    B. A disorder that affects how people interact with others, communicate, learn, and behave
                    C. A disorder that causes ongoing patterns of inattention and/or hyperactivity that interferes with functioning and/or development

                    2. You observe that a student has difficulties counting, putting documents in numerical order, and calculating doses when the order specifies a mg/kg dosing. What type of disability is this MOST LIKELY to be?
                    A. Dyslexia
                    B. Dyscalculia
                    C. Dysgraphia

                    3. Once the school confirms a student’s site, what information can the school share with the preceptor?
                    A. The required accommodation
                    B. The student’s diagnosis
                    C. The student’s health information

                    4. How can the school of pharmacy help students with disabilities to be comfortable and meet their needs at various clinical sites?
                    A. Informing the site that the student will be doing all their clinical rotations at that site
                    B. Providing policies and student-specific accommodation plans that can be adjusted
                    C. Only using preceptors who have experience accommodating students with disabilities

                    5. Mary, a preceptor, is preparing for Elwin to start a rotation at her site. Elwin told the preceptor that he struggles with organization. They are identifying accommodation and exploring if they need to make any changes to the site. Which of the following is the most appropriate accommodation to keep the site organized for the student?
                    A. Color-code the shelving system in the pharmacy
                    B. Provide both written and oral instructions
                    C. Provide directions away from the workplace

                    6. A pharmacy student, Sarah, has attention deficit hyperactivity disorder (ADHD) and will be going on her clinical rotation. She has been in communication with the school and the preceptor about accommodation, indicating her key limitation is distractibility. Which of the following is the is the BEST accommodation the preceptor can provide?
                    A. Encourage use of appropriate read aloud and voice to text software
                    B. Plan the days and weeks, setting achievable goals, and prioritizing tasks.
                    C. Provide a quiet space away and a “Do Not Disturb” sign

                    7. Which of the following factors would a preceptor consider when providing a reasonable accommodation?
                    A. The accommodation’s feasibility and financial cost
                    B. The student’s academic grade point average
                    C. The student’s specific diagnosis

                    8. Which answer correctly lists the steps when choosing an accommodation for a student?
                    A. Lower your expectations, assess whether the accommodation is meeting the student’s needs, analyze the required tasks
                    B. Maintain your expectations, analyze the required tasks, periodically assess whether the accommodation is meeting the student’s needs
                    C. Meet with the student, ask about the specific diagnosis of neurodiversity, develop a plan you think is suitable for the student

                    References

                    Full List of References

                    REFERENCES
                    1. Vos S, Kooyman C, Feudo D, et al. When Experiential Education Intersects with Learning Disabilities. Am J Pharm Educ. 2019;83(8):7468.
                    2. Anxiety Disorders. National Institutes of Mental Health. Accessed August 9, 2023. https://www.nimh.nih.gov/health/topics/anxiety-disorders
                    3. Autism Spectrum Disorder. National Institutes of Mental Health. Accessed August 14, 2023. https://www.nimh.nih.gov/health/topics/autism-spectrum-disorders-asd
                    4. Attention-Deficit/Hyperactivity Disorder. National Institute of Mental Health. Accessed August 5, 2023. https://www.nimh.nih.gov/health/topics/attention-deficit-hyperactivity-disorder-adhd
                    5. Dysgraphia. National Institutes of Neurological Disorders and Stroke. Accessed August 5, 2023. https://www.ninds.nih.gov/health-information/disorders/dysgraphia
                    6. Dyscalculia. Dycalculia.org. Accessed August 5, 2023. https://www.dyscalculia.org/
                    7. Dyslexia. National Institutes of Neurological Disorders and Stroke. Accessed August 5, 2023. https://www.ninds.nih.gov/health-information/disorders/dyslexia
                    8. Baumer N. What is Neurodiversity? Accessed August 14, 2023. https://www.health.harvard.edu/blog/what-is-neurodiversity-202111232645
                    9. Neurodivergent. The Cleveland Clinic. Accessed August 15, 2023. https://my.clevelandclinic.org/health/symptoms/23154-neurodivergent
                    10. Austin RD, Pisano GP. Neurodiversity as a Competitive Advantage. Harvard Business Review. May-June 2017. Accessed August 15, 2023. https://hbr.org/2017/05/neurodiversity-as-a-competitive-advantage
                    11. Elliott HW, Arnold EM, Brenes GA, et al. Attention deficit hyperactivity disorder accommodations for psychiatry residents. Acad Psychiatry. 2007;31(4):290-296.
                    12. Shrewsbury D. Dyslexia in general practice education considerations for recognition and support. Educ Prim Care. 2016;27(4):267-270.
                    13. Kieser M, Feudo D, Legg J, et al. Accommodating Pharmacy Students with Physical Disabilities During the Experiential Learning Curricula. Amer J Pharm Ed. Published online April 2, 2021:8426.
                    14. L’Ecuyer KM. Clinical education of nursing students with learning difficulties: An integrative review (part 1). Nurse Educ Pract. 2019;34:173-184.
                    15. Vos SS, Sandler LA, Chavez R. Help! Accommodating learners with disabilities during practice‐based activities. 2021;4(6):730-737.
                    16. Job Accommodation Ideas for People with Learning Disabilities. Learning Disabilities Association of American. Accessed August 5, 2023. https://ldaamerica.org/info/job-accommodation-ideas-for-people-with-learning-disabilities/
                    17. Horesh A. Conquer Anxiety in Clinical Rotations: A Guide for Medical Students. Accessed August 9, 2023. https://futuredoctor.ai/anxiety-in-clinical-rotations/

                    Who are you? Who are We? Professional Identity in Experiential Learning

                    Learning Objectives

                     

                    After completing this application-based continuing education activity, pharmacist preceptors will be able to

                      1. Describe professional identify formation
                      2. Apply the steps in development of a professional identity
                      3. Identify activities that develop professional identity appropriately

                      Healthcare professionals with arms crossed.

                       

                      Release Date: November 1, 2023

                      Expiration Date: November 1, 2026

                      Course Fee

                      Pharmacists: $7

                      UConn Faculty & Adjuncts:  FREE

                      There is no grant funding for this CE activity

                      ACPE UANs

                      Pharmacist: 0009-0000-23-049-H04-P

                      Session Code

                      Pharmacist:  23PC49-ABC37

                      Accreditation Hours

                      2.0 hours of CE

                      Accreditation Statements

                      The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit for the online activity ACPE UAN 0009-0000-23-049-H04-P  will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

                       

                      Disclosure of Discussions of Off-label and Investigational Drug Use

                      The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

                      Faculty

                      Jennifer Luciano, PharmD
                      Director, Office of Experiential Education; Associate Clinical Professor
                      UConn School of Pharmacy
                      Storrs, CT

                      Jeannette Y. Wick, RPh, MBA, FASCP
                      Director, Office of Pharmacy Professional Development
                      UConn School of Pharmacy
                      Storrs, CT

                      Ethan Yazdanpanah
                      PharmD Candidate 2025
                      UConn School of Pharmacy
                      Storrs, CT

                       

                       

                      Faculty Disclosure

                      In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

                      Jeannette Wick, Ethan Yazdanpanah, and Jennifer Luciano do not have any relationships with ineligible companies

                       

                      ABSTRACT

                      Discovering what it means to be a good healthcare provider goes beyond knowledge acquisition and education for pharmacy students; it demands a transformative journey of professional identity formation (PIF). The pharmacy profession, through its professional organizations, has identified a number of core values, but as the profession changes, new core values are emerging. PIF occurs over a trajectory, starting in pharmacy school (or even before) and continuing throughout life. Preceptors can use a number of techniques to help pharmacy students with PIF, assuring that our future pharmacists hold the same values ats the profession at large. Exposing students to a variety of situations, asking open-ended questions, using teach-back methods, and introducing students to professional organizations are a few.

                      CONTENT

                      Content

                      INTRODUCTION

                      Let’s begin this continuing education activity with some questions. What makes a nurse a nurse? What makes a nurse a good or exceptional nurse? What makes an electrician an electrician? What makes an electrician a good or exceptional electrician? What makes a pharmacist a pharmacist? What makes a pharmacist a good or exceptional pharmacist? Those questions are no doubt difficult to answer. Preceptors may be making a list mentally of the qualities that the ideal nurse, electrician, or pharmacist should possess. Certainly, for each of these professions, education will be the foundation. Here’s a harder question: Is it possible to be a good or exceptional nurse, electrician, or pharmacist but a terrible person? And is it possible to be a good and loyal pharmacy employee, but not such a good pharmacist? All these questions speak to the concept discussed here: professional identity.

                       

                      Discovering what it truly means to be a healthcare provider goes beyond knowledge acquisition and education for pharmacy students; it demands a transformative journey of professional identity formation (PIF) starting even before introductory pharmacy practice experiences (IPPE) (perhaps with acceptance into a pharmacy program or during professionalism ceremonies) and continuing past graduation and over an entire career. As the introduction hints, preceptors must distinguish between education, professionalism, and professional identity. A quick way to differentiate between the latter two is that a student’s professionalism is outwardly observable. Professional identity, however, is defined by a student’s internal thinking, feeling, and acting like a member of the pharmacy profession and its community.1

                       

                      Pharmacists can use their extensive, science-based education to assume many professional identities; they may work in community, hospital, health-system, research, information technology, marketing, or a vast number of other positions. Viewing the history of the profession in just the last century, various identities have accumulated (rather than shifted) over time.2 The typical pharmacist’s main responsibility was once compounding. As the industrial revolution made it possible to produce dosage forms en masse, compounding fell out of favor and dispensing manufactured products became the primary focus of a typical pharmacist. Within just the last 20 years, pharmacists have made major inroads into establishing their role as necessary health care professionals rather than just retailers.3 Pharmacists have been shown to be key in improving therapeutic outcomes with a new focus on patient focused intervention.4 Pharmacists’ employment opportunities are growing and adapting to a changing field but the profession’s fundamental or core values are somewhat fixed. Table 1 lists the pharmacy profession’s current core values as promulgate by the American Pharmacists Association.

                       

                      Table 1. The Pharmacist’s Core Values5,6

                      Commitment to the patient’s well-being ·       Engage in shared decision making and respect patients’ right to self determination

                      ·       Protect patient life and aim for best outcomes

                      Pharmaceutical expertise ·       Maintain competence in knowledge and abilities to ensure the safe and effective use of medication
                      Reliability and care ·       Find balance between risk and benefit in treatments

                      ·       Maintain trust and confidentiality with patients

                      ·       Collaborate reliably with other healthcare professionals to ensure best health outcomes

                      Social responsibility ·       Act with honesty and integrity in professional relationships

                      ·       Avoid discrimination and seek healthcare equity in society

                       

                      PAUSE AND PONDER: Look at Table 1. What other values would you add to the table?

                       

                      As the profession’s identity evolves, pharmacists’ identities and their core values must follow suit. While pharmacists must be lifelong learners and adapt over time to new conditions, change is most readily achieved in the initial learning process as pharmacy students. In other words, you can teach old dogs new tricks, but it’s easier to teach puppies. In class, faculty teach students information a pharmacist should know and address how to outwardly act like a professional, but the profession demands something more: the development of a professional identity. We rely on our community of pharmacist preceptors to augment the various didactic courses to cultivate new pharmacist graduates who identify strongly with our core values.

                       

                      PIF is a crucial aspect of pharmacy experiential education. Students require experiential learning and immersion into the profession to assimilate the qualities that make pharmacists unique and different from other healthcare providers. The Accreditation Council for Pharmacy Education (ACPE)-required IPPE rotations provide students with important opportunities to influence PIF, and the PIF process continues during a student’s advanced pharmacy practice experiences (APPE).7

                       

                      The Pharmacy Student’s IPPE Rotation

                      IPPE rotations serve a much broader purpose than students fulfilling educational requirements and completing dreaded 50-page workbooks that some schools use that aim to help them reflect on or consolidate learning. IPPE rotations should introduce students to the way front line pharmacists navigate real-world pharmacy practice situations. Students primarily relegated to counting pills and organizing stock in the back of a pharmacy are unlikely to develop professional identities. If students perceive that preceptors think of them as free labor or burdensome obligations, they will not engage in the deeper discussions about the preceptor as a person fulfilling professional obligations. Students should observe and actively take part in various aspects of the profession, applying theoretical knowledge acquired in classrooms to real-world situations. Practical knowledge gained through these experiences helps students to develop essential professional skills and test their learning.

                       

                      Experiential learning rotations should also expose students to different types of pharmacist positions and responsibilities. By observing different practice settings and interacting with pharmacists, patients, and other healthcare professionals, students can explore their interests, while realizing their strengths and developing professional values.

                       

                      Step-by-Step to Professional Identity

                      Throughout pharmacy education, faculty members encourage students to exhibit professionalism; they may

                      • suggest more productive ways to present ideas
                      • prompt students to elevate or refine language or speak in ways patients will understand, or
                      • suggest that certain clothing choices can diminish peoples’ view of them and their credibility

                       

                      While classroom faculty can teach and model the concept of professionalism, preceptors have the responsibility of supporting students in their PIF journey. Teaching starts the learning process; ultimately, students will need to “create their own adventures.” In other words, they must learn to apply aspects of specific material and explore different experiences to develop a professional identity. Relating to the definition of PIF, a pharmacy student’s PIF process must involve thinking, feeling, and acting like a pharmacist.

                       

                      To discuss professional identity, preceptors and all pharmacists who influence the student’s learning process must acknowledge the steps inherent in PIF. Personal identity is based on an individual’s concept of who they are and how others perceive them.7 Individuals develop personal identity in stages starting at birth but personal identity begins at birth and continues throughout life. Professional identity develops in a similar but slightly different way.

                       

                      Robert Kegan, a Harvard psychologist, developed a framework for longitudinal development of the self into a moral meaning-making entity that has had lasting impact on PIF in education of professionals.3,8-10 His framework includes six stages with stage 0 beginning at birth. Stages 0 and 1 concern young children’s development of basic motor function and sensing the physical world around them (and are not discussed here).8

                       

                      In relation to PIF, the health professional must pass through at least stages 2 through 4 of the framework: imperial, interpersonal, and institutional.10 This framework, with steps 2 through 5 shown in Table 2, defines the personal characteristics and related professional context of an individual in continuous stages of development. Individuals who reach the final stage, stage 5, or the inter-individual self-transforming stage, open themselves to multiple identities and other value systems, achieving full personal autonomy.8 Research shows that not all individuals reach stage 5.10,11 However, with effective socialization partnered with experience in the pharmacist’s potential identities, students may reach this level during their careers.

                       

                      Table 2. Kegan’s Stages of Personal and Professional Identity Development­8,10

                      Stage Personal characteristics Professional context
                      2. Imperial Individuals put their own needs and interests first but consider other people’s views. Individuals fill their professional roles but do so with a primary motivation of following rules. Individuals exhibit low self-reflection and may struggle to balance emotions with reason.
                      3. Interpersonal Individuals are concerned with others’ perceptions of them and able to reduce focus on self-interest. Individuals balance multiple perspectives simultaneously. Individuals are idealistic and self-reflective, seeking others to guide them. Individuals manage emotions acceptably and generally understand right and wrong.
                      4. Institutional Individuals assess relationships with a focus on self-defined principles and standards. Individuals define themself independently of others. Individuals can understand relationships by appreciating different values and expectations. They internalize professional values and do not allow emotion relating to needs, desires, and passion to gain control over reason.
                      5. Self-transforming Individuals reconcile contradictory or paradoxical ways of constructing meaning. They can recognize the interdependencies of different systems or ways of thinking. The self-transforming professional has a strong sense of self but also relies upon others knowledge and opinion in professional development. The professional integrates other identities into the total professional identity.

                       

                       

                      The constantly evolving pharmacy profession and the lack of a specific list of steps for PIF makes it challenging for students to define an identity (and preceptors to help them). As the profession continues to develop to offer a wide range of opportunities for pharmacists, preceptors will observe students finding varying paths of PIF. Different pharmacists will define the profession differently depending on their experiences. Pharmacy students might generally navigate this list of steps, common among many young people developing professionally12-15:

                       

                      1. Exploration: In any career path, exploration is the first step in PIF. In pharmacy, the American Pharmacists Association offers the Career Pathway Evaluation (https://www.pharmacist.com/Career/Career-Pathways) to help aspiring pharmacists find a path forward. IPPE and APPE rotations should ideally provide students with opportunities to explore various pharmacy practice settings and work with pharmacists with a range of responsibilities. Students need to augment their existing identities—formed by their upbringing and personal beliefs—as they begin their pharmacy education and careers. Students come from diverse backgrounds with varying past experiences, cultural values, learning styles, and personal characteristics.
                      2. Reflection and integration: Educators should encourage students to reflect on their experiences, strengths, values, and areas for improvement. Reflection helps students align personal and professional values, shaping their professional identities. Self-reflection and reflection from preceptors during IPPE rotations is necessary for growth. For example, a technician told Jayne, a pharmacist for a chain pharmacy, that a patient was in the counseling room and ready for an immunization. Jayne took her student with her to observe. Jayne asked the student to review the necessary paperwork and make sure the patient, a 17-year-old adolescent, met all the criteria for the human papilloma virus vaccine. The student said he did. When Jayne reviewed the paperwork, she found one problem. She asked the patient, “Which of your parents is here with you today?” In Jayne’s state, the legal age of consent was 18. When contacted by phone, the parent agreed to come in immediately and Jayne administered the vaccination. After all was done, she spent just a few minutes talking to the student about the duty to protect and comply with the law, describing a couple of other instances when she encountered similar situations.
                      3. Commitment and advocacy: Commitment to the pharmacy profession and dedication to lifelong learning are essential elements in the development of a professional identity. Pharmacy students will become spokespeople for the profession and advocate for the inevitable change from retail-based to clinically- or service-based work. Pharmacists with solid professional identities will be lifelong learners and educators.

                       

                      Students who have never worked in a pharmacy or observed a pharmacist at work (and some who have) may have inaccurate ideas about the profession. Preceptor Eddie encountered a curious situation when Adam, a P2 student, reported for an IPPE rotation. Adam was more than self-assured; Adam had an exaggerated sense of self-worth. He was bumptious (self-important or smug), so Eddie needed to work around Adam’s personal identity. Adam told Eddie that his older brother was a pharmacist who had told him that pharmacy schooling is pretty worthless. Adam said, “All you need to do is pass and you’re on your way to a darned good salary.” Eddie was astounded. Adam needed help reaching Step 2 of the PIF model—he was putting his own needs and beliefs first and disregarding others’ views. Eddie created a plan to help Adam develop more insight.

                       

                      Each day when Adam came to work, Eddie presented two or three situations from his work experience that required more than just a body behind a computer. He would ask Adam to work through the problems and present the answers by the end of the day. In this way, he educated Adam about professional responsibility and clarified the difference between a person with a pharmacy degree and an exceptional pharmacist. PIF’s goal is for students to move from playing or imagining the pharmacist’s role to internalizing the pharmacist’s identity and acting as pharmacists at the unconscious level. The process shifts emphasis from ‘doing’ to ‘being.’ While professionalism can be put on and taken off like a white coat, professional identity stays with the healthcare professional at all times. Eddie was able to improve Adam’s professionalism, which was poor at the rotations start, and contribute to Adam’s professional identity.

                       

                      PAUSE AND PONDER: When you were a student, which preceptors influenced your core values and how did you internalize them?

                       

                      Activities that Develop Professional Identity

                      Preceptors who work in different types of positions need to acknowledge their personal and professional strengths and limitations to determine what they can realistically offer to students. Before taking on the preceptor’s or mentor’s responsibilities, professionals must be familiar with their own skillsets.7,14

                      • The first step preceptors should take is to embrace self-reflection. Just as preceptors should encourage students to engage in reflective practice, pharmacy is a profession in which preceptors must be lifelong learners. Established pharmacists will continue to accumulate PIF-related experiences over time to aid their effectiveness in guiding others.
                      • Preceptors will then need to plan intentionally and commit to helping students develop professional identity. A reluctant or unprepared preceptor usually cannot teach students effectively. Sometimes pharmacists with extensive work experience on the frontlines might feel that students come with a more contemporary knowledge base and therefore, they have nothing to teach them. However, that pharmacist could be well-positioned to support the student’s PIF by embracing how their professional experiences led to a deeper understanding of their profession and the pharmacist’s role in supporting patient outcomes.

                       

                      PAUSE AND PONDER: What are the most efficient ways to help your students develop professional identity in your practice location? What are the most important ideas you can teach? Are they the same?

                       

                      PIF is a gradual process that revolves around socialization, not classroom lecture. IPPE rotations provide an ideal platform for students to engage in activities that promote professional development. Preceptors can work with students to facilitate PIF during an IPPE rotation in several ways. 7,16,17

                       

                      Patient interactions: Direct patient interaction during IPPE can help students apply theoretical learning and develop communication skills, empathy, and a patient-centered approach to care. These experiences help students internalize a sense of responsibility toward patient well-being and strengthen trust in the caregiver-patient relationship.

                       

                      Preceptors should expose students to patient counseling sessions as observers as often as possible. Consider Leonard, a preceptor who frequently tells students, “I am not going to bring you into this counseling session because it is too complicated. You won’t understand what’s going on.” This is a mistake. IPPE is an opportunity for students to be exposed to difficult real-life examples before they have to handle them alone. These experiences help develop professional identity and may even stimulate an “ah-HA!” moment about pharmacist responsibility for the student. Preceptors who ask students a few open-ended questions (e.g., What did you see that surprised you? What three points did I emphasize? What counseling techniques will you remember from this?) prompt students to engage. Inviting students to see a situation that requires pharmacists to work at the top of their license introduces step 4 (institutional)  and epitomizes PIF. Leonard has the opportunity to show his version of an independent and talented pharmacist who contributes to healthcare positively.

                       

                      PIF opportunities need not be complicated. Sometimes PIF occurs concurrent with simple everyday tasks. Preceptors who walk students through their thought process when processing an order (i.e., Why does this document go here in the electronic medical record? Why am I looking at that lab before processing the order?) introduce students to the necessity of questioning routinely as a professional function. They can also ask students to find or calculate doses, explore drug interactions, and then provide the information to another interdisciplinary team member.

                       

                      Not all patient interactions are pleasant or welcome, but they may be professionally necessary. Alex, the pharmacist, was dismayed when a technician came to him and said, “Mrs. Royce is here and wants to talk to you,” while rolling her eyes. Mrs. Royce was notorious for being loud, disrespectful, and a know-it-all. Alex didn’t answer immediately. The technician said, “Shall I tell her you are busy?” Alex said he would talk to her and briefed the IPPE student on Mrs. Royce’s personality. He said he was concerned because Mrs. Royce had recently had surgery, had a reaction to the opioid that was prescribed, and was switched to tramadol. He explained that regardless of his personal feelings, he needed to deal with the situation. When he asked Mrs. Royce how he could help her, she said, “The oxycodone made me sick as a dog. My friend up the street who is a nurse says the tramadol I am taking now is not worth anything. I am taking it and it is super mild but at least it’s something. I have an anti-inflammatory, too. I know this is a first-world problem since this was an elective surgery, so I should not complain. I am just a whiner with pain.” Alex reassured her that no one deserves pain, even if the surgery was elective. Alex counseled the patient with these points18-20:

                      • Tramadol is a funny drug. People with certain genetic variations called CYP2D6 deficiencies get less relief from it. It gets a bad reputation because many clinicians don't know that. Take it if it helps. And it sounds like it helps a bit.
                      • Schedule your anti-inflammatory around the clock. Don't wait until the pain is horrible. Take it every four to six hours for a few days. Eat a little something when you take it.
                      • Use warm or cold compresses if they help but use them only for 10 minutes at a time once every hour. (You don't want to fry or freeze your skin.) If warm helps, use warm. If cold helps, use cold.
                      • Move around as much as you can. It increases blood flow to the area.
                      • Have you tried some acetaminophen? Some people find that taking a couple of acetaminophen once or twice a day for a couple of days helps--it won't address the inflammation but it may help with pain.
                      • Consider finding an acupuncturist and/or a massage therapist who specializes in pain.

                      After the session, Alex explained that dealing with patients like Mrs. Royce is an obligation, as is not showing whether he likes her. This attitude aligns with the “interpersonal” step of PIF (step 3)—balancing multiple perspectives and putting others’ needs first. He said that all pharmacists encounter difficult patients. He also said that he planned to check in on her by phone the next day. He asked the student if anything surprised her, and she said, “Yes. You didn’t say anything about the nurse’s bad advice!” Alex explained that professionals don’t speak badly of each other, especially when the information from Mrs. Royce was hearsay. He said he trusts that Mrs. Royce, the consummate know-it-all, will talk to the nurse and the nurse will call if she wants more information. The student was able to teach-back the key points of professional identity:

                      • Treat all patients with respect, even when they don’t return the favor
                      • Counsel carefully
                      • Do not disparage other healthcare providers (talk to them directly if you have a concern about their advice)
                      • Follow-up.

                      When the student asked this preceptor for a letter of reference several months later, the preceptor said, “Remember Mrs. Royce? Her attitude is entirely different now. She’s kind and respectful when she comes in.”

                       

                      Collaborative Practice: Preceptors can highlight interdisciplinary healthcare experiences, demonstrating teamwork, collaboration, and the ability to contribute effectively within a healthcare setting. In a health system setting, for example, many different pharmacists work in the same organization with varying responsibilities. A health system may include an inpatient and outpatient, specialized clinical, emergency department, investigational drug service, and oncology pharmacy. Each position requires modified professional identities and collaboration with different healthcare professionals. A preceptor can join forces with other pharmacists—a model that is increasingly popular and often called team precepting—to ensure students receive a well-rounded education in the short period of time provided.

                       

                      Exposure to eustress (healthy, stimulating kind and level of stress): A preceptor should take the time to facilitate a learning environment that optimizes the likelihood that PIF will occur. Preceptors can discuss situations that present ethical dilemmas during IPPE rotations, prompting critical thinking, ethical decision-making, and the development of moral reasoning. As students are exposed to common ethical dilemmas, they will begin to develop problem solving skills; build confidence; and think, act, and feel like pharmacists. Students who have not yet assimilated the second step of PIF—the imperial—may be more concerned with packing up to leave at their assigned quitting time than finishing a task. Helping students learn that sometimes the clock should not dictate decisions also develops professional identity.

                       

                      Exposure to unanticipated, stressful misadventure. Marguerite was precepting a student when a technician came behind the bench with arms raised and a robber holding a gun behind her. The four other employees and the student froze, and Marguerite handled the situation, emptying the vault into the robber’s duffel bag. After the robbery, everyone was shaken but no one was hurt. Although the store manager’s opinion was to send the student home, Marguerite insisted on a post-incident stress debriefing. It gave everyone the opportunity to vent and identify what they did well and what they could do better, and reduced the likelihood of post-incident stress.21 As they met, the police returned and said they had apprehended the robber because Marguerite had placed a tracking device in the duffel bag. Marguerite has traversed all the steps of PIF. She considered others in her decisions, balanced multiple perspectives, and maintained her standards.

                       

                      Although this is an extreme example that underscores the meaning of “unanticipated,” the student reported feeling better and understanding more about the pharmacist’s responsibilities. Other unanticipated events that can convey PIF include dealing with irrationally irate customers, diffusing the situation with a vaccine refuser who wants to espouse her opinion loudly to other patients, or dealing with a patient or employee medical emergency in the workplace. Appropriate and deliberate use of emotion can also focus learners and enhance learning, especially when the material is moving or highlights the patient’s perspective. Preceptors should employ emotion as a teaching tool carefully, since negative emotion (e.g., anger, embarrassment) erodes trust and can disenfranchise students.

                       

                      Professional involvement: If time allows, preceptors can encourage students to engage with professional organizations. Attending conferences, workshops, state pharmacy board meetings, or seminars that promote professional growth, networking, and exposure to current trends in the pharmacy field builds professional identity. Preceptor Eddie, discussed previously, took Adam to a Board of Pharmacy meeting. Adam seemed uninterested until the Board discussed disciplinary action against a pharmacist who had failed to perform due diligence, leading to a patient’s death and a pharmacist with a drug abuse problem. Adam was less bumptious in the car on the way back to work, and Eddie took time to ask open-ended questions to mold Adam’s professional identity. He asked, “What questions do you have for me?” Adam said, “What is the chance they will get their licenses back?” It created a chance to talk about professional responsibilities and how state boards monitor and ensure public safety. Eddie asked a question of his own “What do you think the patients who experienced poor care or unprofessional behavior from those pharmacists think about the profession of pharmacy? In the world of social media, how far do you think those negative sentiments about pharmacists can spread?" This discussion moved Adam further through Step 2, and away from a preoccupation with self-interest.

                       

                      Formative feedback (feedback that helps students recognize knowledge gaps and molds the student’s beliefs and values; see the SIDEBAR) and encourage reflection. Preceptors should7

                      • Provide students with regular feedback, but also schedule time for check-ins and reviews mid-rotation. As students’ professional identities develop, they will become their own sources of feedback.
                      • Employ teaching methods such as using teach-back and open-ended questions.
                      • Schedule time for students to work on workbooks or other tools for reflection and encourage discussion and questions.
                      • Assign meaningful work to help students integrate ethical principles, evidence-based practice, effective communication, and patient-centered care.

                       

                       

                      SIDEBAR: Formative Feedback22,23

                      Formative feedback

                      • refers to informal constructive feedback provided throughout a learning process
                      • is ongoing and proactive
                      • is specific and actionable
                      • helps to develop self-awareness and independence
                      • gives students the opportunity to reflect and adjust without being graded
                      • and is not summative feedback (a method of assessment where students are evaluated and/or graded on their overall performance usually at the end of a learning period)

                       

                      Open ended questions are important in formative feedback. Just as healthcare professionals are encouraged to ask patients open-ended questions, preceptors should do the same with their students. Open-ended questions

                      • give students the opportunity to participate in discussion actively and gain a deeper understanding of a topic or situation
                      • can help the preceptor identify gaps in a student’s understanding
                      • develop students’ critical thinking skills and autonomy to further their PIF
                      • are especially useful after patient counseling or other interaction.

                       

                      Teach-back, or the "show-me" method, confirms whether a person—a patient or in this case, a student—understands the topic being explained. Pharmacists and other healthcare providers use the teach-back in patient counseling to facilitate better communication between patient and provider. This tool allows a healthcare provider to assess patient understanding by having a patient explain, or teach-back, what they took away from the counseling session. The healthcare provider can gently correct misunderstandings. Using teach-back with students is especially effective when

                      • Students observe a complicated counseling session or process
                      • Students are learning about a new medical device or a medication with an unusual administration route or schedule
                      • Students need to research a topic that is new to them and may have missed some critical information
                      • Students witness a situation that is emotionally charged or creates a safety concern

                       

                       

                      Demonstrating vulnerability. Preceptors often want to hide their deficiencies, limitations, or weaknesses from students so students will have greater confidence in the preceptor’s expertise. Students need to see how mistakes happen and lead to improvement. They also need to see the ethical challenges that are inherent in pharmacy practice. Preceptor Terry received a phone call from a pharmacist who worked at another of her chain’s locations. She knew the pharmacist quite well, and the pharmacist said she had received a prescription for a patient well known to them for hydromorphone 8 milligrams. They were out of hydromorphone and the pharmacist asked if Terry had any 8 milligram tablets. Terry said she did, and the pharmacist said she would send the patient over and to expect him within 30 minutes. When the patient arrived, Terry filled the prescription and being alone with just the IPPE student, prepared to dispense it at the cash register. As required by law, she asked the patient for identification. Much to her surprise, the person presented his driver’s license and he was not the patient. In fact, the identification card was for the prescriber who had written the prescription, a medical resident at a local hospital. She asked the prescriber why he was picking up the prescription and he said that he was helping out the patient who was in terrible pain. It was late in the day, and Terry had received this referral from a colleague who she trusted. She dispensed the prescription despite her misgivings.

                       

                      The next day when the IPPE student arrived, Terry explained the immediacy of the situation and conflicting professional interests led to dispensing the prescription yesterday, but she still had some nagging doubts. With the prescription volume a bit slower now, she decided to do some follow up. She found that the “patient” had a number of prescriptions filled over months, most of which were filled at her colleague’s pharmacy. However, the initial prescriptions were filled in a town 40 miles away. She eventually called the hospital, found the name of the residents’ supervising physician, and contacted him. After brief discussion, he indicated that he would handle it going forward and that he appreciated the information. Although the supervising physician did not say outright that he suspected this resident of wrongdoing, the implication was that was the case. The supervising physician did follow through and eventually, the state requested documentation. Terry was able to talk through the situation with the student and explain the pharmacist's responsibility in cases like this. Terry exemplifies Step 4 of PIF. She was secure in her identity and despite the way others had handled this situation, she was concerned and confident enough to do the right thing.

                       

                      Teach-back is useful in many situations, but especially when processes are involved. In one busy pharmacy, a man approached the pharmacy student at counter. He said, “Can I get a shingles vaccine today?” The student, having no prior experience in a community pharmacy, politely asked the patient to wait while she asked the pharmacist. Her preceptor said quickly, “Get the patient’s insurance information and enter him into the system.” With the patient’s insurance card in hand, she began to enter his information. Unsure how to proceed, she asked the pharmacist for assistance again. A line began to form behind the man, so the pharmacist said, “Don’t worry, I’ll do it and you can watch.” The intern watched and thought the process looked easy enough. The pharmacist asked if she understands (a close-ended question), and she said yes. Later in the day, a new patient came in and the student began to enter the patient’s insurance information. She hit a point where she was unsure how to continue. But earlier she told her preceptor that she understood how to do it! She really thought she did know how! The student, becoming flustered, was embarrassed to ask for help again on something she had just learned. How could this situation have been avoided? If the preceptor had asked the student to describe the process, correcting any inaccuracies in recollection, and explained why pharmacies need to provide accurate information, the student would have been in a better position to help.

                       

                      Overall, preceptors need to provide students with the best experience possible with available time and resources. For example, a student may be in a health systems rotation in a department that has little patient interaction and plenty of down time. The preceptor may worry he cannot give the student the experience she deserves. This preceptor could assign the student to review a journal article on a relevant subject and present it to an interprofessional team of nurses, pharmacists, and doctors. Subsequently, the student may realize the pharmacist’s potential impact and help the student internalize what it means to be a pharmacist.

                       

                      PAUSE AND PONDER: Can you recall a time when you were taught how to do something, told your teacher you understood it, then could not perform the action on your own? As a preceptor, how would you avoid this situation with your own student?

                       

                      Finally, let's return to the questions asked at the beginning of this continuing education activity. In particular, the question of whether a pharmacist can be a good employee, but a bad pharmacist, is of tremendous interest right now. The situation it brings to mind is that of the good employee pharmacist whose supervisors urge him to dispense opioid prescriptions as written and avoid asking too many questions. Doing so makes customers happy, increases prescription volume, and reflects positively in the store’s metrics. Many pharmacists conducted themselves this way for many years, despite the fact that they probably had an inkling that they should be checking more closely or perhaps turning some prescriptions away. These pharmacists were not necessarily bad pharmacists, but their employers considered them good employees because they followed directions and turned a blind eye to a developing opioid epidemic.

                       

                      In November 2021, a federal jury in Ohio found three of the nation's largest pharmacy chains liable for contributing to the U.S. opioid crisis.24,25 The jury found that the prosecution provided ample evidence that some medications dispensed at chain pharmacies legally were sold on the black market. That finding has resonated nationally as state after state filed similar lawsuits. In December of 2022, two chain pharmacies agreed to share a $10.7 billion fine to settle allegations that they failed to oversee opioid analgesic prescriptions adequately. These funds are being distributed to states, local governments, and federally recognized tribes to improve opioid crisis abatement and remediation programs. Both chains agreed to improve their controlled substance compliance programs and provide mandatory training to pharmacists. Expediency in the short term and compliance with procedures that are unethical seldom avoid long term consequences.

                       

                      Other states have also secured settlements from pharmacies, and independent pharmacies have also been prosecuted. Discussing situations related to pharmacy that appear in the media is another way that preceptors can introduce discussion of our professional values. The nation is hopeful that pharmacists everywhere have learned that part of our professional identity is the necessity to speak up and to challenge our employers when they ask us to do things that walk the line of professionally ethical behaviors. Starting discussions with students about newsworthy events like this in which preceptors talk about self-interest, other people’s perception of pharmacy and pharmacists, and maintaining standards can advance our profession. Pharmacists are part of a complex system of drug distribution. We need to establish our core values and uphold them to keep society’s respect.

                       

                      CONCLUSION

                      Pharmacy educators, preceptors, and mentors must realize the significance of IPPE and APPE rotations and their influence in shaping future pharmacists’ professional identities. Professional identity formation is essential for students’ transformation into successful and compassionate pharmacists. IPPE rotations with effective preceptors enable students to observe, participate, and reflect on various aspects of pharmacy practice. Often these exercises take very little time, and small actions can have tremendous impact. Through exploration, reflection, and commitment to the profession, students can develop professional identities that align with the core values and beliefs of the pharmacy profession and their own personal values.

                       

                      As students grow throughout their educational and professional careers, they will internalize what it means to be a pharmacist. Changes may not be apparent in the short amount of time a preceptor is with a student. If students are comfortable with the idea, preceptors can connect with them on LinkedIn, stay in contact through email, and be open to being a mentor to the student after the rotation ends. Pharmacy is a profession of many interconnected individuals with unique and valuable professional identities.

                       

                       

                      Pharmacist Post Test (for viewing only)

                      Who are you? Who are We? Professional Identity in Experiential Learning

                      Post-test

                      After competing this continuing education activity, preceptors will be able to
                      ● Describe professional identify formation
                      ● Apply the steps in development of a professional identity
                      ● Identify activities that develop professional identity appropriately

                      1. Lyle is a preceptor whose student arrives to work wearing a tee shirt with a silly slogan on it, a ball cap, and brightly colored foam clogs. The student puts on a wrinkled and somewhat dirty white coat and steps out behind the register to start helping patients in the line. What is Lyle’s main concern with regard to this student?
                      A. Professionalism
                      B. Cleanliness
                      C. Professional identity

                      2. As the end of the day approaches, a prescriber calls in a set of prescriptions for a child who has a serious infection. Lyle assigns his student to check the dosing. The student asks if he can do the task tomorrow morning, as it's late and he'd like to head home for dinner. He also says that the prescriber probably double checked her own work. What is the BEST way for Lyle to explain the importance of completing the task today?
                      A. Explaining that one never knows when a patient will arrive to pick up prescriptions and how that reflects on the pharmacy staff. He is trying to help develop the student’s professionalism.
                      B. Explaining that most prescribers rarely double check their own work so the pharmacy needs to do it before the prescriber leaves for the day. This encourages professional identity formation.
                      C. Explaining that pharmacists have a duty to be diligent about medication doses, especially in pediatric patients. This should contribute to the student’s professional identity formation.

                      3. Mr. Walker, a patient who has successfully overcome an addiction to heroin, presents a prescription for oxycodone after having dental work. He wants to talk to the pharmacist, and you invite your student to join you. Mr. Walker asks if the prescription is for an addictive substance and says that the dentist never asked if he had a current or previous addiction problem. He would like you to call the dentist and have the prescription changed. You agree, and when you return to the pharmacy, your student asks, “Why don't you have him call the dentist himself? We're really busy.” What part of the pharmacist core values should you discuss with this student?
                      A. Pharmaceutical expertise
                      B. Commitment to the patient’s well-being
                      C. Social responsibility

                      4. Which of the following describes Step 2 in Kegan’s Stages of Personal and Professional Identity Development?
                      A. A student's primary concern is understanding others’ values and expectations.
                      B. A student's primary concern is ensuring the team approves of her work.
                      C. A student’s primary concern is in learning and following the rules of dispensing.

                      5. Which of the following accurately represents the sequence in which students can be expected to develop professional identity?
                      A. Learning the rules of pharmacy; learning to differentiate between right and wrong and working with other team members; removing emotion and using reason to make decisions
                      B. Learning to differentiate between right and wrong and work with other team members; removing emotion and using reason to make decisions; learning the rules of pharmacy
                      C. Removing emotion and using reason to make decisions; learning the rules of pharmacy; learning to differentiate between right and wrong and work with other team members

                      6. Which of the following accurately describes PIF opportunities in the pharmacy?
                      A. Preceptors who take IPPE students should use the simplest of examples to help students with PIF because students have little experience.
                      B. Preceptors should concentrate on situations that are complex so that students see pharmacists practicing at the top of their licenses.
                      C. Preceptors can use simple everyday tasks to help students understand the pharmacist's role and develop their professional identities.

                      7. Which of the following activities would be MOST appropriate for an IPPE student who has never worked in a pharmacy with regard to professional identity formation?
                      A. Having the student observe a controlled substance inventory and asking questions like, “Why do you think we conduct an inventory every day? What would we do if we found a discrepancy?”
                      B. Having the student observe a technician who is running the cash register and coaching the technician to ask questions like, “Do you have any experience running a cash register or dealing with customers?”
                      C. Having the student restock the OTC section of the pharmacy and make a list of OTCs that need to be ordered, and asking the student to justify her reasons for ordering the various drugs and the quantity she designates.

                      8. Which of the following activities is MORE appropriate for an APPE student than an IPPE student to develop professional identity?
                      A. Reviewing the case of a patient with drug resistant tuberculosis and several drug allergies and presenting the case on medical rounds with physicians and nurses
                      B. Checking that the dose of amoxicillin for a 5-year-old child who weighs 36 pounds is correct and that the child has no allergy to penicillin antibiotics
                      C. Asking the student to shadow you while you provide counseling to a patient who has a question about OTC cough and cold formulations

                      9. A new IPPE student has a casual attitude about pharmacy and expresses opinions that indicate that she knows very little about professional responsibilities. Several times and despite gentle correction, she has counted controlled substances incorrectly and returned control substance bottles to the regular shelves, not the vault. Which of the following activities might increase her awareness of the pharmacist’s responsibilities and legal obligations?
                      A. Having the student accompany you to your state’s Board of Pharmacy meeting
                      B. Abandoning formative feedback and pointing out the student’s errors forcefully
                      C. Restricting this student’s activity to handling the front end of the store only

                      10. Your state announces that it will now impose significant restrictions on all prescriptions for a certain drug because of a growing number of patient deaths related to its abuse. During the morning huddle, your staff discusses the increased paperwork burden and the potential that patients will be upset. After the huddle, the student asks, “Why is this our problem? Shouldn't this be handled by the drug’s manufacturer?” What is the best answer?
                      A. Technically pharmacists are nothing more than the medication police. Our job is to enforce the rules other create strictly and unemotionally.
                      B. In an ideal world, pharmaceutical companies would take complete responsibility for the damage their drugs do. This is not an ideal world.
                      C. Pharmacists are part of a complex system of drug distribution. We need to establish our core values and uphold them to keep society’s respect.

                      References

                      Full List of References

                      REFERENCES
                      1. Larose-Pierre M, Cleven AJ, Renaud A, et al. Reevaluating core elements of emotional intelligence in professional identity formation for inclusion in Pharmacy Education. American Journal of Pharmaceutical Education. 2023;87(6):100082. doi:10.1016/j.ajpe.2023.100082
                      2. Kellar J, Paradis E, van der Vleuten CPM, oude Egbrink MGA, Austin Z. A historical discourse analysis of Pharmacist Identity in Pharmacy Education. American Journal of Pharmaceutical Education. 2020;84(9). doi:10.5688/ajpe7864
                      3. Jarvis‐Selinger, S., Pratt, D.D., and Regehr, G. (2012). Competency is not enough: integrating identity formation into the medical education discourse. Academic Medicine 87: 1185
                      4. Toklu HZ, Hussain A. The changing face of pharmacy practice and the need for a new model of pharmacy education. J Young Pharm. 2013;5(2):38-40. doi:10.1016/j.jyp.2012.09.001
                      5. Kruijtbosch M, Göttgens-Jansen W, Floor-Schreudering A, van Leeuwen E, Bouvy ML. Moral dilemmas reflect professional core values of pharmacists in community pharmacy. Int J Pharm Pract. 2019;27(2):140-148. doi:10.1111/ijpp.12490
                      6. https://www.ashp.org/-/media/assets/policy-guidelines/docs/endorsed-documents/code-of-ethics-for-pharmacists.ashx
                      7. Johnson JL, Arif S, Bloom TJ, Isaacs AN, Moseley LE, Janke KK. Preparing pharmacy educators as expedition guides to support professional identity formation in Pharmacy Education. American Journal of Pharmaceutical Education. 2023;87(1). doi:10.5688/ajpe8944
                      8. Kegan, R. (1982). The Evolving Self: Problem and Process in Human Development. Cambridge, MA: Harvard University Press
                      9. Irby, D.M. and Hamstra, S.J. (2016). Parting the clouds: three professionalism frameworks in medical education. Academic Medicine 91: 1606–1611
                      10. Swanwick T, Forrest K, O’Brien BC, Cruess RL, Cruess SR. The Development of Professional Identity. In: Understanding Medical Education: Evidence, Theory and Practice. Wiley-Blackwell; 2019:239-254.
                      11. Hafferty, F.W. (2016). Professionalism and the socialization of medical students. In: Teaching Medical Professionalism (ed. R.L. Cruess, S.R. Cruess and Y. Steinert), 54–68. Cambridge: Cambridge University Press.
                      12. Briceland LL, Martinez T. Exploring the impact of reflecting upon pharmacy experts’ written career guidance on Student Professional Identity Formation. INNOVATIONS in pharmacy. 2022;13(3):5. doi:10.24926/iip.v13i3.4778
                      13. Arnoldi J, Kempland M, Newman K. Assessing student reflections of significant professional identity experiences. Currents in Pharmacy Teaching and Learning. 2022;14(12):1478-1486. doi:10.1016/j.cptl.2022.10.003
                      14. Janke KK, Bloom TJ, Boyce EG, et al. A pathway to professional identity formation: Report of the 2020-2021 AACP student affairs standing committee. American Journal of Pharmaceutical Education. 2021;85(10). doi:10.5688/ajpe8714
                      15. Luyckx K, Goossens L, Soenens B, Beyers W. Unpacking commitment and exploration: Preliminary validation of an integrative model of late adolescent identity formation. Journal of Adolescence. 2005;29(3):361-378. doi:10.1016/j.adolescence.2005.03.008

                      16. AFPC Educational Outcomes for First Professional Degree Programs in Pharmacy in Canada 2017. Association of Faculties of Pharmacy of Canada. Accessed August 26, 2023. http://www.afpc.info/system/files/public/AFPC-educational%20Outcomes%202017_final%20Jun2017.pdf
                      17. Elnicki DM. Learning with emotion: which emotions and learning what? Acad Med 2010;85:1111.
                      18. Poulsen L, Brosen K, Arendt-Nielsen L, et al. Codeine and morphine in extensive and poor metabolizers of sparteine:pharmacokinetics, analgesic effect and side effects. Eur J Clin Pharmacol. 1996. 51(3-4): 289-295.
                      19. Caraco Y, Sheller J, and Wood AJ. Pharmacogenetic determination of the effects of codeine and prediction of drug interactions. J Pharmacol Exp Ther. 1996. 278: 1165-1174.
                      20. Lalovic B, Phillips B, Resler LL, et al. Quantitative contribution of CYP2D6 & CYP3A4 to oxycodone metabolism in human liver and intestinal microsomes. Drug Metab Dispos. 2004. 32: 447-454.
                      21. Campfield KM, Hills AM. Effect of timing of critical incident stress debriefing (CISD) on posttraumatic symptoms. J Trauma Stress. 2001;14(2):327-340. doi:10.1023/A:1011117018705
                      22. Formative Assessment and Feedback. Stanford | Teaching Commons. Accessed August 16, 2023. https://teachingcommons.stanford.edu/teaching-guides/foundations-course-design/feedback-and-assessment/formative-assessment-and-feedback#:~:text=Formative%20feedback%20helps%20students%20recognize,to%20meet%20the%20course%20outcomes.
                      23. Formative and Summative Feedback. Teaching@Tufts. Accessed August 6, 2023. https://sites.tufts.edu/teaching/assessment/assessment-approaches/formative-and-summative-feedback/.
                      24. Mann B. 3 of America's biggest pharmacy chains have been found liable for the opioid crisis. November 23, 2023. Accessed August 16, 2023. Ohio jury holds CVS, Walgreens and Walmart liable for opioid crisis : NPR
                      25. Wile R. CVS and Walgreens to pay a combined $10.7 billion settlement for alleged opioid prescription lapses. December 12, 2022. Accessed August 16, 2023. CVS, Walgreens to pay $10.7 billion for alleged opioid prescription lapses (nbcnews.com)

                      The Path to Time Management: Time to Hit the Road!

                      Learning Objectives

                      After completing this knowledge-based continuing education activity, pharmacy technicians will be able to

                        • Describe how an individual technician’s time management impacts the whole pharmacy’s efficiency
                        • List three time management techniques that could improve a technician's function
                        • Recognize time management techniques to apply in specific settings and situations

                         

                        Re-Release Date: September 24, 2023

                        Expiration Date: September 24, 2026

                        Course Fee

                        Pharmacy Technicians: $4

                        There is no funding for this CE.

                        ACPE UAN

                        Pharmacy Technician: 0009-0000-23-027-H04-T

                        Session Codes

                        Pharmacy Technician:  20YC65-TJX49

                        Accreditation Hours

                        1.0 hours of CE

                        Accreditation Statements

                        The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit for the online activity ACPE UAN 0009-0000-23-027-H04-T  will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

                         

                        Disclosure of Discussions of Off-label and Investigational Drug Use

                        The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

                        Faculty

                         

                        Isabella Bean
                        PharmD Candidate 2022
                        UConn School of Pharmacy
                        Storrs, CT

                        Sara Miller, PharmD, RPh
                        CVS
                        Foxboro, MA

                        May Zhang
                        PharmD Candidate 2022
                        UConn School of Pharmacy
                        Storrs, CT

                        Faculty Disclosure

                        In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

                        Isabella Bean, Sarah Miller and May Zang do not have any relationships with ineligible companies.

                         

                        VIDEO

                        html

                        Pharmacy Technician Post Test (for viewing only)

                        The Path to Time Management: Time to Hit the Road!

                        LEARNING OBJECTIVES
                        After completing this continuing education activity, the pharmacy technician should be able to
                        1. Describe how an individual technicians' time management impacts the whole pharmacy’s efficiency
                        2. List three time management techniques that could improve a technician's function
                        3. Recognize time management techniques to apply in specific settings and situations

                        1. Barbara and Linda are great multitaskers. They are able to work and talk while getting everything done effectively. While ringing out a customer, Barbara continues her conversation with Linda. What should Barbara have done instead?
                        a. Paused the conversation, because it makes the customer feel unimportant
                        b. Done nothing different—in situations like this, she never makes errors
                        c. Asked someone else to ring the customer so she can go on her 15 minute break

                        2. Lilly makes it to work within the 7 minute grace period every day. Technically she is on time, but she’s not ready and at her station at her 7:30 shift time. How does this disturb workflow when she takes advantage of the grace period every day?
                        a. It doesn’t disturb workflow because she is not late. The grace period is in effect so that she doesn’t have to be in right when her shift starts.
                        b. Exploiting the grace period means the other technicians who arrive before the official start time have to cover her station until she comes in.
                        c. Employers know how often employees are late and why, and communicate problems like traffic congestion to local governments, so the effect on the workplace is positive.

                        3. You’re heading to work and you know it takes exactly 11 minutes to travel there. Your shift starts at 9 am. What time do you leave?
                        a. I leave by 8:40 am at the latest so that I have time to park and walk in.
                        b. I leave at 8:49 am because I know it takes 11 minutes to get there.
                        c. I leave at 9:00 am because I know they can handle me being a little late.

                        4. You are entering in an insurance card that you haven’t seen before. You’ve been struggling with it for five minutes and can’t figure it out. You are unsure of how to proceed, but the pharmacist is busy. What do you do?
                        a. Politely interrupt the pharmacist to ask your question
                        b. Ask a more senior technician if they have seen it before
                        c. Go to a different station to avoid this insurance card

                        5. Laura is a new pharmacy technician. The customers will ask her where to find an OTC or grocery item frequently, but she doesn’t know yet. She asks you how she can become more familiar with where everything is. What do you say?
                        a. Suggest that she ask the manager for front store training so that she can become more familiar with the store
                        b. Tell Laura that it takes time to learn the store, and to keep asking the other techs and pharmacists
                        c. Tell Laura she that she should identify this problem’s quadrant and decide whether to ask or act

                        6. You are working in the pharmacy and a huge order arrives. You know you have to finish putting away the order before your shift ends, but prescriptions and patients keep popping up. What do you do?
                        a. Prioritize the customers and prescriptions that are here now and do as much of the order as possible
                        b. The other technicians are busy too, but leave it for them because you’ve had to put the order away on three recent days
                        c. Multitask by putting the order away as you ring customers and retrieve and count controlled substances

                        7. The phone is ringing! When you answer it, a provider is on the line. She’s very frustrated because she’s been on hold for 10 minutes, and she “doesn’t have the time for this kind of thing” and “needs an answer ASAP.” She has a clinical question about a medication you fill very frequently. What is the most appropriate response?
                        a. ACT—you’ve been a tech for four years; you’ve seen this medication dozens of times. You know enough to answer the provider’s question.
                        b. ASK—you’re in the middle of something else right now. Ask another tech to handle this provider.
                        c. ASK—the pharmacist should take the call, since it involves a clinical question and you may not know all the details.

                        8. The phone is ringing! When you answer it, a provider is on the line. She’s very frustrated because she’s been on hold for 10 minutes, and she “doesn’t have the time for this kind of thing” and “needs an answer ASAP.” She has a clinical question about a medication you fill very frequently. What quadrant of workplace activity best describes this situation?
                        a. Quadrant 1: important and urgent
                        b. Quadrant 2: important but not urgent
                        c. Quadrant 4: not important and not urgent

                        9. Flu season is coming. Martha, an experienced pharmacy technician, knows that the store serves a very elderly population. She decides to ask the pharmacist to order more high potency flu vaccines, in anticipation of a higher customer demand. This best describes which time management technique?
                        a. Good organization
                        b. Planning ahead
                        c. Multitasking effectively

                        10. You’ve just transferred pharmacies, and you’re trying to figure out the lay of the land. It’s really hard to find things in your new pharmacy. Some meds are ordered by brand name, some by generic. Topicals, inhalers, and DME are all combined on the same shelf. When you bring this up to other techs, they sympathize but say you’ll figure it out eventually, like they had to. Which time management technique would best solve this issue?
                        a. Acting instead of asking
                        b. Multitasking effectively
                        c. Good organization

                        References

                        Full List of References

                        References

                           

                          Prepping Pharmacist Preceptors on the Pharmacists’ Patient Care Process (PPCP)

                          Learning Objectives

                           

                          After completing this application-based continuing education activity, pharmacists will be able to

                            • Describe the PPCP model and its uses
                            • Apply the PPCP when students address clinical problems in the workplace
                            • Identify areas where pharmacy students need the most guidance when using the PPCP

                            Two healthcare professionals talking while looking at a vial filled with medication capsules

                             

                            Release Date: July 21, 2023

                            Expiration Date: July 21, 2026

                            Course Fee

                            Pharmacists: $7

                            UConn Faculty & Adjuncts:  FREE

                            There is no grant funding for this CE activity

                            ACPE UANs

                            Pharmacist: 0009-0000-23-028-H04-P

                            Session Code

                            Pharmacist:  23PC28-XPK68

                            Accreditation Hours

                            2.0 hours of CE

                            Accreditation Statements

                            The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Statements of credit for the online activity ACPE UAN 0009-0000-23-028-H04-P  will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.

                             

                            Disclosure of Discussions of Off-label and Investigational Drug Use

                            The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

                            Faculty

                            Kimberly Ma
                            PharmD Candidate 2024
                            UConn School of Pharmacy
                            Storrs, CT

                            Jeannette Y. Wick, RPh, MBA, FASCP
                            Director, Office of Pharmacy Professional Development
                            UConn School of Pharmacy
                            Storrs, CT

                            Faculty Disclosure

                            In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

                            Kimberly Ma and Jeannette Wick do not have any relationships with ineligible companies

                             

                            ABSTRACT

                            Preceptors often work with students to review patient cases in an organized way. Experts developed the Pharmacists’ Patient Care Process (PPCP) in 2014 to provide a template that is consistent and concise, but also comprehensive. Using this process, students and licensed pharmacists develop SOAP notes to document the subjective and objective data they need to complete an assessment, and ultimately make a plan. PPCP stresses an important point: follow-up is critical and a well-written SOAP note can be extremely helpful in the follow-up process. This continuing education activity uses a case study to demonstrate how the PPCP process should work and emphasize areas where preceptors can provide tangential learning. It includes PRO TIPS for preceptors when they supervise students who are attempting to complete PPCP. It highlights the most common errors and suggest ways that preceptors can work with students to improve their experiential education.

                            CONTENT

                            Content

                            INTRODUCTION: A PATIENT CASE

                            JM, an 8-year-old white male presents to your clinic. It’s a pediatric care clinic located in an area where many financially challenged families live. After talking with his parents, you learn he was recently diagnosed with central precocious puberty (CPP). His endocrinologist recommends initiating therapy and would like to know what treatment you recommend. His parents also have questions.

                            Your spry pharmacy student jumps at the opportunity to write a SOAP note using the “PPCP.” To you, PPCP sounds like an illegal drug that was abused in the 1980s. She explains that the Pharmacists’ Patient Care Process (PPCP) is a standardized model for collaborative medication management. She clarifies what it entails and how to apply the process in a clinical setting.

                            PPCP’s Importance

                            Schools of pharmacy have taught the PPCP for the past few years. Preceptors who are unfamiliar with the process may find it helpful to review the PPCP as many students will take this approach when addressing clinical problems in the workplace.

                            PPCP: THE DETAILS

                            Teamwork in healthcare has achieved major goals for many patients (although we have room for improvement): accessible, affordable, and high-quality care. In addition to the many healthcare team members, pharmacists are critical contributors to care plans. Medication expertise equips pharmacists with the knowledge to reduce drug adverse events, prevent medication errors, and provide invaluable input for decision-making.1

                            In 2014, the Joint Commission of Pharmacy Practitioners (JCPP) developed a standardized process for medication management that could be used across interdisciplinary teams and dubbed it PPCP. JCPP’s members developed the approach using principles of evidence-based practice. The five steps—collect, assess, plan, implement, and follow-up—are tied together with careful communication and documentation.2 Pharmacists can remember the steps as the pneumonic “CAP-IF.”

                            SOAP Notes

                            The subjective, objective, assessment, and plan (SOAP) note provides a method of documentation for the collect, assess, and plan steps of the PPCP. SOAP notes are probably familiar to most preceptors, as clinicians have used them for roughly 50 years.3 Table 1 highlights the key components of SOAP notes.

                            Table 1. Components of a SOAP Note1

                             

                            Objective Information Subjective Information
                            ·       Current medication list (prescription and nonprescription)

                            ·       Medical history

                            ·       Physical assessments (i.e., blood pressure, heart rate, weight, height, respiratory rate, etc.)

                            ·       Laboratory results

                            ·       Chief complaint

                            ·       Symptoms

                            ·       Patient lifestyle habits, preferences, and beliefs

                            ·       Patient goals for care

                            ·       Socioeconomic factors

                            Assessment
                            ·       Problem: statement highlighting the chief complaint or main medication-related problem

                            ·       Rationale: the reasoning for the intervention cited from guidelines and supporting evidence from the collected information

                            ·       Goals of care: possible barriers to adherence, socioeconomic considerations, and desired outcome of intervention

                            Plan
                            ·       Specific recommendation or intervention based on practice guidelines (i.e., initiation of drug therapy, referral to another provider, or non-pharmacologic lifestyle modifications)

                            ·       Plan for upcoming sessions, specific monitoring parameters, and progress indicators

                             

                            Collect

                            Thorough collection of the right information supplies pharmacists with tools to make safe, effective decisions. A combination of objective and subjective information paints a more complete picture of a patient’s clinical status. If possible, pharmacists should obtain and verify their information across multiple sources. Past medical records, active medication lists, and laboratory results are great places to start.

                            When soliciting subjective information, pharmacists should use open-ended questions. Prompting patients with questions formatted to avoid “yes” or “no” answers allow providers to obtain more information in less time, prioritize chief complaints better, and minimize implicit assumptions.4

                            Back to the Case

                            Your head is spinning trying to sort all the “P’s” in PPCP, CPP, and JCPP, but your student assures you that she will start with collecting relevant clinical information. First, you and your student perform a physical assessment of JM including taking his height and weight. JM takes no medication except an occasional antihistamine, but if he took other chronic medications, this would be the time to direct your student to perform a medication reconciliation. Next, you prompt JM’s parents with open ended questions, and they recall JM’s past medical history. You should ask your student if JM needs to be involved in the discussion (see SIDEBAR). After meeting with JM and his parents, here is the relevant information your student jots down:

                            Subjective information

                            • At age 5, JM frequently soaked through his underarm clothing with pungent perspiration, so since then, he uses a strong deodorant
                            • He is starting to develop pubic and underarm hair
                            • He has some acne on his face and upper back
                            • JM occasionally tells his parents he feels “different” than his classmates because he is so much bigger and taller
                            • He has no past surgeries or hospitalizations
                            • Takes OTC multivitamins daily and loratadine for allergies in the spring

                            Objective Information

                            • Height = 4’8” inches
                            • Weight = 102 pounds
                            • DHEA Sulfate = Tanner stage III - 60 ug/dL (N = < 28 ug/dL)
                            • Clinical exam findings = testicle size indicates puberty
                            • X-ray bone age hand and wrist = greater than 2 standard deviations, 156 months (expected = 108.9 months)
                            • Luteinizing hormone (LH) = 0.4 units/L (N = < 0.3 units/L)

                            SIDEBAR: Pediatric Involvement in Healthcare Decisions5,6

                            In pediatric cases, clinicians may choose to consult only parents when making decisions regarding their child’s medical care. However, this practice, which is rooted in legal precedence, should shift to involve affected children to some extent. The American Academy of Pediatrics advocates that adolescents actively participate in decisions based on their ability and maturity. 5 While research is lacking on how exactly to assess a child’s aptitude to participate in decision making, some studies show that children can participate as young as age 5.6 Regardless, it doesn’t hurt to ask children if they have questions or concerns. In the case, JM is 8 and has voiced his concern previously about his height and size. Therefore, including him in the conversation is a possibility if his parents agree.

                            Preceptors can and should provide tangential learning when working with special populations. Reminding students that adolescents, older adults, people who have cognitive decline or dementia, and people for whom English is a second language will need careful counseling. Pharmacists and pharmacy staff will also need to select their words carefully and accommodate these patients’ needs. Assigning students to do some research on the various needs in these populations is an excellent way to help them develop skills and a professional identity.

                            Upon looking at your student’s notes so far, you assure her she has done well. However, you still have some questions. You remind her that sometimes information like height and weight requires additional evaluation and ask her to calculate JM’s BMI; she finds that it’s 22.9. You ask your student, “How does JM’s height and weight compare to the expected height and weight of boys his age?” To which she replies, “Pediatric growth charts will give us a better idea!” After consulting the growth charts, she determined and documented that JM falls within the 112th percentile for both measurements.

                            To make learning comprehensive, you could ask the student if the only kind of precocious puberty is central in nature. This will help your student learn to differentiate among different forms of similar diagnoses.

                            Assessment

                            An assessment of comprehensive patient information helps prioritize the problems that require attention. Pharmacists should consider all information when identifying the problem, the rationale, and the goals of therapy. Some example questions pharmacists can consider include1

                            Medication appropriateness

                            • What is the indication for each medication?
                            • What is the correct dosing?
                            • What are the common adverse effects?
                            • What are the possible drug interactions?

                            Factors that impact access to care

                            • What cultural factors create barriers to care?
                            • What socioeconomic factors impact the patient?
                            • What is the patient’s level of healthcare literacy?
                            • What goals does the patient or his parents have?
                            • What barriers impact patient adherence?

                            Additional services

                            • What preventive care measures does the patient qualify for?
                            • Which immunizations has the patient received?
                            • What other concerns does the patient have?

                            THE CASE RESUMED...

                            After compiling the objective and subjective information on JM, the student finds guidelines in the Journal of Clinical Endocrinology for the management of CPP.7 Due to JM’s symptoms and lab values showing consistencies with CPP, the guidelines recommend initiating a gonadotropin releasing hormone (GnRH) analog. Depending on JM’s and his parents' preferences, the endocrinologist can choose either an injectable (leuprolide) or long-acting implantable device (histrelin) provided the insurance covers it or the cost is manageable.

                            Once again, you should have some questions for your student. For example, asking the student to list the search terms and search engines she employed can shed light on her process. Another question might be, “Are these the only guidelines available?” You can show her that you used PubMed, as she did, but when you used Google Scholar, you found an excellent review article that lists five other publications. You suggest she look at them since expert recommendations can vary. She might also contact the endocrinologist and ask if he plans to follow the guidelines she identified, and if not, why not.

                            The endocrinologist messages back saying he agrees leuprolide and histrelin are both reasonable options to consider for first-line therapy. However, he also cites a 2019 update published on Hormone Research in Paediatrics. These guidelines recommend a third U.S. Food and Drug Administration (FDA)-approved option for the treatment of CPP, triptorelin.8 He says the student should consider this choice as a potential treatment for JM as well.

                            After reading the endocrinologist’s note, you emphasize to your student the importance of citing multiple guidelines when drafting an assessment. In this case, the FDA approved an additional treatment, triptorelin, in 2022. You walk through your student’s process of finding clinical information to identify more ways she can improve next time. Furthermore, you point out how the endocrinologist’s insight exemplifies the importance of interdisciplinary care.

                            Simultaneously, you and your student read through all three monographs and discuss the major differences you’d like to share with his parents. You ask the student to practice her delivery of the information, and she says, “Leuprolide is a long acting injectable administered intramuscularly (IM) or subcutaneously. Your doctor will administer the IM formulation every month, three months, or six months. “Triptorelin is similar to leuprolide, but is only available as a six month IM formulation. The other option is for your doctor to administer the subcutaneous formulation every six-months.9 On the other hand, histrelin comes as a long-acting 1¼ inch implant surgically placed into the upper arm every 12 to 24 months. For the first 24 hours after the surgery, JM should avoid swimming or bathing. As long as JM avoids heavy play or exercise for the first week, he will not have to worry about any further restrictions after that. The implant also requires surgical removal.”10

                            Now, you prompt the student to recall that JM’s parents expressed concern about what would happen if JM experienced an adverse reaction to the long-acting implantable device. They asked, “What is the procedure like?” and “If JM has a reaction to the implant, must he continue to wear it for 12 months or can the doctor remove it easily before then?”

                            The student does more research and says she will assure JM’s parents that this outpatient procedure lasts only 10 minutes, though the appointment may last 60 to 90 minutes. Most surgeons will just numb the area; however, children may undergo sedation if necessary. The surgeon will insert the narrow implant into a small approximately 5 mm opening made in the skin on the inner surface of the arm. With this option, JM can return to school the same day. The student plans to mention that complications don’t commonly occur, but minor discomfort and bruising may.11 The student plans to continue, “The implant may be removed immediately if JM presents at any time a severe allergic reaction or adverse effect. However, this is not common.”

                            Before you and the student document the assessment section of your SOAP note, the student indicates she will ask JM if he has questions. He shares that he “HATES needles” but is also scared of the surgery hurting.” The student plans to tell him not to worry because he won’t feel any pain during the operation. He can also choose to sleep during the surgery if he prefers.

                            Here, the preceptor should step in with gentle corrections about patient-appropriate language. First, most Americans have no idea what a 5 mm incision will look like. You ask her to calculate its length in inches and explain it by comparing it to something the child will recognize, like the size of small dice or a stack of 20 playing cards. Next, it’s critical to remind the student that we must never tell patients that something won’t hurt. This is a lesson students should learn during immunization training and creates an opportunity for cross training (applying this principle to other areas of pharmacy) that applies regardless of patient age. Healthcare professionals should never say, “This will not hurt a bit!” or anything similar. People have different pain thresholds making it impossible to predict whether it will hurt. Student pharmacists need to develop language they are comfortable with and use it. A good response if people ask if it will hurt is, “It may hurt or sting a little but just for a minute or two.” In this case, the preceptor suggests saying, “The doctor will numb the area.”

                            Finally, the preceptor may point out that “operation” can be a scary word for children. The student needs to use a word like “procedure” or find a way to avoid either of those words.

                            The preceptor should also point out that JM’s parents had also said they were worried about two things: (1) potential side effects and (2) the cost of care. They heard on the news that expenses associated with these medications can add up quickly. The cost of care and determining what the patient’s insurance will cover is probably foremost in the endocrinologist’s mind, too.

                            In terms of potential side effects, your student says that both GnRH analogs have similar side effect profiles. From the pediatric studies she read on GnRH adverse effects, she shares that signs of puberty may increase transiently with therapy before growth velocity eventually slows down. Some children experience weight gain, changes in appetite, body aches, headaches, gastrointestinal (GI) symptoms, or signs of a common cold. Parameters like physical growth and bone mass density may decrease during treatment but usually return to normal one year after treatment discontinuation.9, 10

                            Before selecting JM’s treatment option, it’s critical to evaluate insurance coverage since it’s on the forefront of everyone’s concerns. The student needs to determine if they have insurance and what the plan covers. She starts by finding information on ballpark cost. She reports a histrelin implant costs around $40,000. If the patient requires mild sedation when the doctor inserts the implant, the cost may increase. However, in some cases, the implant may be used for up to two years. Leuprolide’s median annual cost ranges from $20,000-$40,000 depending on the formulation.12 A single injection of triptorelin costs roughly $19,000, making the annual cost nearly $40,000 as well. Then says she will remind JM’s parents that while this may give them an idea, the cost may vary outside of that range.

                            Plan

                            Following the assessment, pharmacists work to develop a personalized patient care plan in collaboration with other healthcare professionals. The plan should reflect recommendations from the most recent evidence-based clinical practice guidelines. Pharmacists should focus on optimization of care in a safe, effective, and cost-effective manner.

                            1. Address medication-related problems and optimize medication therapy
                            2. Set specific, measurable, achievable, realistic, and timed (SMART) goals in the context of the patient’s healthcare goals and access to care
                            3. Involve patients to engage in education, empowerment, and self-management
                            4. Support non-pharmacologic interventions as appropriate

                            SMART Goals. When creating an action plan for patients, pharmacists should aim to set goals that are SMART.

                            • Specific instructions provide other clinicians with accurate information about the patient.
                            • Measurable outcomes provide clinicians the ability to evaluate the patient’s progress and whether the plan requires adjustments
                            • Achievable and realistic goals
                            • A timeline for the plan ensures healthcare providers routinely follow up with their patient

                            A PLAN FOR JM

                            After you document JM’s main problem, rationale, and goals for care in the assessment section, you move on to create his plan. Following careful consideration of the assessment, you and your student decide to recommend starting histrelin to treat his CPP since his insurance will cover it once the endocrinologist completes prior authorization forms. (Here, you suggest that the student find the prior authorization forms and volunteer to complete as many sections as she can for the endocrinologist. You explain that she can expedite the process and this is a skill she can apply to many different pharmacy practice locations.) Choosing histrelin is also a needle-free option, which may make JM happy. You remind your student that the plan should also include scheduling necessary appointments and follow-ups with JM’s other providers in addition to counseling on the specific adverse effects of the medication detailed in Table 2.

                            Table 2. Example SOAP note for JM 7

                            Name: JM

                            Age: 8    

                            DOB: 10/02/14

                            Allergies: Seasonal allergies, NKDA

                            Chief Complaint: Patient referred to clinic by endocrinologist for medication therapy; patient was recently diagnosed with central precocious puberty (CPP)
                            Subjective Information

                            JM is an 8-year old white male presenting to the clinic. He recently met with his endocrinologist on 6/28/23 and has been referred to the clinic for drug therapy to treat CPP. His parents confirm JM’s use of deodorant to combat excessive perspiration and body odor since the age of 5. He has also developed pubic and underarm hair in addition to acne on his face and upper back. His parents are concerned regarding JM’s reported insecurities at school due to his larger size.

                            PMH: no surgeries or hospitalizations Medications: daily multivitamin, OTC loratadine (prn for allergies)
                            Objective Information

                            Clinical exam findings = testicle size indicates puberty

                            112th percentile for weight and height

                            Relevant Labs: Bone age of 13, LH 0.4 units/L, DHEA sulfate 60 ug/dL

                            Height: 55 in Weight: 102 lbs BMI: 22.9 BP: 110/61 mmHg HR: 75 bpm Temp: 98.6 ℉ RR: 15
                            Assessment

                            Problem: Patient requires medication therapy for untreated indication.

                            Rationale: According to the Journal of Clinical Endocrinology Practice Guidelines for Central Precocious Puberty, JM requires hormone suppression therapy. Symptoms of rapid linear growth, advanced skeletal maturation, and basal LH levels > 0.3 units/L require treatment with GnRH analogs until the normal age of puberty.

                            Goals of Care: The goal of treatment is to reduce signs of premature pubertal progression while ensuring therapy is well tolerated and medication side effects are minimized. Patient’s parents would like to choose an option that is cost effective and safe.

                            Plan

                            Initiate histrelin 50mg SQ implant to be administered by JM’s surgeon every 12-24 months depending on safety and efficacy parameters evaluated at follow up appointments

                            Schedule surgery appointment with JM’s surgeon at earliest convenience

                            Schedule follow up in 3 months to evaluate pubertal progression, growth velocity, skeletal maturation, and tolerability

                            Counsel JM/JM’s parents on possible adverse effects including weight gain, changes in appetite, initial flare of puberty symptoms, GI symptoms, body aches/pains, and signs of common cold

                            Counsel JM’s parents on providing support to make JM feel good about himself. Children who are undergoing rapid development at this age may feel different when comparing themselves to other children their age.

                            Implement

                            During the implementation phase, pharmacists set the action plan into motion. This may include the administration of vaccines, initiating or discontinuing a medication, or scheduling the next follow-up appointment. Pharmacists, primary care physicians, or caregivers work together to provide care based on the goals made in the planning step.1

                            Follow-up and Monitor

                            The pharmacist in collaboration with other health care providers should follow-up with the patient as recommended in practice guidelines and referring back to the SOAP note. Continuous monitoring of medication appropriateness, adherence, safety, laboratory results, and patient concerns will indicate if the plan requires revision. Routine medication reconciliations, check-ups, or conversations with patients improve outcomes and help to achieve goals of therapy.

                            Putting it All Together

                            Upon completion of the SOAP note, you send the endocrinologist your recommendations. You contact JM’s parents to discuss scheduling a follow-up appointment in three months with the endocrinologist and counsel on histrelin.

                            IMPLICATIONS FOR PRECEPTORS

                            The Benefits. The PPCP model creates a reproducible framework that demonstrates clinical pharmacists’ contributions to medication-related outcomes.13 In addition to improving the quality and completeness of patient medical records, SOAP notes give pharmacists a place to start when working up a new patient. As students practice developing SOAP notes, preceptors should emphasize how the lessons they learn in one case can apply to future cases.

                            The Drawbacks. As more pharmacy programs integrate PPCP into their curriculum, new students will have access to courses that teach the model. But because the PPCP model is relatively new, many licensed pharmacists have not yet familiarized themselves with the process. Extracting the necessary information to write quality SOAP notes can also be time consuming. Depending on the setting, pharmacists may not have enough time to walk through every step with students. Finally, the PPCP method does not encompass all clinical situations. The framework relies on pharmacists to exercise clinical judgment and reasoning to modify the model as needed.

                            Uncomfortable Topics. Students often have little exposure to difficult topics. These may include end-of-life issues, psychiatric diagnoses, cultural or ethnic differences, drug abuse/misuse, and gender-related topics. In this case, students may feel strong discomfort in discussing matters related to sex and sexual development. Preceptors need to help students reduce their hesitancy when communicating with you and the patient because improper communication can lead to poor collection of relevant information. Keep in mind strong note-writing skills facilitate good care. Two things help: (1) practice, and (2) finding resources designed to help with difficult topics. The Conversation Project (https://theconversationproject.org/resources/healthcare/) is one such resource that can help students become more comfortable with difficult topics.

                            In addition, students may have implicit and explicit biases for uncomfortable topics such as the use of hormone blockers, which may bring to mind their use in transgender children. Creating a safe place for your student to share opinions provides a great opportunity for you to teach students how to avoid these biases. Preceptors need to remember that learning—especially if it changes a student's perspective or points out a student's mistake—can be threatening, and students can feel vulnerable while learning. It’s an emotional experience.6

                            To help guide students through these experiences, the SIDEBAR provides 10 additional tips preceptors can use when supervising the PPCP.

                            SIDEBAR: PRO TIPS for Preceptors Who Supervise the PPCP

                            (1) Don't let the acronym scare you! This is a new name for a process you've probably used knowingly or unknowingly for years.

                            (2) Encourage independence. Hand over the problem to the student once you've described the problem and fielded the student's questions. Establish a time for the student to be prepared to discuss it but check in periodically to see if the student is having trouble.

                            (3) Rescue when necessary. Some students will need more support than others. If a student is clearly flummoxed, spend more time and provide more direction.

                            (4) Promote interdisciplinary communication. Having students discuss a clinical problem with another clinician, either with you or on their own, fosters interdisciplinary care. Students will also learn from the other clinicians, which will lighten your load!

                            (5) When students present findings, always ask them to describe things like the search terms and search engines they used or the obstacles they encountered. Help them refine their processes to reduce barriers or find more appropriate resources.

                            (6) Consistently prompt students to determine if the case is typical or unusual. Asking questions based on a modification of the case can help students learn more globally.

                            (7) Don't "stay in your lane"! In this CE, the practice site is an ambulatory care location specific to pediatrics. The lessons a student learns in this rotation, if they go beyond pediatrics, will be invaluable. Helping students develop communication skills or analyze how disease states present or are treated in adults or other special populations will increase their clinical acumen in future rotations.

                            (8) Address implicit biases or misconceptions. Students may not know that an attitude or opinion is biased, incorrect, or simply rude.

                            (9) Debrief. After the PPCP is done, provide feedback, ask others who may have been involved to provide feedback, and ask the student to perform a self-assessment.

                            (10) Appreciate reverse mentoring. Remember that students often teach us new things!

                             

                            Common Sources of Error

                            Collecting too little information. Not all the information pharmacists need to collect will be obvious. In the patient case, the student collected important objective information like height and weight. However, without something like growth charts to evaluate JM’s height/weight compared to other kids his age, the information does not help in the assessment. Preceptors can aid students who are new to documenting SOAP notes when they are required to dive deeper into collected information. Students should not make assumptions as to what other clinicians know off the top of their heads. In this case, other areas where the preceptor helped the student included directing her to seek other expert opinions like the endocrinologist. That puts the “inter” in “interdisciplinary” care!

                            Collecting too much information. Pharmacists and students should collect information worthy of appraisal. In other words, only collect the necessary information that will contribute to the identification, prevention, and resolution of either the chief complaint or medication-related problems. If pharmacists/students do not actively use collected information to make the assessment or plan, they should omit it in the note. Documenting more information does not equate to better information. This leads to overly lengthy or confusing SOAP notes. Here, as in the previous error, preceptors should ask students to examine and explain their processes.

                            Not verifying information. All information should be verified across multiple sources like when performing traditional medication reconciliations. This prevents possible errors in note-taking that may arise from outdated documentation.

                            Sourcing one guideline. Depending on the disease state, the frequency in which guidelines are updated can vary. Preceptors should emphasize the importance of looking for multiple guidelines and paying attention to their publication dates. Occasionally, the FDA may approve new treatment options after the release of clinical guidelines or updates. In this case, the student completely missed an additional treatment option as a result of sourcing a single guideline from 2013. Similar to how preceptors should encourage students to verify collected information across multiple sources, preceptors should also encourage students to cross-check sources that aid in their assessment.

                            The assessment lacks evidence. As mentioned above, the assessment should communicate the assessor’s thought process. The information collected by the pharmacist/student should justify why the problem is a problem. If there is no subjective or objective information to back up the assessment, the assessment has no basis.

                            Forgetting recommendations on current medications. Pharmacists/students should not forget to include instructions for the patient’s current medications, not just the newly prescribed medications.

                            Forgetting non-pharmacologic recommendations. The plan section also encompasses non-pharmacologic interventions such as referral to another provider, ordering additional laboratory tests, education, or counseling on lifestyle interventions. Pharmacists/students should remember that not all patients require initiation of a new medication.

                            Being vague. When initiating new therapy appropriately, pharmacists/students should always provide specific recommendations with the drug name, dose, and frequency. Vague instructions such as “Initiate hormone blocker therapy” are unhelpful. Similarly, instead of “monitor for side effects,” pharmacists/students can list the specific symptoms that present most commonly.

                            Poor communication. Errors due to poor communication directly hinder the PPCP. Furthermore, clinicians with experience are not necessarily better communicators. Therefore, pharmacists should engage in education/training to constantly improve communication skills. SOAP notes should effectively communicate the pertinent information used to create a plan and document important details for the patient’s medical record.

                            Setting it and forgetting it. The PPCP is not a linear process. While this framework provides clinicians a place to start and a checklist of sections to complete in order, pharmacists should remember to review and revise all sections at any given time. For example, pharmacists may identify new information they should go back to collect as they work on their assessments. Preceptors should encourage their students to occasionally step back and evaluate the completeness and coherence of the SOAP note. Sometimes patient cases will require students to revise sections of the SOAP note they already completed.

                            And a New Case

                            Just before the end of the month, the endocrinologist sends yet another patient with precocious puberty to you. The patient LD is a 9-year old Hispanic female. Her endocrinologist recently diagnosed her with idiopathic precocious puberty and wants to know which treatment you recommend. Her parents also want to know why this is happening to their daughter. Before taking LD’s family from the clinic waiting room, you decide to let your student take charge of this case while you supervise. You ask your student “Now that you have practiced writing SOAP notes and know a little about this disease state, how will you approach the PPCP this time?”

                            The student says to you...

                            “I stored all my notes from the last case on precocious puberty from earlier this month. I have a document containing the guidelines from the Journal of Clinical Endocrinology along with several updated publications that cite all additional first-line medications approved after the original guideline’s release. I will start with the collection of subjective information such as LD’s symptoms and medical history followed by objective information, specifically pertaining to her growth statistics. I should calculate BMI and her height/weight percentiles since precocious puberty is usually associated with accelerated growth. Next, I will examine her relevant lab values. Since the patient is female, I will be looking out for progesterone levels this time. If possible, I shall cross-reference all of the information I collect across multiple sources.”

                            “Before I move onto making an assessment, I understand LD’s parents may feel very concerned about their daughter's condition. I don’t want to forget to address their question. I will explain that idiopathic precocious puberty does not have a definitive cause. To help them better understand, I’ll mention that idiopathic cases may result from anything ranging from a head injury in childhood to exposure to certain chemicals. Regardless of the cause, I will assure them there are several treatment options that may be appropriate for LD at this time. I can walk them through the pros and cons of all the available options.”

                            “Next, I would prompt LD’s parents with open-ended questions to learn more about their major concerns, potential barriers to medication therapy, and insurance eligibility. I know these are important considerations for my assessment. It would also be appropriate for me to engage with LD using appropriate language for a 9-year-old girl. I realize the topic may be uncomfortable to discuss, but without taking initiative of the discussion I may forget to include pertinent details in my SOAP note.”

                            “Finally, using the information I collected about the family’s preferences and LD’s medical history, I will draft the chief complaint, rationale for treatment, goals of therapy, and eventually a completed plan. The plan will include which treatment I recommend along with the dose, frequency, and which adverse effects are most common. I will write when I recommend a follow-up with her endocrinologist and make note of which lifestyle modifications may support her specific treatment. If the endocrinologist is on board, then we can collaboratively implement and follow-up with the patient as appropriate.”

                            You are overjoyed to hear that your student has taken what she learned from the previous case and applied it to this case as well. Although some of the parameters were different, such as the patient’s sex, she was able to anticipate how the changes may impact her SOAP note this time. While you identify a few areas in which she can improve, you are happy that she is continuing to expand her clinical pharmacy knowledge.

                            Conclusion

                            The PPCP model can be applied to any healthcare setting in which pharmacists practice. This comprehensive approach to patient-centered care has established a streamlined method of documenting patient information to be shared among healthcare teams. As the PPCP continues to grow in clinical settings, practicing pharmacists should become familiar with its methods and applications.

                            Pharmacist Post Test (for viewing only)

                            Prepping Pharmacist Preceptors on the Pharmacists’ Patient Care Process (PPCP)
                            Post-test
                            Learning Objectives
                            After completing this continuing education activity, preceptor-pharmacist will be able to
                            • Describe the PPCP model and its uses
                            • Apply the PPCP when students address clinical problems in the workplace
                            • Identify areas where pharmacy students need the most guidance when using the PPCP
                            POST TEST
                            1. Which of the following correctly lists the steps of the PPCP process in order?
                            A. Collect, plan, assess, follow-up, implement
                            B. Collect, assess, plan, implement, follow-up
                            C. Plan, collect, assess, follow-up, implement
                            2. Which of the following best describes the JCPP’s reason for developing the PPCP?
                            A. To establish a more efficient method of medical documentation
                            B. To provide an opportunity for pharmacists to expand their clinical role
                            C. To create a reproducible method of managing patient medications

                            3. Which of the following examples is a common error pharmacy students make when using the PPCP?
                            A. Avoiding discussion involving uncomfortable topics such as those sexual in nature
                            B. Spending too long counseling the patient as opposed to documenting the SOAP note
                            C. Omitting recommendations to follow up with the patient’s primary care provider
                            4. Which of the following is a common source of error with the PPCP?
                            A. Using a single clinical guideline for recommendations
                            B. Spending the most time documenting the assessment section
                            C. Cross-referencing medication lists against too many sources
                            5. A nurse practitioner calls your clinic and would like you and your student to work up a patient with stage II hypertension. The patient is a 64-year-old African American male who is currently taking amlodipine 2.5 mg and chlorthalidone 6.25 mg. His blood pressure was 150/90 mmHg at his last doctors appointment. Which of the following would be an appropriate first step?
                            A. Increase the dose of his medications. The SOAP note does not need to be performed as his blood pressure remains elevated due to subtherapeutic dosing.
                            B. Ask the patient about his/her medication adherence recently. This information will dictate how you decide to approach the patient.
                            C. Contact the patient’s local pharmacy for a complete list of active medications. This will be valuable information to collect prior to assessing the patient.
                            6. A student working on a SOAP note cites a 2012 guideline from Europe. The preceptor notices the student forgets to consider a first-line treatment option that was approved in 2022. What should the preceptor do at this point?
                            A. Call the physician to get his/her opinion on the newly approved medication
                            B. Discuss the importance of citing multiple sources with the student
                            C. When the student finishes the note, add in the missing information
                            7. Laboratory values belong under which of the following sections of the PPCP?
                            A. Assessment
                            B. Objective information
                            C. Subjective information
                            8. Your student is counseling a patient who has dementia. When you ask him to practice how he would counsel the patient, he looks puzzled and asks “What for? He has dementia and he won’t understand anyway.” How do you proceed?
                            A. Ask the student to find guidelines on how to determine when and how dementia patients should be counseled.
                            B. Tell him it was a trick question and that he is correct that dementia patients should never be counseled.
                            C. Explain pharmacists are legally required to offer counseling and he should be prepared if the patient requests it.
                            9. A preceptor and student are working in an ambulatory care clinic. A patient presents to the counter and says she has been experiencing terrible adverse effects from one of her medications. The patient places a bottle of sertraline on the counter. She believes this is the medication causing her persistent insomnia. After talking with the doctor, she has switched to taking it in the morning, but she claims it does not help. How should the preceptor advise the student to continue?
                            A. Advise the student to counsel the patient on ways to manage this adverse effect of sertraline. The student may consult the monograph or other recent guidelines.
                            B. Remind the student that persistent insomnia is a flag to contact the provider. The psychiatrist can handle this as it isn’t in the scope of the preceptor’s practice.
                            C. Advise the student to start by evaluating the patient’s past medical history and evaluating her medications before sending her back to see her doctor.
                            10. A general practitioner refers a patient with mild asthma to your clinic. He has recommended the patient to start SMART therapy and would like you to supply your recommendations through a SOAP note. Under your supervision, the student finishes collecting the necessary objective and subjective information and has begun a draft of the assessment as follows:
                            “The patient needs medication therapy for an untreated indication. According to the GINA guidelines, the patient should initiate a low dose inhaled corticosteroid plus a long-acting beta agonist combination in low doses as needed.”
                            Which of the following best describes the feedback the preceptor should give the student when applying the PPCP model?
                            A. The student has done a good job so far. However, the assessment should also consider patient concerns such as insurance coverage.
                            B. The student has done a good job so far. The student should provide specific doses and monitoring parameters for completeness.
                            C. The student has done a good job so far. The student should call the provider to check if they follow the GINA guidelines, and if not, why.

                            References

                            Full List of References

                            References

                               
                              REFERENCES
                              1. Joint Commission of Pharmacy Practitioners. Pharmacists’ Patient Care Process. Published May 29, 2014. Accessed June 21, 2023. https://jcpp.net/patient-care-process/
                              2. Cooley J, Lee J. Implementing the Pharmacists' Patient Care Process at a Public Pharmacy School. Am J Pharm Educ. 2018;82(2):6301. doi:10.5688/ajpe6301
                              3. Podder V, Lew V, Ghassemzadeh S. SOAP Notes. [Updated 2022 Aug 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 January. https://www.ncbi.nlm.nih.gov/books/NBK482263/
                              4. Takemura Y, Sakurai Y, Yokoya S, et al. Open-ended questions: are they really beneficial for gathering medical information from patients?. Tohoku J Exp Med. 2005;206(2):151-154. doi:10.1620/tjem.206.151
                              5. Taub S. Learning to Decide: Involving Children in their Health Care Decisions. Virtual Mentor. 2003;5(8): virtualmentor.2003.5.8. pfor3-0308. Published 2003 Aug 1. doi: 10.1001/virtualmentor.2003.5.8.pfor3-0308
                              6. Elnicki DM. Learning with emotion: which emotions and learning what?. Acad Med. 2010;85(7):1111. doi:10.1097/ACM.0b013e3181e20205
                              7. Fuqua JS. Treatment and outcomes of precocious puberty: an update. J Clin Endocrinol Metab. 2013;98(6):2198-2207. doi:10.1210/jc.2013-1024
                              8. Bangalore Krishna K, Fuqua JS, Rogol AD, et al. Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium. Horm Res Paediatr. 2019;91(6):357-372. doi:10.1159/000501336
                              9. Lexicomp. Wolters Kluwer Health, Inc. Updated June 20, 2023. Accessed June 21, 2023. https://online-lexi-com.ezproxy.lib.uconn.edu/lco/action/doc/retrieve/docid/pdh_f/129683?cesid=afdPrd0aazi&searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3Dleuprolide%26t%3Dname%26acs%3Dfalse%26acq%3Dleuprolide#rfs
                              10. Lexicomp. Wolters Kluwer Health, Inc. Updated June 6, 2023. Accessed June 21, 2023. https://online-lexi-com.ezproxy.lib.uconn.edu/lco/action/doc/retrieve/docid/pdh_f/128793?cesid=4Ds6TlNfgKm&searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3Dhistrelin%26t%3Dname%26acs%3Dfalse%26acq%3Dhistrelin
                              11. Supprelin LA (Histrelin) Subcutaneous Implant Procedure. Children’s Hospital of Philidelphia. Published May 4, 2021. Accessed June 21, 2023. https://www.chop.edu/treatments/supprelin-la-histrelin-subcutaneous-implant-procedure
                              12. Kaplowitz P, Hoffman, R. Precocious Puberty Medication. Medscape. Updated January 24, 2022. Accessed June 21, 2023. https://emedicine.medscape.com/article/924002-medication
                              13. Harris IM, Phillips B, Boyce E, et al. Clinical pharmacy should adopt a consistent process of direct patient care. Pharmacotherapy. 2014;34(8):e133-e148. doi:10.1002/phar.1459
                              14. Silverman LA, Han X, Huang H, Near AM, Hu Y. Clinical characteristics and treatment patterns with histrelin acetate subcutaneous implants vs. leuprolide injections in children with precocious puberty: a real-world study using a US claims database. J Pediatr Endocrinol Metab. 2021;34(8):961-969. Published 2021 Jun 21. doi:10.1515/jpem-2020-0721